Home The Word Brain Fast Track My Amedeo FAQ About Flying Publisher   

Fast Track

OLIENA
Language recovery after stroke
App | Video | PDF (278 pp) | Web

Free Abstracts

  Alzheimer's Disease

  Free Subscription


Articles published in J Alzheimers Dis

Retrieve available abstracts of 1032 articles:
HTML format
Text format



Single Articles


    January 2018
  1. REDDY PH, Manczak M, Yin X, Reddy AP, et al
    Synergistic Protective Effects of Mitochondrial Division Inhibitor 1 and Mitochondria-Targeted Small Peptide SS31 in Alzheimer's Disease.
    J Alzheimers Dis. 2018 Jan 30. pii: JAD170988. doi: 10.3233/JAD-170988.
    PubMed     Text format     Abstract available


  2. SCHARRE DW, Weichart E, Nielson D, Zhang J, et al
    Deep Brain Stimulation of Frontal Lobe Networks to Treat Alzheimer's Disease.
    J Alzheimers Dis. 2018 Jan 30. pii: JAD170082. doi: 10.3233/JAD-170082.
    PubMed     Text format     Abstract available


  3. GRASSI M, Perna G, Caldirola D, Schruers K, et al
    A Clinically-Translatable Machine Learning Algorithm for the Prediction of Alzheimer's Disease Conversion in Individuals with Mild and Premild Cognitive Impairment.
    J Alzheimers Dis. 2018 Jan 17. pii: JAD170547. doi: 10.3233/JAD-170547.
    PubMed     Text format     Abstract available


  4. ROBINSON M, Lee BY, Hanes FT
    Recent Progress in Alzheimer's Disease Research, Part 2: Genetics and Epidemiology.
    J Alzheimers Dis. 2018;61:459.
    PubMed     Text format    


  5. CHATTERJEE P, Roy D, Rathi N
    Epigenetic Drug Repositioning for Alzheimer's Disease Based on Epigenetic Targets in Human Interactome.
    J Alzheimers Dis. 2018;61:53-65.
    PubMed     Text format     Abstract available


  6. LAO PJ, Handen BL, Betthauser TJ, Mihaila I, et al
    Alzheimer-Like Pattern of Hypometabolism Emerges with Elevated Amyloid-beta Burden in Down Syndrome.
    J Alzheimers Dis. 2018;61:631-644.
    PubMed     Text format     Abstract available


  7. DODICH A, Cerami C, Cappa SF, Marcone A, et al
    Combined Socio-Behavioral Evaluation Improves the Differential Diagnosis Between the Behavioral Variant of Frontotemporal Dementia and Alzheimer's Disease: In Search of Neuropsychological Markers.
    J Alzheimers Dis. 2018;61:761-772.
    PubMed     Text format     Abstract available


  8. VALECH N, Tort-Merino A, Coll-Padros N, Olives J, et al
    Executive and Language Subjective Cognitive Decline Complaints Discriminate Preclinical Alzheimer's Disease from Normal Aging.
    J Alzheimers Dis. 2018;61:689-703.
    PubMed     Text format     Abstract available


  9. CHAI YL, Xing H, Chong JR, Francis PT, et al
    Mitochondrial Translocase of the Outer Membrane Alterations May Underlie Dysfunctional Oxidative Phosphorylation in Alzheimer's Disease.
    J Alzheimers Dis. 2018;61:793-801.
    PubMed     Text format     Abstract available


  10. SAKSIDA T, Koprivica I, Vujicic M, Stosic-Grujicic S, et al
    Impaired IL-17 Production in Gut-Residing Immune Cells of 5xFAD Mice with Alzheimer's Disease Pathology.
    J Alzheimers Dis. 2018;61:619-630.
    PubMed     Text format     Abstract available


  11. WHARTON W, Goldstein FC, Tansey MG, Brown AL, et al
    Rationale and Design of the Mechanistic Potential of Antihypertensives in Preclinical Alzheimer's (HEART) Trial.
    J Alzheimers Dis. 2018;61:815-824.
    PubMed     Text format     Abstract available


  12. JONVEAUX TR, Fescharek R
    When Art Meets Gardens: Does It Enhance the Benefits? The Nancy Hypothesis of Care for Persons with Alzheimer's Disease.
    J Alzheimers Dis. 2018;61:885-898.
    PubMed     Text format     Abstract available


  13. CHIZIANE E, Telemann H, Krueger M, Adler J, et al
    Free Heme and Amyloid-beta: A Fatal Liaison in Alzheimer's Disease.
    J Alzheimers Dis. 2018;61:963-984.
    PubMed     Text format     Abstract available


  14. TAKENOSHITA S, Terada S, Yokota O, Kutoku Y, et al
    Sally-Anne Test in Patients with Alzheimer's Disease Dementia.
    J Alzheimers Dis. 2018;61:1029-1036.
    PubMed     Text format     Abstract available


  15. FAN Y, Luo R, Su LY, Xiang Q, et al
    Does the Genetic Feature of the Chinese Tree Shrew (Tupaia belangeri chinensis) Support Its Potential as a Viable Model for Alzheimer's Disease Research?
    J Alzheimers Dis. 2018;61:1015-1028.
    PubMed     Text format     Abstract available


  16. ROZZINI L, Lanfranchi F, Pilotto A, Catalani S, et al
    Serum Non-Ceruloplasmin Non-Albumin Copper Elevation in Mild Cognitive Impairment and Dementia due to Alzheimer's Disease: A Case Control Study.
    J Alzheimers Dis. 2018;61:907-912.
    PubMed     Text format     Abstract available


  17. HEMACHANDRA REDDY P, Manczak M, Yin X, Grady MC, et al
    Protective Effects of Indian Spice Curcumin Against Amyloid-beta in Alzheimer's Disease.
    J Alzheimers Dis. 2018;61:843-866.
    PubMed     Text format     Abstract available


  18. LIU G, Zhang Y, Wang L, Xu J, et al
    Alzheimer's Disease rs11767557 Variant Regulates EPHA1 Gene Expression Specifically in Human Whole Blood.
    J Alzheimers Dis. 2018;61:1077-1088.
    PubMed     Text format     Abstract available


  19. SNIR JA, Suchy M, Bindseil GA, Kovacs M, et al
    An Aspartyl Cathepsin Targeted PET Agent: Application in an Alzheimer's Disease Mouse Model.
    J Alzheimers Dis. 2018;61:1241-1252.
    PubMed     Text format     Abstract available


  20. WANG H, Stewart T, Toledo JB, Ginghina C, et al
    A Longitudinal Study of Total and Phosphorylated alpha-Synuclein with Other Biomarkers in Cerebrospinal Fluid of Alzheimer's Disease and Mild Cognitive Impairment.
    J Alzheimers Dis. 2018;61:1541-1553.
    PubMed     Text format     Abstract available


  21. SERPENTE M, Fenoglio C, Cioffi SMG, Oldoni E, et al
    Profiling of Specific Gene Expression Pathways in Peripheral Cells from Prodromal Alzheimer's Disease Patients.
    J Alzheimers Dis. 2018;61:1289-1294.
    PubMed     Text format     Abstract available


  22. YANG CC, Chiu MJ, Chen TF, Chang HL, et al
    Assay of Plasma Phosphorylated Tau Protein (Threonine 181) and Total Tau Protein in Early-Stage Alzheimer's Disease.
    J Alzheimers Dis. 2018;61:1323-1332.
    PubMed     Text format     Abstract available


  23. SUZUKI A, Shinozaki J, Yazawa S, Ueki Y, et al
    Establishing a New Screening System for Mild Cognitive Impairment and Alzheimer's Disease with Mental Rotation Tasks that Evaluate Visuospatial Function.
    J Alzheimers Dis. 2018;61:1653-1665.
    PubMed     Text format     Abstract available


  24. PALEY EL, Merkulova-Rainon T, Faynboym A, Shestopalov VI, et al
    Geographical Distribution and Diversity of Gut Microbial NADH:Ubiquinone Oxidoreductase Sequence Associated with Alzheimer's Disease.
    J Alzheimers Dis. 2018;61:1531-1540.
    PubMed     Text format     Abstract available


  25. PORTACOLONE E, Johnson JK, Covinsky KE, Halpern J, et al
    The Effects and Meanings of Receiving a Diagnosis of Mild Cognitive Impairment or Alzheimer's Disease When One Lives Alone.
    J Alzheimers Dis. 2018;61:1517-1529.
    PubMed     Text format     Abstract available


  26. HALLIKAINEN I, Hongisto K, Valimaki T, Hanninen T, et al
    The Progression of Neuropsychiatric Symptoms in Alzheimer's Disease During a Five-Year Follow-Up: Kuopio ALSOVA Study.
    J Alzheimers Dis. 2018;61:1367-1376.
    PubMed     Text format     Abstract available


  27. CHE XQ, Zhao QH, Huang Y, Li X, et al
    Mutation Screening of the CHCHD2 Gene for Alzheimer's Disease and Frontotemporal Dementia in Chinese Mainland Population.
    J Alzheimers Dis. 2018;61:1283-1288.
    PubMed     Text format     Abstract available


  28. LU J, Shu R, Zhu Y
    Dysregulation and Dislocation of SFPQ Disturbed DNA Organization in Alzheimer's Disease and Frontotemporal Dementia.
    J Alzheimers Dis. 2018;61:1311-1321.
    PubMed     Text format     Abstract available


  29. PEDRINOLLA A, Venturelli M, Fonte C, Munari D, et al
    Exercise Training on Locomotion in Patients with Alzheimer's Disease: A Feasibility Study.
    J Alzheimers Dis. 2018;61:1599-1609.
    PubMed     Text format     Abstract available


  30. NAKAIZUMI K, Ouchi Y, Terada T, Yoshikawa E, et al
    In vivo Depiction of alpha7 Nicotinic Receptor Loss for Cognitive Decline in Alzheimer's Disease.
    J Alzheimers Dis. 2018;61:1355-1365.
    PubMed     Text format     Abstract available


  31. GOMEZ-TORTOSA E, Ruggiero M, Sainz MJ, Villarejo-Galende A, et al
    SORL1 Variants in Familial Alzheimer's Disease.
    J Alzheimers Dis. 2018;61:1275-1281.
    PubMed     Text format     Abstract available


  32. KIM J, Park S, Yoo H, Jang H, et al
    The Impact of APOE varepsilon4 in Alzheimer's Disease Differs According to Age.
    J Alzheimers Dis. 2018;61:1377-1385.
    PubMed     Text format     Abstract available


  33. TUCHOLKA A, Grau-Rivera O, Falcon C, Rami L, et al
    Structural Connectivity Alterations Along the Alzheimer's Disease Continuum: Reproducibility Across Two Independent Samples and Correlation with Cerebrospinal Fluid Amyloid-beta and Tau.
    J Alzheimers Dis. 2018;61:1575-1587.
    PubMed     Text format     Abstract available


  34. LIBARD S, Laurell K, Cesarini KG, Alafuzoff I, et al
    Progression of Alzheimer's Disease-Related Pathology and Cell Counts in a Patient with Idiopathic Normal Pressure Hydrocephalus.
    J Alzheimers Dis. 2018;61:1451-1462.
    PubMed     Text format     Abstract available


  35. GUREL B, Cansev M, Sevinc C, Kelestemur S, et al
    Early Stage Alterations in CA1 Extracellular Region Proteins Indicate Dysregulation of IL6 and Iron Homeostasis in the 5XFAD Alzheimer's Disease Mouse Model.
    J Alzheimers Dis. 2018;61:1399-1410.
    PubMed     Text format     Abstract available


  36. MAHADY L, Nadeem M, Malek-Ahmadi M, Chen K, et al
    Frontal Cortex Epigenetic Dysregulation During the Progression of Alzheimer's Disease.
    J Alzheimers Dis. 2018;62:115-131.
    PubMed     Text format     Abstract available


  37. REALE M, D'Angelo C, Costantini E, Di Nicola M, et al
    Expression Profiling of Cytokine, Cholinergic Markers, and Amyloid-beta Deposition in the APPSWE/PS1dE9 Mouse Model of Alzheimer's Disease Pathology.
    J Alzheimers Dis. 2018;62:467-476.
    PubMed     Text format     Abstract available


  38. ZHOU F, Chen S
    Effects of Gender and Other Confounding Factors on Leptin Concentrations in Alzheimer's Disease: Evidence from the Combined Analysis of 27 Case-Control Studies.
    J Alzheimers Dis. 2018;62:477-486.
    PubMed     Text format     Abstract available


  39. IHARA M, Washida K
    Linking Atrial Fibrillation with Alzheimer's Disease: Epidemiological, Pathological, and Mechanistic Evidence.
    J Alzheimers Dis. 2018;62:61-72.
    PubMed     Text format     Abstract available


  40. WEZYK M, Szybinska A, Wojsiat J, Szczerba M, et al
    Overactive BRCA1 Affects Presenilin 1 in Induced Pluripotent Stem Cell-Derived Neurons in Alzheimer's Disease.
    J Alzheimers Dis. 2018;62:175-202.
    PubMed     Text format     Abstract available


  41. XU L, Zhang W, Liu X, Zhang C, et al
    Circulatory Levels of Toxic Metals (Aluminum, Cadmium, Mercury, Lead) in Patients with Alzheimer's Disease: A Quantitative Meta-Analysis and Systematic Review.
    J Alzheimers Dis. 2018;62:361-372.
    PubMed     Text format     Abstract available


  42. VOGELGSANG J, Wedekind D, Bouter C, Klafki HW, et al
    Reproducibility of Alzheimer's Disease Cerebrospinal Fluid-Biomarker Measurements under Clinical Routine Conditions.
    J Alzheimers Dis. 2018;62:203-212.
    PubMed     Text format     Abstract available


  43. CORVOL A, Netter A, Campeon A, Somme D, et al
    Implementation of an Occupational Therapy Program for Alzheimer's Disease Patients in France: Patients' and Caregivers' Perspectives.
    J Alzheimers Dis. 2018;62:157-164.
    PubMed     Text format     Abstract available


  44. MULLAN K, Cardwell CR, McGuinness B, Woodside JV, et al
    Plasma Antioxidant Status in Patients with Alzheimer's Disease and Cognitively Intact Elderly: A Meta-Analysis of Case-Control Studies.
    J Alzheimers Dis. 2018;62:305-317.
    PubMed     Text format     Abstract available


  45. BABILONI C, Del Percio C, Lizio R, Noce G, et al
    Abnormalities of Resting State Cortical EEG Rhythms in Subjects with Mild Cognitive Impairment Due to Alzheimer's and Lewy Body Diseases.
    J Alzheimers Dis. 2018;62:247-268.
    PubMed     Text format     Abstract available


  46. BETTCHER BM, Johnson SC, Fitch R, Casaletto KB, et al
    Cerebrospinal Fluid and Plasma Levels of Inflammation Differentially Relate to CNS Markers of Alzheimer's Disease Pathology and Neuronal Damage.
    J Alzheimers Dis. 2018;62:385-397.
    PubMed     Text format     Abstract available


  47. HAAPALINNA F, Kokki M, Jaaskelainen O, Hallikainen M, et al
    Subtle Cognitive Impairment and Alzheimer's Disease-Type Pathological Changes in Cerebrospinal Fluid are Common Among Neurologically Healthy Subjects.
    J Alzheimers Dis. 2018;62:165-174.
    PubMed     Text format     Abstract available


  48. WATREMEZ W, Jackson J, Almari B, McLean SL, et al
    Stabilized Low-n Amyloid-beta Oligomers Induce Robust Novel Object Recognition Deficits Associated with Inflammatory, Synaptic, and GABAergic Dysfunction in the Rat.
    J Alzheimers Dis. 2018;62:213-226.
    PubMed     Text format     Abstract available


  49. SCHWEDA M, Kogel A, Bartels C, Wiltfang J, et al
    Prediction and Early Detection of Alzheimer's Dementia: Professional Disclosure Practices and Ethical Attitudes.
    J Alzheimers Dis. 2018;62:145-155.
    PubMed     Text format     Abstract available


  50. JESKO H, Lukiw WJ, Wilkaniec A, Cieslik M, et al
    Altered Expression of Urea Cycle Enzymes in Amyloid-beta Protein Precursor Overexpressing PC12 Cells and in Sporadic Alzheimer's Disease Brain.
    J Alzheimers Dis. 2018;62:279-291.
    PubMed     Text format     Abstract available


  51. MALPAS CB, Saling MM, Velakoulis D, Desmond P, et al
    Cerebrospinal Fluid Biomarkers are Differentially Related to Structural and Functional Changes in Dementia of the Alzheimer's Type.
    J Alzheimers Dis. 2018;62:417-427.
    PubMed     Text format     Abstract available


    December 2017
  52. RAHA-CHOWDHURY R, Henderson JW, Raha AA, Stott SRW, et al
    Erythromyeloid-Derived TREM2: A Major Determinant of Alzheimer's Disease Pathology in Down Syndrome.
    J Alzheimers Dis. 2017 Dec 16. pii: JAD170814. doi: 10.3233/JAD-170814.
    PubMed     Text format     Abstract available


  53. KONISHI K, Joober R, Poirier J, MacDonald K, et al
    Healthy versus Entorhinal Cortical Atrophy Identification in Asymptomatic APOE4 Carriers at Risk for Alzheimer's Disease.
    J Alzheimers Dis. 2017 Dec 16. pii: JAD170540. doi: 10.3233/JAD-170540.
    PubMed     Text format     Abstract available


  54. BOTCHWAY BOA, Moore MK, Akinleye FO, Iyer IC, et al
    Nutrition: Review on the Possible Treatment for Alzheimer's Disease.
    J Alzheimers Dis. 2017 Dec 15. pii: JAD170874. doi: 10.3233/JAD-170874.
    PubMed     Text format     Abstract available


  55. WANG SS, Jia J, Wang Z
    Mesenchymal Stem Cell-Derived Extracellular Vesicles Suppresses iNOS Expression and Ameliorates Neural Impairment in Alzheimer's Disease Mice.
    J Alzheimers Dis. 2017 Dec 15. pii: JAD170848. doi: 10.3233/JAD-170848.
    PubMed     Text format     Abstract available


  56. WEI EX, Oh ES, Harun A, Ehrenburg M, et al
    Vestibular Loss Predicts Poorer Spatial Cognition in Patients with Alzheimer's Disease.
    J Alzheimers Dis. 2017 Dec 15. pii: JAD170751. doi: 10.3233/JAD-170751.
    PubMed     Text format     Abstract available


  57. GABRIEL AJ, Almeida MR, Ribeiro MH, Carneiro D, et al
    Influence of Butyrylcholinesterase in Progression of Mild Cognitive Impairment to Alzheimer's Disease.
    J Alzheimers Dis. 2017 Dec 15. pii: JAD170695. doi: 10.3233/JAD-170695.
    PubMed     Text format     Abstract available


  58. ELDHOLM RS, Barca ML, Persson K, Knapskog AB, et al
    Progression of Alzheimer's Disease: A Longitudinal Study in Norwegian Memory Clinics.
    J Alzheimers Dis. 2017 Dec 15. pii: JAD170436. doi: 10.3233/JAD-170436.
    PubMed     Text format     Abstract available


  59. ATANASOVA B, Mondon K, Dreyfuss L, Beaufils E, et al
    Hedonic Assessment of Odors: A Comparison of Two Sensory Scales for Use with Alzheimer's Disease Patients and Elderly Individuals.
    J Alzheimers Dis. 2017 Dec 13. pii: JAD170433. doi: 10.3233/JAD-170433.
    PubMed     Text format     Abstract available


  60. LOVHEIM H, Olsson J, Weidung B, Johansson A, et al
    Interaction between Cytomegalovirus and Herpes Simplex Virus Type 1 Associated with the Risk of Alzheimer's Disease Development.
    J Alzheimers Dis. 2017 Dec 13. pii: JAD161305. doi: 10.3233/JAD-161305.
    PubMed     Text format     Abstract available


  61. DI MECO A, Li JG, Pratico D
    Dissecting the Role of 5-Lipoxygenase in the Homocysteine-Induced Alzheimer's Disease Pathology.
    J Alzheimers Dis. 2017 Dec 12. pii: JAD170700. doi: 10.3233/JAD-170700.
    PubMed     Text format     Abstract available


  62. WISCHIK CM, Schelter BO, Wischik DJ, Storey JMD, et al
    Modeling Prion-Like Processing of Tau Protein in Alzheimer's Disease for Pharmaceutical Development.
    J Alzheimers Dis. 2017 Dec 8. pii: JAD170727. doi: 10.3233/JAD-170727.
    PubMed     Text format     Abstract available


  63. FERRARI C, Lombardi G, Polito C, Lucidi G, et al
    Alzheimer's Disease Progression: Factors Influencing Cognitive Decline.
    J Alzheimers Dis. 2017 Dec 8. pii: JAD170665. doi: 10.3233/JAD-170665.
    PubMed     Text format     Abstract available


  64. EL HAJ M, Coello Y, Kapogiannis D, Gallouj K, et al
    Negative Prospective Memory in Alzheimer's Disease: "Do Not Perform That Action".
    J Alzheimers Dis. 2017 Dec 6. pii: JAD170807. doi: 10.3233/JAD-170807.
    PubMed     Text format     Abstract available


  65. HARRIS R, Miners JS, Allen S, Love S, et al
    VEGFR1 and VEGFR2 in Alzheimer's Disease.
    J Alzheimers Dis. 2017 Dec 6. pii: JAD170745. doi: 10.3233/JAD-170745.
    PubMed     Text format     Abstract available


  66. SINAI A, Mokrysz C, Bernal J, Bohnen I, et al
    Predictors of Age of Diagnosis and Survival of Alzheimer's Disease in Down Syndrome.
    J Alzheimers Dis. 2017 Dec 6. pii: JAD170624. doi: 10.3233/JAD-170624.
    PubMed     Text format     Abstract available


  67. KEHOE PG, Blair PS, Howden B, Thomas DL, et al
    The Rationale and Design of the Reducing Pathology in Alzheimer's Disease through Angiotensin TaRgeting (RADAR) Trial.
    J Alzheimers Dis. 2017 Dec 6. pii: JAD170101. doi: 10.3233/JAD-170101.
    PubMed     Text format     Abstract available


  68. TELL-MARTI G, Puig-Butille JA, Potrony M, Plana E, et al
    A Common Variant in the MC1R Gene (p.V92M) is associated with Alzheimer's Disease Risk.
    J Alzheimers Dis. 2017 Dec 3. doi: 10.3233/JAD-161113.
    PubMed     Text format     Abstract available


  69. TONNIES E, Trushina E
    Oxidative Stress, Synaptic Dysfunction, and Alzheimer's Disease.
    J Alzheimers Dis. 2017 Dec 3. doi: 10.3233/JAD-161088.
    PubMed     Text format     Abstract available


  70. SATHYA M, Moorthi P, Premkumar P, Kandasamy M, et al
    Resveratrol Intervenes in the Cholesterol- and Isoprenoid-Mediated Amyloidogenic Processing of AbetaPP in Familial Alzheimer's Disease.
    J Alzheimers Dis. 2017 Dec 3. doi: 10.3233/JAD-161034.
    PubMed     Text format     Abstract available


  71. WANG H, Hong X, Wang Y
    Mitochondrial Repair Effects of Oxygen Treatment on Alzheimer's Disease Model Mice Revealed by Quantitative Proteomics.
    J Alzheimers Dis. 2017 Dec 3. doi: 10.3233/JAD-161010.
    PubMed     Text format     Abstract available


  72. BASTIAN FO
    Combined Creutzfeldt-Jakob-Jacob/ Alzheimer's Disease Cases are Important in Search for Microbes in Alzheimer's Disease.
    J Alzheimers Dis. 2017 Dec 3. doi: 10.3233/JAD-160999.
    PubMed     Text format     Abstract available


  73. DASHINIMAEV EB, Artyuhov AS, Bolshakov AP, Vorotelyak EA, et al
    Neurons Derived from Induced Pluripotent Stem Cells of Patients with Down Syndrome Reproduce Early Stages of Alzheimer's Disease Type Pathology in vitro.
    J Alzheimers Dis. 2017 Dec 3. doi: 10.3233/JAD-160945.
    PubMed     Text format     Abstract available


  74. VAN WAALWIJK VAN DOORN LJ, Gispert JD, Kuiperij HB, Claassen JA, et al
    Improved Cerebrospinal Fluid-Based Discrimination between Alzheimer's Disease Patients and Controls after Correction for Ventricular Volumes.
    J Alzheimers Dis. 2017 Dec 3. doi: 10.3233/JAD-160668.
    PubMed     Text format     Abstract available


  75. SHEA TB
    While I Still Remember: 30 Years of Alzheimer's Disease Research.
    J Alzheimers Dis. 2017 Dec 2. pii: JAD170724. doi: 10.3233/JAD-170724.
    PubMed     Text format     Abstract available


  76. TSOU HH, Hsu WC, Fuh JL, Chen SP, et al
    Alterations in Acrolein Metabolism Contribute to Alzheimer's Disease.
    J Alzheimers Dis. 2017 Dec 1. pii: JAD170736. doi: 10.3233/JAD-170736.
    PubMed     Text format     Abstract available


  77. SLACHEVSKY A, Barraza P, Hornberger M, Munoz-Neira C, et al
    Neuroanatomical Comparison of the "Word" and "Picture" Versions of the Free and Cued Selective Reminding Test in Alzheimer's Disease.
    J Alzheimers Dis. 2017 Dec 1. pii: JAD160973. doi: 10.3233/JAD-160973.
    PubMed     Text format     Abstract available


    November 2017
  78. THANGAVEL R, Bhagavan SM, Ramaswamy SB, Surpur S, et al
    Co-Expression of Glia Maturation Factor and Apolipoprotein E4 in Alzheimer's Disease Brain.
    J Alzheimers Dis. 2017 Nov 20. pii: JAD170777. doi: 10.3233/JAD-170777.
    PubMed     Text format     Abstract available


  79. DI FEDE G, Giaccone G, Salmona M, Tagliavini F, et al
    Translational Research in Alzheimer's and Prion Diseases.
    J Alzheimers Dis. 2017 Nov 20. pii: JAD170770. doi: 10.3233/JAD-170770.
    PubMed     Text format     Abstract available


  80. PEREIRA CD, Martins F, Wiltfang J, da Cruz E Silva OAB, et al
    ABC Transporters Are Key Players in Alzheimer's Disease.
    J Alzheimers Dis. 2017 Nov 20. pii: JAD170639. doi: 10.3233/JAD-170639.
    PubMed     Text format     Abstract available


  81. ROE CM, Babulal GM, Mishra S, Gordon BA, et al
    Tau and Amyloid Positron Emission Tomography Imaging Predict Driving Performance Among Older Adults with and without Preclinical Alzheimer's Disease.
    J Alzheimers Dis. 2017 Nov 20. pii: JAD170521. doi: 10.3233/JAD-170521.
    PubMed     Text format     Abstract available


  82. KIMURA A, Yoshikura N, Hayashi Y, Inuzuka T, et al
    Cerebrospinal Fluid C-C Motif Chemokine Ligand 2 Correlates with Brain Atrophy and Cognitive Impairment in Alzheimer's Disease.
    J Alzheimers Dis. 2017 Nov 20. pii: JAD170519. doi: 10.3233/JAD-170519.
    PubMed     Text format     Abstract available


  83. DOECKE JD, Rembach A, Villemagne VL, Varghese S, et al
    Concordance Between Cerebrospinal Fluid Biomarkers with Alzheimer's Disease Pathology Between Three Independent Assay Platforms.
    J Alzheimers Dis. 2017 Nov 20. pii: JAD170128. doi: 10.3233/JAD-170128.
    PubMed     Text format     Abstract available


  84. CUBERAS-BORROS G, Roca I, Boada M, Tarraga L, et al
    Longitudinal Neuroimaging Analysis in Mild-Moderate Alzheimer's Disease Patients Treated with Plasma Exchange with 5% Human Albumin.
    J Alzheimers Dis. 2017 Nov 17. doi: 10.3233/JAD-170693.
    PubMed     Text format     Abstract available


  85. WILCOCK GK, Gauthier S, Frisoni GB, Jia J, et al
    Potential of Low Dose Leuco-Methylthioninium Bis(Hydromethanesulphonate) (LMTM) Monotherapy for Treatment of Mild Alzheimer's Disease: Cohort Analysis as Modified Primary Outcome in a Phase III Clinical Trial.
    J Alzheimers Dis. 2017 Nov 17. doi: 10.3233/JAD-170560.
    PubMed     Text format     Abstract available


  86. FREDERIKSEN KS, Gjerum L, Waldemar G, Hasselbalch SG, et al
    Effects of Physical Exercise on Alzheimer's Disease Biomarkers: A Systematic Review of Intervention Studies.
    J Alzheimers Dis. 2017 Nov 16. doi: 10.3233/JAD-170567.
    PubMed     Text format     Abstract available


  87. SEDDIGHI S, Varma VR, An Y, Varma S, et al
    SPARCL1 Accelerates Symptom Onset in Alzheimer's Disease and Influences Brain Structure and Function During Aging.
    J Alzheimers Dis. 2017 Nov 16. doi: 10.3233/JAD-170557.
    PubMed     Text format     Abstract available


  88. GEIJSELAERS SLC, Aalten P, Ramakers IHGB, De Deyn PP, et al
    Association of Cerebrospinal Fluid (CSF) Insulin with Cognitive Performance and CSF Biomarkers of Alzheimer's Disease.
    J Alzheimers Dis. 2017 Nov 16. doi: 10.3233/JAD-170522.
    PubMed     Text format     Abstract available


  89. MUTHUKUMARAN K, Kanwar A, Vegh C, Marginean A, et al
    Ubisol-Q10 (a Nanomicellar Water- Soluble Formulation of CoQ10) Treatment Inhibits Alzheimer-Type Behavioral and Pathological Symptoms in a Double Transgenic Mouse (TgAPEswe, PSEN1dE9) Model of Alzheimer's Disease.
    J Alzheimers Dis. 2017 Nov 16. doi: 10.3233/JAD-170275.
    PubMed     Text format     Abstract available


  90. DOS SANTOS JPA, Vizuete A, Hansen F, Biasibetti R, et al
    Early and Persistent O-GlcNAc Protein Modification in the Streptozotocin Model of Alzheimer's Disease.
    J Alzheimers Dis. 2017 Nov 16. doi: 10.3233/JAD-170211.
    PubMed     Text format     Abstract available


  91. LANGE C, Suppa P, Pietrzyk U, Makowski MR, et al
    Prediction of Alzheimer's Dementia in Patients with Amnestic Mild Cognitive Impairment in Clinical Routine: Incremental Value of Biomarkers of Neurodegeneration and Brain Amyloidosis Added Stepwise to Cognitive Status.
    J Alzheimers Dis. 2017 Nov 14. doi: 10.3233/JAD-170705.
    PubMed     Text format     Abstract available


  92. HASEGAWA Y, Toyama K, Uekawa K, Ichijo H, et al
    Role of ASK1/p38 Cascade in a Mouse Model of Alzheimer's Disease and Brain Aging.
    J Alzheimers Dis. 2017 Nov 14. doi: 10.3233/JAD-170645.
    PubMed     Text format     Abstract available


  93. HUBER CM, Yee C, May T, Dhanala A, et al
    Cognitive Decline in Preclinical Alzheimer's Disease: Amyloid-Beta versus Tauopathy.
    J Alzheimers Dis. 2017 Nov 14. doi: 10.3233/JAD-170490.
    PubMed     Text format     Abstract available


  94. GELMAN S, Palma J, Tombaugh G, Ghavami A, et al
    Differences in Synaptic Dysfunction Between rTg4510 and APP/PS1 Mouse Models of Alzheimer's Disease.
    J Alzheimers Dis. 2017 Nov 14. doi: 10.3233/JAD-170457.
    PubMed     Text format     Abstract available


  95. FAXEN-IRVING G, Falahati F, Basun H, Eriksdotter M, et al
    Does Fatty Acid Composition in Subcutaneous Adipose Tissue Differ between Patients with Alzheimer's Disease and Cohabiting Proxies?
    J Alzheimers Dis. 2017 Nov 14. doi: 10.3233/JAD-170359.
    PubMed     Text format     Abstract available


  96. KIRSON NY, Andrews JS, Desai U, King SB, et al
    Patient Characteristics and Outcomes Associated with Receiving an Earlier Versus Later Diagnosis of Probable Alzheimer's Disease.
    J Alzheimers Dis. 2017 Nov 14. doi: 10.3233/JAD-170078.
    PubMed     Text format     Abstract available


  97. MATIAS-GUIU JA, Cabrera-Martin MN, Curiel RE, Valles-Salgado M, et al
    Comparison between FCSRT and LASSI-L to Detect Early Stage Alzheimer's Disease.
    J Alzheimers Dis. 2017 Nov 8. doi: 10.3233/JAD-170604.
    PubMed     Text format     Abstract available


  98. VILLAMIL-ORTIZ JG, Barrera-Ocampo A, Arias-Londono JD, Villegas A, et al
    Differential Pattern of Phospholipid Profile in the Temporal Cortex from E280A-Familiar and Sporadic Alzheimer's Disease Brains.
    J Alzheimers Dis. 2017 Nov 8. doi: 10.3233/JAD-170554.
    PubMed     Text format     Abstract available


  99. GLEASON CE, Norton D, Anderson ED, Wahoske M, et al
    Cognitive Variability Predicts Incident Alzheimer's Disease and Mild Cognitive Impairment Comparable to a Cerebrospinal Fluid Biomarker.
    J Alzheimers Dis. 2017 Nov 8. doi: 10.3233/JAD-170498.
    PubMed     Text format     Abstract available


  100. MEDORO A, Bartollino S, Mignogna D, Passarella D, et al
    Complexity and Selectivity of gamma-Secretase Cleavage on Multiple Substrates: Consequences in Alzheimer's Disease and Cancer.
    J Alzheimers Dis. 2017 Nov 1. doi: 10.3233/JAD-170628.
    PubMed     Text format     Abstract available


  101. NACMIAS B, Bagnoli S, Piaceri I, Sorbi S, et al
    Genetic Heterogeneity of Alzheimer's Disease: Embracing Research Partnerships.
    J Alzheimers Dis. 2017 Nov 1. doi: 10.3233/JAD-170570.
    PubMed     Text format     Abstract available


    October 2017
  102. FAJARDO VA, Fajardo VA, LeBlanc PJ, MacPherson REK, et al
    Examining the Relationship between Trace Lithium in Drinking Water and the Rising Rates of Age-Adjusted Alzheimer's Disease Mortality in Texas.
    J Alzheimers Dis. 2017 Oct 30. doi: 10.3233/JAD-170744.
    PubMed     Text format     Abstract available


  103. MCGEER PL, Guo JP, Lee M, Kennedy K, et al
    Alzheimer's Disease Can Be Spared by Nonsteroidal Anti-Inflammatory Drugs.
    J Alzheimers Dis. 2017 Oct 30. doi: 10.3233/JAD-170706.
    PubMed     Text format     Abstract available


  104. TAMAGNO E, Guglielmotto M, Monteleone D, Manassero G, et al
    The Unexpected Role of Abeta1-42 Monomers in the Pathogenesis of Alzheimer's Disease.
    J Alzheimers Dis. 2017 Oct 30. doi: 10.3233/JAD-170581.
    PubMed     Text format     Abstract available


  105. BLACK CM, Fillit H, Xie L, Hu X, et al
    Economic Burden, Mortality, and Institutionalization in Patients Newly Diagnosed with Alzheimer's Disease.
    J Alzheimers Dis. 2017 Oct 30. doi: 10.3233/JAD-170518.
    PubMed     Text format     Abstract available


  106. DEVANAND DP, Lentz C, Chunga RE, Ciarleglio A, et al
    Change in Odor Identification Impairment is Associated with Improvement with Cholinesterase Inhibitor Treatment in Mild Cognitive Impairment.
    J Alzheimers Dis. 2017 Oct 21. doi: 10.3233/JAD-170497.
    PubMed     Text format     Abstract available


  107. HANDELS RLH, Wimo A, Dodel R, Kramberger MG, et al
    Cost-Utility of Using Alzheimer's Disease Biomarkers in Cerebrospinal Fluid to Predict Progression from Mild Cognitive Impairment to Dementia.
    J Alzheimers Dis. 2017 Oct 21. doi: 10.3233/JAD-170324.
    PubMed     Text format     Abstract available


  108. VAN DUIJN S, Bulk M, van Duinen SG, Nabuurs RJA, et al
    Cortical Iron Reflects Severity of Alzheimer's Disease.
    J Alzheimers Dis. 2017 Oct 21. doi: 10.3233/JAD-161143.
    PubMed     Text format     Abstract available


  109. SEJUNAITE K, Lanza C, Riepe MW
    Everyday Memory in Patients with Alzheimer's Disease: Fragmentary and Distorted.
    J Alzheimers Dis. 2017 Oct 16. doi: 10.3233/JAD-170493.
    PubMed     Text format     Abstract available


  110. HARES K, Miners JS, Cook AJ, Rice C, et al
    Overexpression of Kinesin Superfamily Motor Proteins in Alzheimer's Disease.
    J Alzheimers Dis. 2017 Oct 16. doi: 10.3233/JAD-170094.
    PubMed     Text format     Abstract available


  111. DUMURGIER J, Hanseeuw BJ, Hatling FB, Judge KA, et al
    Alzheimer's Disease Biomarkers and Future Decline in Cognitive Normal Older Adults.
    J Alzheimers Dis. 2017 Oct 12. doi: 10.3233/JAD-170511.
    PubMed     Text format     Abstract available


  112. GUO R, Fan G, Zhang J, Wu C, et al
    A 9-microRNA Signature in Serum Serves as a Noninvasive Biomarker in Early Diagnosis of Alzheimer's Disease.
    J Alzheimers Dis. 2017 Oct 12. doi: 10.3233/JAD-170343.
    PubMed     Text format     Abstract available


  113. SUNDARAM JR, Poore CP, Sulaimee NHB, Pareek T, et al
    Curcumin Ameliorates Neuroinflammation, Neurodegeneration, and Memory Deficits in p25 Transgenic Mouse Model that Bears Hallmarks of Alzheimer's Disease.
    J Alzheimers Dis. 2017 Oct 12. doi: 10.3233/JAD-170093.
    PubMed     Text format     Abstract available


  114. PATERSON EN, Williams MA, Passmore P, Silvestri G, et al
    Estimated Glomerular Filtration Rate is not Associated with Alzheimer's Disease in a Northern Ireland Cohort.
    J Alzheimers Dis. 2017 Oct 11. doi: 10.3233/JAD-170480.
    PubMed     Text format     Abstract available


  115. JOSHI A, Jimenez E, Mendez MF
    Initial Heart Rate Reactivity to Socioemotional Pictures in Early-Onset Alzheimer's Disease.
    J Alzheimers Dis. 2017 Oct 11. doi: 10.3233/JAD-170319.
    PubMed     Text format     Abstract available


  116. REIJS BLR, Vos SJB, Soininen H, Lotjonen J, et al
    Association Between Later Life Lifestyle Factors and Alzheimer's Disease Biomarkers in Non-Demented Individuals: A Longitudinal Descriptive Cohort Study.
    J Alzheimers Dis. 2017 Oct 11. doi: 10.3233/JAD-170039.
    PubMed     Text format     Abstract available


  117. MANZINE PR, Pelucchi S, Horst MA, Vale FAC, et al
    microRNA 221 Targets ADAM10 mRNA and is Downregulated in Alzheimer's Disease.
    J Alzheimers Dis. 2017 Oct 7. doi: 10.3233/JAD-170592.
    PubMed     Text format     Abstract available


  118. SWERDLOW RH
    Mitochondria and Mitochondrial Cascades in Alzheimer's Disease.
    J Alzheimers Dis. 2017 Oct 7. doi: 10.3233/JAD-170585.
    PubMed     Text format     Abstract available


  119. BRUNO D
    The Emergence of a New Conceptual Framework for Alzheimer's Disease.
    J Alzheimers Dis. 2017 Oct 7. doi: 10.3233/JAD-170536.
    PubMed     Text format     Abstract available


  120. ZHANG L, Wang Y, Xiayu X, Shi C, et al
    Altered Gut Microbiota in a Mouse Model of Alzheimer's Disease.
    J Alzheimers Dis. 2017 Oct 7. doi: 10.3233/JAD-170020.
    PubMed     Text format     Abstract available


  121. SHENG M, Lu H, Liu P, Li Y, et al
    Sildenafil Improves Vascular and Metabolic Function in Patients with Alzheimer's Disease.
    J Alzheimers Dis. 2017 Oct 7. doi: 10.3233/JAD-161006.
    PubMed     Text format     Abstract available


  122. TUWAIG M, Savard M, Jutras B, Poirier J, et al
    Deficit in Central Auditory Processing as a Biomarker of Pre-Clinical Alzheimer's Disease.
    J Alzheimers Dis. 2017 Oct 3. doi: 10.3233/JAD-170545.
    PubMed     Text format     Abstract available


  123. KIRSEBOM BE, Espenes R, Waterloo K, Hessen E, et al
    Screening for Alzheimer's Disease: Cognitive Impairment in Self-Referred and Memory Clinic-Referred Patients.
    J Alzheimers Dis. 2017 Oct 3. doi: 10.3233/JAD-170385.
    PubMed     Text format     Abstract available


    September 2017
  124. COWAN RL, Beach PA, Atalla SW, Dietrich MS, et al
    Sex Differences in the Psychophysical Response to Contact Heat in Moderate Cognitive Impairment Alzheimer's Disease: A Cross-Sectional Brief Report.
    J Alzheimers Dis. 2017 Sep 29. doi: 10.3233/JAD-170532.
    PubMed     Text format     Abstract available


  125. WARAGAI M, Moriya M, Nojo T
    Decreased N-Acetyl Aspartate/Myo-Inositol Ratio in the Posterior Cingulate Cortex Shown by Magnetic Resonance Spectroscopy May Be One of the Risk Markers of Preclinical Alzheimer's Disease: A 7-Year Follow-Up Study.
    J Alzheimers Dis. 2017 Sep 29. doi: 10.3233/JAD-170450.
    PubMed     Text format     Abstract available


  126. MCLIMANS KE, Webb JL, Anantharam V, Kanthasamy A, et al
    Peripheral versus Central Index of Metabolic Dysfunction and Associations with Clinical and Pathological Outcomes in Alzheimer's Disease.
    J Alzheimers Dis. 2017 Sep 29. doi: 10.3233/JAD-170263.
    PubMed     Text format     Abstract available


  127. DIFRANCESCO JC, Tremolizzo L, Polonia V, Giussani G, et al
    Adult-Onset Epilepsy in Presymptomatic Alzheimer's Disease: A Retrospective Study.
    J Alzheimers Dis. 2017 Sep 28. doi: 10.3233/JAD-170392.
    PubMed     Text format     Abstract available


  128. BLONZ ER
    Alzheimer's Disease as the Product of a Progressive Energy Deficiency Syndrome in the Central Nervous System: The Neuroenergetic Hypothesis.
    J Alzheimers Dis. 2017 Sep 19. doi: 10.3233/JAD-170549.
    PubMed     Text format     Abstract available


  129. MARTINEZ MARTINEZ P, Mielke M
    Sphingolipids in Alzheimer's Disease and Related Disorders.
    J Alzheimers Dis. 2017 Sep 11. doi: 10.3233/JAD-170735.
    PubMed     Text format    


  130. KISHI T, Matsunaga S, Oya K, Nomura I, et al
    Memantine for Alzheimer's Disease: An Updated Systematic Review and Meta-analysis.
    J Alzheimers Dis. 2017 Sep 11. doi: 10.3233/JAD-170424.
    PubMed     Text format     Abstract available


  131. INUI Y, Ito K, Kato T
    Longer-Term Investigation of the Value of 18F-FDG-PET and Magnetic Resonance Imaging for Predicting the Conversion of Mild Cognitive Impairment to Alzheimer's Disease: A Multicenter Study.
    J Alzheimers Dis. 2017 Sep 11. doi: 10.3233/JAD-170395.
    PubMed     Text format     Abstract available


  132. KARKI R, Tom Kodamullil A, Hofmann-Apitius M
    Comorbidity Analysis between Alzheimer's Disease and Type 2 Diabetes Mellitus (T2DM) Based on Shared Pathways and the Role of T2DM Drugs.
    J Alzheimers Dis. 2017 Sep 8. doi: 10.3233/JAD-170440.
    PubMed     Text format     Abstract available


  133. PONGAN E, Tillmann B, Leveque Y, Trombert B, et al
    Can Musical or Painting Interventions Improve Chronic Pain, Mood, Quality of Life, and Cognition in Patients with Mild Alzheimer's Disease? Evidence from a Randomized Controlled Trial.
    J Alzheimers Dis. 2017 Sep 8. doi: 10.3233/JAD-170410.
    PubMed     Text format     Abstract available


  134. KUTTNER-HIRSHLER Y, Venkatasubramanian PN, Apolinario J, Bonds J, et al
    Brain Biomarkers in Familial Alzheimer's Disease Mouse Models.
    J Alzheimers Dis. 2017 Sep 8. doi: 10.3233/JAD-170269.
    PubMed     Text format     Abstract available


  135. ZHANG L, Sun C, Jin Y, Gao K, et al
    Dickkopf 3 (Dkk3) Improves Amyloid-beta Pathology, Cognitive Dysfunction, and Cerebral Glucose Metabolism in a Transgenic Mouse Model of Alzheimer's Disease.
    J Alzheimers Dis. 2017 Sep 8. doi: 10.3233/JAD-161254.
    PubMed     Text format     Abstract available


  136. WEISSBERGER GH, Melrose RJ, Fanale CM, Veliz JV, et al
    Cortical Metabolic and Cognitive Correlates of Disorientation in Alzheimer's Disease.
    J Alzheimers Dis. 2017 Sep 1. doi: 10.3233/JAD-170420.
    PubMed     Text format     Abstract available


  137. AMORIM JA, Canas PM, Tome AR, Rolo AP, et al
    Mitochondria in Excitatory and Inhibitory Synapses have Similar Susceptibility to Amyloid-beta Peptides Modeling Alzheimer's Disease.
    J Alzheimers Dis. 2017 Sep 1. doi: 10.3233/JAD-170356.
    PubMed     Text format     Abstract available


  138. NIEMANTSVERDRIET E, Ottoy J, Somers C, De Roeck E, et al
    The Cerebrospinal Fluid Abeta1-42/Abeta1-40 Ratio Improves Concordance with Amyloid-PET for Diagnosing Alzheimer's Disease in a Clinical Setting.
    J Alzheimers Dis. 2017 Sep 1. doi: 10.3233/JAD-170327.
    PubMed     Text format     Abstract available


  139. POULIN SP, Bergeron D, Dickerson BC
    Risk Factors, Neuroanatomical Correlates, and Outcome of Neuropsychiatric Symptoms of Alzheimer's Disease.
    J Alzheimers Dis. 2017 Sep 1. doi: 10.3233/JAD-160767.
    PubMed     Text format     Abstract available


    August 2017
  140. LEVY NOGUEIRA M, Samri D, Epelbaum S, Lista S, et al
    Alzheimer's Disease Diagnosis Relies on a Twofold Clinical-Biological Algorithm: Three Memory Clinic Case Reports.
    J Alzheimers Dis. 2017 Aug 30. doi: 10.3233/JAD-170574.
    PubMed     Text format     Abstract available


  141. LARSSON SC, Traylor M, Burgess S, Markus HS, et al
    Genetically-Predicted Adult Height an Alzheimer's Disease.
    J Alzheimers Dis. 2017 Aug 30. doi: 10.3233/JAD-170528.
    PubMed     Text format     Abstract available


  142. GIIL LM, Midttun O, Refsum H, Ulvik A, et al
    Kynurenine Pathway Metabolites in Alzheimer's Disease.
    J Alzheimers Dis. 2017 Aug 30. doi: 10.3233/JAD-170485.
    PubMed     Text format     Abstract available


  143. PORTBURY SD, Hare DJ, Sgambelloni C, Perronnes K, et al
    Trehalose Improves Cognition in the Transgenic Tg2576 Mouse Model of Alzheimer's Disease.
    J Alzheimers Dis. 2017 Aug 30. doi: 10.3233/JAD-170322.
    PubMed     Text format     Abstract available


  144. WILLEN K, Sroka A, Takahashi RH, Gouras GK, et al
    Heterogeneous Association of Alzheimer's Disease-Linked Amyloid-beta and Amyloid-beta Protein Precursor with Synapses.
    J Alzheimers Dis. 2017 Aug 30. doi: 10.3233/JAD-170262.
    PubMed     Text format     Abstract available


  145. MORALES I, Cerda-Troncoso C, Andrade V, Maccioni RB, et al
    The Natural Product Curcumin as a Potential Coadjuvant in Alzheimer's Treatment.
    J Alzheimers Dis. 2017 Aug 21. doi: 10.3233/JAD-170354.
    PubMed     Text format     Abstract available


  146. BASSELERIE H, Bracoud L, Zeestraten E, Bouguen E, et al
    Incident Cerebral Microbleeds on Longitudinal 3T MRI with Susceptibility Weight-Imaging Help to Identify Patients with Mild Cognitive Impairment Progressing to Alzheimer's Disease.
    J Alzheimers Dis. 2017 Aug 17. doi: 10.3233/JAD-170470.
    PubMed     Text format     Abstract available


  147. PAOURI E, Tzara O, Zenelak S, Georgopoulos S, et al
    Genetic Deletion of Tumor Necrosis Factor-alpha Attenuates Amyloid-beta Production and Decreases Amyloid Plaque Formation and Glial Response in the 5XFAD Model of Alzheimer's Disease.
    J Alzheimers Dis. 2017 Aug 17. doi: 10.3233/JAD-170065.
    PubMed     Text format     Abstract available


  148. BEAGLE AJ, Darwish SM, Ranasinghe KG, La AL, et al
    Relative Incidence of Seizures and Myoclonus in Alzheimer's Disease, Dementia with Lewy Bodies, and Frontotemporal Dementia.
    J Alzheimers Dis. 2017 Aug 17. doi: 10.3233/JAD-170031.
    PubMed     Text format     Abstract available


  149. GERSTENECKER A, Hoagey DA, Marson DC, Kennedy KM, et al
    White Matter Degradation is Associated with Reduced Financial Capacity in Mild Cognitive Impairment and Alzheimer's Disease.
    J Alzheimers Dis. 2017 Aug 16. doi: 10.3233/JAD-170341.
    PubMed     Text format     Abstract available


  150. OIKONOMIDI A, Tautvydaite D, Gholamrezaee MM, Henry H, et al
    Macrophage Migration Inhibitory Factor is Associated with Biomarkers of Alzheimer's Disease Pathology and Predicts Cognitive Decline in Mild Cognitive Impairment and Mild Dementia.
    J Alzheimers Dis. 2017 Aug 16. doi: 10.3233/JAD-170335.
    PubMed     Text format     Abstract available


  151. SUGIMOTO T, Nakamura A, Kato T, Iwata K, et al
    Decreased Glucose Metabolism in Medial Prefrontal Areas is Associated with Nutritional Status in Patients with Prodromal and Early Alzheimer's Disease.
    J Alzheimers Dis. 2017 Aug 16. doi: 10.3233/JAD-170257.
    PubMed     Text format     Abstract available


  152. FLADBY T, Palhaugen L, Selnes P, Waterloo K, et al
    Detecting At-Risk Alzheimer's Disease Cases.
    J Alzheimers Dis. 2017 Aug 16. doi: 10.3233/JAD-170231.
    PubMed     Text format     Abstract available


  153. SANTANGELO R, Cecchetti G, Bernasconi MP, Cardamone R, et al
    Cerebrospinal Fluid Amyloid-beta 42, Total Tau, and Phosphorylated Tau are Low in Patients with Normal Pressure Hydrocephalus: Analogies and Differences with Alzheimer's Disease.
    J Alzheimers Dis. 2017 Aug 16. doi: 10.3233/JAD-170186.
    PubMed     Text format     Abstract available


  154. CHUNG JK, Plitman E, Nakajima S, Caravaggio F, et al
    The Effects of Cortical Hypometabolism and Hippocampal Atrophy on Clinical Trajectories in Mild Cognitive Impairment with Suspected Non-Alzheimer's Pathology: A Brief Report.
    J Alzheimers Dis. 2017 Aug 16. doi: 10.3233/JAD-170098.
    PubMed     Text format     Abstract available


  155. NAGATA T, Nakajima S, Shinagawa S, Plitman E, et al
    Baseline Predictors of Antipsychotic Treatment Continuation and Response at Week 8 in Patients with Alzheimer's Disease with Psychosis or Aggressive Symptoms: An Analysis of the CATIE-AD Study.
    J Alzheimers Dis. 2017 Aug 9. doi: 10.3233/JAD-170412.
    PubMed     Text format     Abstract available


  156. THIBEAU S, McFall GP, Camicioli R, Dixon RA, et al
    Alzheimer's Disease Biomarkers Interactively Influence Physical Activity, Mobility, and Cognition Associations in a Non-Demented Aging Population.
    J Alzheimers Dis. 2017 Aug 8. doi: 10.3233/JAD-170130.
    PubMed     Text format     Abstract available


  157. KOYCHEV I, Gunn RN, Firouzian A, Lawson J, et al
    PET Tau and Amyloid-beta Burden in Mild Alzheimer's Disease: Divergent Relationship with Age, Cognition, and Cerebrospinal Fluid Biomarkers.
    J Alzheimers Dis. 2017 Aug 8. doi: 10.3233/JAD-170129.
    PubMed     Text format     Abstract available


  158. KAWALIA SB, Raschka T, Naz M, de Matos Simoes R, et al
    Analytical Strategy to Prioritize Alzheimer's Disease Candidate Genes in Gene Regulatory Networks Using Public Expression Data.
    J Alzheimers Dis. 2017 Aug 8. doi: 10.3233/JAD-170011.
    PubMed     Text format     Abstract available


  159. BEHESHTI I, Maikusa N, Daneshmand M, Matsuda H, et al
    Classification of Alzheimer's Disease and Prediction of Mild Cognitive Impairment Conversion Using Histogram-Based Analysis of Patient-Specific Anatomical Brain Connectivity Networks.
    J Alzheimers Dis. 2017 Aug 8. doi: 10.3233/JAD-161080.
    PubMed     Text format     Abstract available


    July 2017
  160. ADAMS SL, Benayoun L, Tilton K, Chavez OR, et al
    Methionine Sulfoxide Reductase-B3 (MsrB3) Protein Associates with Synaptic Vesicles and its Expression Changes in the Hippocampi of Alzheimer's Disease Patients.
    J Alzheimers Dis. 2017 Jul 29. doi: 10.3233/JAD-170459.
    PubMed     Text format     Abstract available


  161. ZHANG N, Zhang L, Li Y, Gordon ML, et al
    Urine AD7c-NTP Predicts Amyloid Deposition and Symptom of Agitation in Patients with Alzheimer's Disease and Mild Cognitive Impairment.
    J Alzheimers Dis. 2017 Jul 29. doi: 10.3233/JAD-170383.
    PubMed     Text format     Abstract available


  162. LE PAGE A, Lamoureux J, Bourgade K, Frost EH, et al
    Polymorphonuclear Neutrophil Functions are Differentially Altered in Amnestic Mild Cognitive Impairment and Mild Alzheimer's Disease Patients.
    J Alzheimers Dis. 2017 Jul 29. doi: 10.3233/JAD-170124.
    PubMed     Text format     Abstract available


  163. CAVEDO E, Suppa P, Lange C, Opfer R, et al
    Fully Automatic MRI-Based Hippocampus Volumetry Using FSL-FIRST: Intra-Scanner Test-Retest Stability, Inter-Field Strength Variability, and Performance as Enrichment Biomarker for Clinical Trials Using Prodromal Target Populations at Risk for Alzheime
    J Alzheimers Dis. 2017 Jul 29. doi: 10.3233/JAD-161108.
    PubMed     Text format     Abstract available


  164. EVGEN'EV MB, Krasnov GS, Nesterova IV, Garbuz DG, et al
    Molecular Mechanisms Underlying Neuroprotective Effect of Intranasal Administration of Human Hsp70 in Mouse Model of Alzheimer's Disease.
    J Alzheimers Dis. 2017 Jul 25. doi: 10.3233/JAD-170398.
    PubMed     Text format     Abstract available


  165. RADAKOVIC R, Starr JM, Abrahams S
    A Novel Assessment and Profiling of Multidimensional Apathy in Alzheimer's Disease.
    J Alzheimers Dis. 2017 Jul 25. doi: 10.3233/JAD-170292.
    PubMed     Text format     Abstract available


  166. LAWRENCE E, Vegvari C, Ower A, Hadjichrysanthou C, et al
    A Systematic Review of Longitudinal Studies Which Measure Alzheimer's Disease Biomarkers.
    J Alzheimers Dis. 2017 Jul 25. doi: 10.3233/JAD-170261.
    PubMed     Text format     Abstract available


  167. HAJIPOUR MJ, Ghasemi F, Aghaverdi H, Raoufi M, et al
    Sensing of Alzheimer's Disease and Multiple Sclerosis Using Nano-Bio Interfaces.
    J Alzheimers Dis. 2017 Jul 25. doi: 10.3233/JAD-160206.
    PubMed     Text format     Abstract available


  168. DEFRANCESCO M, Marksteiner J, Kemmler G, Fleischhacker WW, et al
    Severity of Depression Impacts Imminent Conversion from Mild Cognitive Impairment to Alzheimer's Disease.
    J Alzheimers Dis. 2017 Jul 19. doi: 10.3233/JAD-161135.
    PubMed     Text format     Abstract available


  169. BILGEL M, Koscik RL, An Y, Prince JL, et al
    Temporal Order of Alzheimer's Disease-Related Cognitive Marker Changes in BLSA and WRAP Longitudinal Studies.
    J Alzheimers Dis. 2017 Jul 18. doi: 10.3233/JAD-170448.
    PubMed     Text format     Abstract available


  170. SHI Y, Gu L, Alsharif AA, Zhang Z, et al
    The Distinction of Amyloid-beta Protein Precursor (AbetaPP) Ratio in Platelet Between Alzheimer's Disease Patients and Controls: A Systematic Review and Meta-Analysis.
    J Alzheimers Dis. 2017 Jul 18. doi: 10.3233/JAD-170253.
    PubMed     Text format     Abstract available


  171. DE BELDER M, Santens P, Sieben A, Fias W, et al
    Impaired Processing of Serial Order Determines Working Memory Impairments in Alzheimer's Disease.
    J Alzheimers Dis. 2017 Jul 17. doi: 10.3233/JAD-170193.
    PubMed     Text format     Abstract available


  172. HONG H, Li Y, Su B
    Identification of Circulating miR-125b as a Potential Biomarker of Alzheimer's Disease in APP/PS1 Transgenic Mouse.
    J Alzheimers Dis. 2017 Jul 17. doi: 10.3233/JAD-170156.
    PubMed     Text format     Abstract available


  173. ZHANG Y, Wang S, Sui Y, Yang M, et al
    Multivariate Approach for Alzheimer's Disease Detection Using Stationary Wavelet Entropy and Predator-Prey Particle Swarm Optimization.
    J Alzheimers Dis. 2017 Jul 17. doi: 10.3233/JAD-170069.
    PubMed     Text format     Abstract available


  174. SOLFRIZZI V, Custodero C, Lozupone M, Imbimbo BP, et al
    Relationships of Dietary Patterns, Foods, and Micro- and Macronutrients with Alzheimer's Disease and Late-Life Cognitive Disorders: A Systematic Review.
    J Alzheimers Dis. 2017 Jul 5. doi: 10.3233/JAD-170248.
    PubMed     Text format     Abstract available


  175. JOHANSSON P, Almqvist EG, Bjerke M, Wallin A, et al
    Reduced Cerebrospinal Fluid Concentration of Apolipoprotein A-I in Patients with Alzheimer's Disease.
    J Alzheimers Dis. 2017 Jul 5. doi: 10.3233/JAD-170226.
    PubMed     Text format     Abstract available


  176. BUSSE C, Anselmi P, Pompanin S, Zorzi G, et al
    Specific Verbal Memory Measures May Distinguish Alzheimer's Disease from Dementia with Lewy Bodies.
    J Alzheimers Dis. 2017 Jul 5. doi: 10.3233/JAD-170154.
    PubMed     Text format     Abstract available


  177. ESQUERDA-CANALS G, Marti-Clua J, Roda AR, Villegas S, et al
    An Intracellular Amyloid-beta/AbetaPP Epitope Correlates with Neurodegeneration in those Neuronal Populations Early Involved in Alzheimer's Disease.
    J Alzheimers Dis. 2017 Jul 4. doi: 10.3233/JAD-170218.
    PubMed     Text format     Abstract available


  178. SANTOS CY, Machan JT, Wu WC, Snyder PJ, et al
    Autonomic Cardiac Function in Preclinical Alzheimer's Disease.
    J Alzheimers Dis. 2017 Jul 4. doi: 10.3233/JAD-170217.
    PubMed     Text format     Abstract available


  179. GIIL LM, Vedeler CA, Kristoffersen EK, Nordrehaug JE, et al
    Antibodies to Signaling Molecules and Receptors in Alzheimer's Disease are Associated with Psychomotor Slowing, Depression, and Poor Visuospatial Function.
    J Alzheimers Dis. 2017 Jul 1. doi: 10.3233/JAD-170245.
    PubMed     Text format     Abstract available


  180. MUSZYNSKI P, Kulczynska-Przybik A, Borawska R, Litman-Zawadzka A, et al
    The Relationship between Markers of Inflammation and Degeneration in the Central Nervous System and the Blood-Brain Barrier Impairment in Alzheimer's Disease.
    J Alzheimers Dis. 2017 Jul 1. doi: 10.3233/JAD-170220.
    PubMed     Text format     Abstract available


  181. DYRBA M, Grothe MJ, Mohammadi A, Binder H, et al
    Comparison of Different Hypotheses Regarding the Spread of Alzheimer's Disease Using Markov Random Fields and Multimodal Imaging.
    J Alzheimers Dis. 2017 Jul 1. doi: 10.3233/JAD-161197.
    PubMed     Text format     Abstract available


  182. TU S, Spiers HJ, Hodges JR, Piguet O, et al
    Egocentric versus Allocentric Spatial Memory in Behavioral Variant Frontotemporal Dementia and Alzheimer's Disease.
    J Alzheimers Dis. 2017 Jul 1. doi: 10.3233/JAD-160592.
    PubMed     Text format     Abstract available


    June 2017
  183. VALERO J, Bernardino L, Cardoso F, Silva AP, et al
    Impact of Neuroinflammation on Hippocampal Neurogenesis: Relevance to Aging and Alzheimer's Disease.
    J Alzheimers Dis. 2017 Jun 28. doi: 10.3233/JAD-170239.
    PubMed     Text format     Abstract available


  184. SERRANO-POZO A, Aldridge GM, Zhang Q
    Four Decades of Research in Alzheimer's Disease (1975-2014): A Bibliometric and Scientometric Analysis.
    J Alzheimers Dis. 2017 Jun 27. doi: 10.3233/JAD-170184.
    PubMed     Text format     Abstract available


  185. CACCIAMANI F, Tandetnik C, Gagliardi G, Bertin H, et al
    Low Cognitive Awareness, but Not Complaint, is a Good Marker of Preclinical Alzheimer's Disease.
    J Alzheimers Dis. 2017 Jun 26. doi: 10.3233/JAD-170399.
    PubMed     Text format     Abstract available


  186. ZAFAR S, Shafiq M, Younas N, Schmitz M, et al
    Prion Protein Interactome: Identifying Novel Targets in Slowly and Rapidly Progressive Forms of Alzheimer's Disease.
    J Alzheimers Dis. 2017 Jun 26. doi: 10.3233/JAD-170237.
    PubMed     Text format     Abstract available


  187. MICHALSKI D, Hofmann S, Pitsch R, Grosche J, et al
    Neurovascular Specifications in the Alzheimer-Like Brain of Mice Affected by Focal Cerebral Ischemia: Implications for Future Therapies.
    J Alzheimers Dis. 2017 Jun 26. doi: 10.3233/JAD-170185.
    PubMed     Text format     Abstract available


  188. VASAVADA MM, Martinez B, Wang J, Eslinger PJ, et al
    Central Olfactory Dysfunction in Alzheimer's Disease and Mild Cognitive Impairment: A Functional MRI Study.
    J Alzheimers Dis. 2017 Jun 24. doi: 10.3233/JAD-170310.
    PubMed     Text format     Abstract available


  189. IACCARINO L, Chiotis K, Alongi P, Almkvist O, et al
    A Cross-Validation of FDG- and Amyloid-PET Biomarkers in Mild Cognitive Impairment for the Risk Prediction to Dementia due to Alzheimer's Disease in a Clinical Setting.
    J Alzheimers Dis. 2017 Jun 24. doi: 10.3233/JAD-170158.
    PubMed     Text format     Abstract available


  190. BAGATTINI C, Mazza V, Panizza L, Ferrari C, et al
    Neural Dynamics of Multiple Object Processing in Mild Cognitive Impairment and Alzheimer's Disease: Future Early Diagnostic Biomarkers?
    J Alzheimers Dis. 2017 Jun 24. doi: 10.3233/JAD-161274.
    PubMed     Text format     Abstract available


  191. BELLANTI F, Iannelli G, Blonda M, Tamborra R, et al
    Alterations of Clock Gene RNA Expression in Brain Regions of a Triple Transgenic Model of Alzheimer's Disease.
    J Alzheimers Dis. 2017 Jun 24. doi: 10.3233/JAD-160942.
    PubMed     Text format     Abstract available


  192. VASQUEZ JB, Simpson JF, Harpole R, Estus S, et al
    Alzheimer's Disease Genetics and ABCA7 Splicing.
    J Alzheimers Dis. 2017 Jun 22. doi: 10.3233/JAD-170872.
    PubMed     Text format     Abstract available


  193. STOCCORO A, Siciliano G, Migliore L, Coppede F, et al
    Decreased Methylation of the Mitochondrial D-Loop Region in Late-Onset Alzheimer's Disease.
    J Alzheimers Dis. 2017 Jun 22. doi: 10.3233/JAD-170139.
    PubMed     Text format     Abstract available


  194. PADALA KP, Padala PR, Lensing SY, Dennis RA, et al
    Home-Based Exercise Program Improves Balance and Fear of Falling in Community-Dwelling Older Adults with Mild Alzheimer's Disease: A Pilot Study.
    J Alzheimers Dis. 2017 Jun 22. doi: 10.3233/JAD-170120.
    PubMed     Text format     Abstract available


  195. ASIH PR, Tegg ML, Sohrabi H, Carruthers M, et al
    Multiple Mechanisms Linking Type 2 Diabetes and Alzheimer's Disease: Testosterone as a Modifier.
    J Alzheimers Dis. 2017 Jun 22. doi: 10.3233/JAD-161259.
    PubMed     Text format     Abstract available


  196. TRIPODIS Y, Alosco ML, Zirogiannis N, Gavett BE, et al
    The Effect of Traumatic Brain Injury History with Loss of Consciousness on Rate of Cognitive Decline Among Older Adults with Normal Cognition and Alzheimer's Disease Dementia.
    J Alzheimers Dis. 2017 Jun 22. doi: 10.3233/JAD-160585.
    PubMed     Text format     Abstract available


  197. LEHRER S, Rheinstein PH, Rosenzweig KE
    Association of Radon Background and Total Background Ionizing Radiation with Alzheimer's Disease Deaths in U.S. States.
    J Alzheimers Dis. 2017 Jun 22. doi: 10.3233/JAD-170308.
    PubMed     Text format     Abstract available


  198. XIE F, Peng F
    Radiopharmaceuticals for Assessment of Altered Metabolism and Biometal Fluxes in Brain Aging and Alzheimer's Disease with Positron Emission Tomography.
    J Alzheimers Dis. 2017 Jun 22. doi: 10.3233/JAD-170280.
    PubMed     Text format     Abstract available


  199. BABILONI C, Del Percio C, Lizio R, Noce G, et al
    Abnormalities of Cortical Neural Synchronization Mechanisms in Subjects with Mild Cognitive Impairment due to Alzheimer's and Parkinson's Diseases: An EEG Study.
    J Alzheimers Dis. 2017 Jun 10. doi: 10.3233/JAD-160883.
    PubMed     Text format     Abstract available


  200. CANSEV M, Turkyilmaz M, Sijben JWC, Sevinc C, et al
    Synaptic Membrane Synthesis in Rats Depends on Dietary Sufficiency of Vitamin C, Vitamin E, and Selenium: Relevance for Alzheimer's Disease.
    J Alzheimers Dis. 2017 Jun 9. doi: 10.3233/JAD-170081.
    PubMed     Text format     Abstract available


  201. ANAND S, Barnes JM, Young SA, Garcia DM, et al
    Discovery and Confirmation of Diagnostic Serum Lipid Biomarkers for Alzheimer's Disease Using Direct Infusion Mass Spectrometry.
    J Alzheimers Dis. 2017 Jun 9. doi: 10.3233/JAD-170035.
    PubMed     Text format     Abstract available


  202. ADEGOKE OO, Qiao F, Liu Y, Longley K, et al
    Overexpression of Ubiquilin-1 Alleviates Alzheimer's Disease-Caused Cognitive and Motor Deficits and Reduces Amyloid-beta Accumulation in Mice.
    J Alzheimers Dis. 2017 Jun 8. doi: 10.3233/JAD-170173.
    PubMed     Text format     Abstract available


  203. WILKINS HM, Mahnken JD, Welch P, Bothwell R, et al
    A Mitochondrial Biomarker-Based Study of S-Equol in Alzheimer's Disease Subjects: Results of a Single-Arm, Pilot Trial.
    J Alzheimers Dis. 2017 Jun 7. doi: 10.3233/JAD-170077.
    PubMed     Text format     Abstract available


  204. NAGAI M, Dote K, Kato M, Sasaki S, et al
    Visit-to-Visit Blood Pressure Variability and Alzheimer's Disease: Links and Risks.
    J Alzheimers Dis. 2017 Jun 7. doi: 10.3233/JAD-161172.
    PubMed     Text format     Abstract available


  205. YU Q, Du F, Douglas JT, Yu H, et al
    Mitochondrial Dysfunction Triggers Synaptic Deficits via Activation of p38 MAP Kinase Signaling in Differentiated Alzheimer's Disease Trans-Mitochondrial Cybrid Cells.
    J Alzheimers Dis. 2017 Jun 6. doi: 10.3233/JAD-170283.
    PubMed     Text format     Abstract available


  206. GONZALEZ-MACIEL A, Reynoso-Robles R, Torres-Jardon R, Mukherjee PS, et al
    Combustion-Derived Nanoparticles in Key Brain Target Cells and Organelles in Young Urbanites: Culprit Hidden in Plain Sight in Alzheimer's Disease Development.
    J Alzheimers Dis. 2017 Jun 3. doi: 10.3233/JAD-170012.
    PubMed     Text format     Abstract available


  207. DILLEN KNH, Jacobs HIL, Kukolja J, Richter N, et al
    Functional Disintegration of the Default Mode Network in Prodromal Alzheimer's Disease.
    J Alzheimers Dis. 2017 Jun 3. doi: 10.3233/JAD-161120.
    PubMed     Text format     Abstract available


  208. ANDREADOU E, Pantazaki AA, Daniilidou M, Tsolaki M, et al
    Rhamnolipids, Microbial Virulence Factors, in Alzheimer's Disease.
    J Alzheimers Dis. 2017 Jun 3. doi: 10.3233/JAD-161020.
    PubMed     Text format     Abstract available


    May 2017
  209. FERGUSON SA, Panos JJ, Sloper D, Varma V, et al
    Neurodegenerative Markers are Increased in Postmortem BA21 Tissue from African Americans with Alzheimer's Disease.
    J Alzheimers Dis. 2017 May 30. doi: 10.3233/JAD-170204.
    PubMed     Text format     Abstract available


  210. LUPTON MK, Benyamin B, Proitsi P, Nyholt DR, et al
    No Genetic Overlap Between Circulating Iron Levels and Alzheimer's Disease.
    J Alzheimers Dis. 2017 May 30. doi: 10.3233/JAD-170027.
    PubMed     Text format     Abstract available


  211. LIN FV, Wang X, Wu R, Rebok GW, et al
    Identification of Successful Cognitive Aging in the Alzheimer's Disease Neuroimaging Initiative Study.
    J Alzheimers Dis. 2017 May 30. doi: 10.3233/JAD-161278.
    PubMed     Text format     Abstract available


  212. BINOSHA FWMAD, Somaratne G, Williams S, Goozee KG, et al
    Diabetes and Alzheimer's Disease: Can Tea Phytochemicals Play a Role in Prevention?
    J Alzheimers Dis. 2017 May 30. doi: 10.3233/JAD-161200.
    PubMed     Text format     Abstract available


  213. SHAW ME, Abhayaratna WP, Anstey KJ, Cherbuin N, et al
    Increasing Body Mass Index at Midlife is Associated with Increased Cortical Thinning in Alzheimer's Disease-Vulnerable Regions.
    J Alzheimers Dis. 2017 May 26. doi: 10.3233/JAD-170055.
    PubMed     Text format     Abstract available


  214. NAVE S, Doody RS, Boada M, Grimmer T, et al
    Sembragiline in Moderate Alzheimer's Disease: Results of a Randomized, Double-Blind, Placebo-Controlled Phase II Trial (MAyflOwer RoAD).
    J Alzheimers Dis. 2017 May 26. doi: 10.3233/JAD-161309.
    PubMed     Text format     Abstract available


  215. OCHOA JF, Alonso JF, Duque JE, Tobon CA, et al
    Precuneus Failures in Subjects of the PSEN1 E280A Family at Risk of Developing Alzheimer's Disease Detected Using Quantitative Electroencephalography.
    J Alzheimers Dis. 2017 May 26. doi: 10.3233/JAD-161291.
    PubMed     Text format     Abstract available


  216. MACEDO AC, Balouch S, Tabet N
    Is Sleep Disruption a Risk Factor for Alzheimer's Disease?
    J Alzheimers Dis. 2017 May 26. doi: 10.3233/JAD-161287.
    PubMed     Text format     Abstract available


  217. MORRIS K J, Uy RAZ, Vidoni ED, Wilkins HM, et al
    Effect of APOE epsilon4 Genotype on Metabolic Biomarkers in Aging and Alzheimer's Disease.
    J Alzheimers Dis. 2017 May 25. doi: 10.3233/JAD-170148.
    PubMed     Text format     Abstract available


  218. CERMAKOVA P, Nelson M, Secnik J, Garcia-Ptacek S, et al
    Living Alone with Alzheimer's Disease: Data from SveDem, the Swedish Dementia Registry.
    J Alzheimers Dis. 2017 May 25. doi: 10.3233/JAD-170102.
    PubMed     Text format     Abstract available


  219. TRIPATHI AK, Karmakar S, Asthana A, Ashok A, et al
    Transport of Non-Transferrin Bound Iron to the Brain: Implications for Alzheimer's Disease.
    J Alzheimers Dis. 2017 May 25. doi: 10.3233/JAD-170097.
    PubMed     Text format     Abstract available


  220. PINNER E, Gruper Y, Ben Zimra M, Kristt D, et al
    CD44 Splice Variants as Potential Players in Alzheimer's Disease Pathology.
    J Alzheimers Dis. 2017 May 25. doi: 10.3233/JAD-161245.
    PubMed     Text format     Abstract available


  221. LIU CY, Ohki Y, Tomita T, Osawa S, et al
    Two Novel Mutations in the First Transmembrane Domain of Presenilin1 Cause Young-Onset Alzheimer's Disease.
    J Alzheimers Dis. 2017 May 25. doi: 10.3233/JAD-161203.
    PubMed     Text format     Abstract available


  222. DETERS KD, Risacher SL, Kim S, Nho K, et al
    Plasma Tau Association with Brain Atrophy in Mild Cognitive Impairment and Alzheimer's Disease.
    J Alzheimers Dis. 2017 May 25. doi: 10.3233/JAD-161114.
    PubMed     Text format     Abstract available


  223. NAKAMURA N, Ohyagi Y, Imamura T, Yanagihara YT, et al
    Apomorphine Therapy for Neuronal Insulin Resistance in a Mouse Model of Alzheimer's Disease.
    J Alzheimers Dis. 2017 May 25. doi: 10.3233/JAD-160344.
    PubMed     Text format     Abstract available


  224. SIEDLAK SL, Jiang Y, Huntley ML, Wang L, et al
    TMEM230 Accumulation in Granulovacuolar Degeneration Bodies and Dystrophic Neurites of Alzheimer's Disease.
    J Alzheimers Dis. 2017 May 17. doi: 10.3233/JAD-170190.
    PubMed     Text format     Abstract available


  225. TANG M, Taghibiglou C
    The Mechanisms of Action of Curcumin in Alzheimer's Disease.
    J Alzheimers Dis. 2017 May 17. doi: 10.3233/JAD-170188.
    PubMed     Text format     Abstract available


  226. OLIVEIRA J, Costa M, de Almeida MSC, da Cruz E Silva OAB, et al
    Protein Phosphorylation is a Key Mechanism in Alzheimer's Disease.
    J Alzheimers Dis. 2017 May 17. doi: 10.3233/JAD-170176.
    PubMed     Text format     Abstract available


  227. LIU G, Sun JY, Xu M, Yang XY, et al
    SORL1 Variants Show Different Association with Early-Onset and Late-Onset Alzheimer's Disease Risk.
    J Alzheimers Dis. 2017 May 17. doi: 10.3233/JAD-170005.
    PubMed     Text format     Abstract available


  228. CALDERON-GARCIDUENAS L, de la Monte SM
    Apolipoprotein E4, Gender, Body Mass Index, Inflammation, Insulin Resistance, and Air Pollution Interactions: Recipe for Alzheimer's Disease Development in Mexico City Young Females.
    J Alzheimers Dis. 2017 May 17. doi: 10.3233/JAD-161299.
    PubMed     Text format     Abstract available


  229. VEGA IE, Cabrera LY, Wygant CM, Velez-Ortiz D, et al
    Alzheimer's Disease in the Latino Community: Intersection of Genetics and Social Determinants of Health.
    J Alzheimers Dis. 2017 May 17. doi: 10.3233/JAD-161261.
    PubMed     Text format     Abstract available


  230. DOUGHERTY RJ, Schultz SA, Kirby TK, Boots EA, et al
    Moderate Physical Activity is Associated with Cerebral Glucose Metabolism in Adults at Risk for Alzheimer's Disease.
    J Alzheimers Dis. 2017 May 17. doi: 10.3233/JAD-161067.
    PubMed     Text format     Abstract available


  231. MUSAEUS CS, Shafi MM, Santarnecchi E, Herman ST, et al
    Levetiracetam Alters Oscillatory Connectivity in Alzheimer's Disease.
    J Alzheimers Dis. 2017 May 17. doi: 10.3233/JAD-160742.
    PubMed     Text format     Abstract available


  232. SALA I, Illan-Gala I, Alcolea D, Sanchez-Saudinos MB, et al
    Diagnostic and Prognostic Value of the Combination of Two Measures of Verbal Memory in Mild Cognitive Impairment due to Alzheimer's Disease.
    J Alzheimers Dis. 2017 May 13. doi: 10.3233/JAD-170073.
    PubMed     Text format     Abstract available


  233. SUN H
    Associations of Spatial Disparities of Alzheimer's Disease Mortality Rates and Soil Selenium, Sulfur Concentrations, and Risk Factors in the United States.
    J Alzheimers Dis. 2017 May 13. doi: 10.3233/JAD-170059.
    PubMed     Text format     Abstract available


  234. BEN JEMAA S, Attia Romdhane N, Bahri-Mrabet A, Jendli A, et al
    An Arabic Version of the Cognitive Subscale of the Alzheimer's Disease Assessment Scale (ADAS-Cog): Reliability, Validity, and Normative Data.
    J Alzheimers Dis. 2017 May 11. doi: 10.3233/JAD-170222.
    PubMed     Text format     Abstract available


  235. JIN WS, Bu XL, Wang YR, Li L, et al
    Reduced Cardiovascular Functions in Patients with Alzheimer's Disease.
    J Alzheimers Dis. 2017 May 11. doi: 10.3233/JAD-170088.
    PubMed     Text format     Abstract available


  236. ZHU JB, Tan CC, Tan L, Yu JT, et al
    State of Play in Alzheimer's Disease Genetics.
    J Alzheimers Dis. 2017 May 11. doi: 10.3233/JAD-170062.
    PubMed     Text format     Abstract available


  237. CHUNG JK, Plitman E, Nakajima S, Caravaggio F, et al
    Hippocampal and Clinical Trajectories of Mild Cognitive Impairment with Suspected Non-Alzheimer's Disease Pathology.
    J Alzheimers Dis. 2017 May 8. doi: 10.3233/JAD-170201.
    PubMed     Text format     Abstract available


  238. SNOW WM, Dale R, O'Brien-Moran Z, Buist R, et al
    In Vivo Detection of Gray Matter Neuropathology in the 3xTg Mouse Model of Alzheimer's Disease with Diffusion Tensor Imaging.
    J Alzheimers Dis. 2017 May 8. doi: 10.3233/JAD-170136.
    PubMed     Text format     Abstract available


  239. EDSBAGGE M, Andreasson U, Ambarki K, Wikkelso C, et al
    Alzheimer's Disease-Associated Cerebrospinal Fluid (CSF) Biomarkers do not Correlate with CSF Volumes or CSF Production Rate.
    J Alzheimers Dis. 2017 May 8. doi: 10.3233/JAD-161257.
    PubMed     Text format     Abstract available


  240. ORGETA V, Tabet N, Nilforooshan R, Howard R, et al
    Efficacy of Antidepressants for Depression in Alzheimer's Disease: Systematic Review and Meta-Analysis.
    J Alzheimers Dis. 2017 May 8. doi: 10.3233/JAD-161247.
    PubMed     Text format     Abstract available


  241. TORT-MERINO A, Valech N, Penaloza C, Gronholm-Nyman P, et al
    Early Detection of Learning Difficulties when Confronted with Novel Information in Preclinical Alzheimer's Disease Stage 1.
    J Alzheimers Dis. 2017 May 8. doi: 10.3233/JAD-161173.
    PubMed     Text format     Abstract available


  242. MANOCHA GD, Ghatak A, Puig KL, Kraner SD, et al
    NFATc2 Modulates Microglial Activation in the AbetaPP/PS1 Mouse Model of Alzheimer's Disease.
    J Alzheimers Dis. 2017 May 8. doi: 10.3233/JAD-151203.
    PubMed     Text format     Abstract available


  243. NELSON TJ, Sun MK, Lim C, Sen A, et al
    Bryostatin Effects on Cognitive Function and PKCvarepsilon in Alzheimer's Disease Phase IIa and Expanded Access Trials.
    J Alzheimers Dis. 2017 May 2. doi: 10.3233/JAD-170161.
    PubMed     Text format     Abstract available


  244. PASQUINI L, Benson G, Grothe MJ, Utz L, et al
    Individual Correspondence of Amyloid-beta and Intrinsic Connectivity in the Posterior Default Mode Network Across Stages of Alzheimer's Disease.
    J Alzheimers Dis. 2017 May 2. doi: 10.3233/JAD-170096.
    PubMed     Text format     Abstract available


  245. YOSHINO Y, Yamazaki K, Ozaki Y, Sao T, et al
    INPP5D mRNA Expression and Cognitive Decline in Japanese Alzheimer's Disease Subjects.
    J Alzheimers Dis. 2017 May 2. doi: 10.3233/JAD-161211.
    PubMed     Text format     Abstract available


    April 2017
  246. MACDONALD IR, Maxwell SP, Reid GA, Cash MK, et al
    Quantification of Butyrylcholinesterase Activity as a Sensitive and Specific Biomarker of Alzheimer's Disease.
    J Alzheimers Dis. 2017 Apr 28. doi: 10.3233/JAD-170164.
    PubMed     Text format     Abstract available


  247. LACOSTA AM, Insua D, Badi H, Pesini P, et al
    Neurofibrillary Tangles of Abetax-40 in Alzheimer's Disease Brains.
    J Alzheimers Dis. 2017 Apr 28. doi: 10.3233/JAD-170163.
    PubMed     Text format     Abstract available


  248. BABULAL GM, Stout SH, Head D, Holtzman DM, et al
    Neuropsychiatric Symptoms and Alzheimer's Disease Biomarkers Predict Driving Decline: Brief Report.
    J Alzheimers Dis. 2017 Apr 28. doi: 10.3233/JAD-170067.
    PubMed     Text format     Abstract available


  249. KOLAROVA M, Sengupta U, Bartos A, Ricny J, et al
    Tau Oligomers in Sera of Patients with Alzheimer's Disease and Aged Controls.
    J Alzheimers Dis. 2017 Apr 28. doi: 10.3233/JAD-170048.
    PubMed     Text format     Abstract available


  250. SUN J, Zhou H, Bai F, Zhang Z, et al
    Remyelination: A Potential Therapeutic Strategy for Alzheimer's Disease?
    J Alzheimers Dis. 2017 Apr 28. doi: 10.3233/JAD-170036.
    PubMed     Text format     Abstract available


  251. SEGAL-GAVISH H, Danino O, Barhum Y, Ben-Zur T, et al
    A Multifunctional Biocompatible Drug Candidate is Highly Effective in Delaying Pathological Signs of Alzheimer's Disease in 5XFAD Mice.
    J Alzheimers Dis. 2017 Apr 28. doi: 10.3233/JAD-161236.
    PubMed     Text format     Abstract available


  252. MALEK-AHMADI M, Lu S, Chan Y, Perez SE, et al
    Cognitive Domain Dispersion Association with Alzheimer's Disease Pathology.
    J Alzheimers Dis. 2017 Apr 28. doi: 10.3233/JAD-161233.
    PubMed     Text format     Abstract available


  253. SADIQ D, Whitfield T, Lee L, Stevens T, et al
    Prodromal Dementia with Lewy Bodies and Prodromal Alzheimer's Disease: A Comparison of the Cognitive and Clinical Profiles.
    J Alzheimers Dis. 2017 Apr 28. doi: 10.3233/JAD-161089.
    PubMed     Text format     Abstract available


  254. SEPEHRY AA, Lee PE, Hsiung GR, Beattie BL, et al
    The 2002 NIMH Provisional Diagnostic Criteria for Depression of Alzheimer's Disease (PDC-dAD): Gauging their Validity over a Decade Later.
    J Alzheimers Dis. 2017 Apr 28. doi: 10.3233/JAD-161061.
    PubMed     Text format     Abstract available


  255. YAMAZAKI C, Tamaoki T, Nunomura A, Tamai K, et al
    Plasma Amyloid-beta and Alzheimer's Disease-Related Changes in Late-Life Depression.
    J Alzheimers Dis. 2017 Apr 25. doi: 10.3233/JAD-170111.
    PubMed     Text format     Abstract available


  256. LAKEY-BEITIA J, Gonzalez Y, Doens D, Stephens DE, et al
    Assessment of Novel Curcumin Derivatives as Potent Inhibitors of Inflammation and Amyloid-beta Aggregation in Alzheimer's Disease.
    J Alzheimers Dis. 2017 Apr 25. doi: 10.3233/JAD-170071.
    PubMed     Text format     Abstract available


  257. HARDING A, Robinson S, Crean SJ, Singhrao SK, et al
    Can Better Management of Periodontal Disease Delay the Onset and Progression of Alzheimer's Disease?
    J Alzheimers Dis. 2017 Apr 25. doi: 10.3233/JAD-170046.
    PubMed     Text format     Abstract available


  258. TAN YJ, Ng ASL, Vipin A, Lim JKW, et al
    Higher Peripheral TREM2 mRNA Levels Relate to Cognitive Deficits and Hippocampal Atrophy in Alzheimer's Disease and Amnestic Mild Cognitive Impairment.
    J Alzheimers Dis. 2017 Apr 25. doi: 10.3233/JAD-161277.
    PubMed     Text format     Abstract available


  259. YILMAZ A, Geddes T, Han B, Bahado-Singh RO, et al
    Diagnostic Biomarkers of Alzheimer's Disease as Identified in Saliva using 1H NMR-Based Metabolomics.
    J Alzheimers Dis. 2017 Apr 25. doi: 10.3233/JAD-161226.
    PubMed     Text format     Abstract available


  260. LI K, Chan W, Doody RS, Quinn J, et al
    Prediction of Conversion to Alzheimer's Disease with Longitudinal Measures and Time-To-Event Data.
    J Alzheimers Dis. 2017 Apr 18. doi: 10.3233/JAD-161201.
    PubMed     Text format     Abstract available


  261. PAOLACCI L, Giannandrea D, Mecocci P, Parnetti L, et al
    Biomarkers for Early Diagnosis of Alzheimer's Disease in the Oldest Old: Yes or No?
    J Alzheimers Dis. 2017 Apr 15. doi: 10.3233/JAD-161127.
    PubMed     Text format     Abstract available


  262. VIANA JNM, Bittlinger M, Gilbert F
    Ethical Considerations for Deep Brain Stimulation Trials in Patients with Early-Onset Alzheimer's Disease.
    J Alzheimers Dis. 2017 Apr 15. doi: 10.3233/JAD-161073.
    PubMed     Text format     Abstract available


  263. REDDY PH
    A Critical Assessment of Research on Neurotransmitters in Alzheimer's Disease.
    J Alzheimers Dis. 2017 Apr 10. doi: 10.3233/JAD-170256.
    PubMed     Text format     Abstract available


  264. YUAN XZ, Sun S, Tan CC, Yu JT, et al
    The Role of ADAM10 in Alzheimer's Disease.
    J Alzheimers Dis. 2017 Apr 10. doi: 10.3233/JAD-170061.
    PubMed     Text format     Abstract available


  265. REDDY PH, Manczak M, Yin X
    Mitochondria-Division Inhibitor 1 Protects Against Amyloid-beta induced Mitochondrial Fragmentation and Synaptic Damage in Alzheimer's Disease.
    J Alzheimers Dis. 2017 Apr 10. doi: 10.3233/JAD-170051.
    PubMed     Text format     Abstract available


  266. ALONSO R, Pisa D, Aguado B, Carrasco L, et al
    Identification of Fungal Species in Brain Tissue from Alzheimer's Disease by Next-Generation Sequencing.
    J Alzheimers Dis. 2017 Apr 3. doi: 10.3233/JAD-170058.
    PubMed     Text format     Abstract available


  267. XIE B, Liu Z, Liu W, Jiang L, et al
    DNA Methylation and Tag SNPs of the BDNF Gene in Conversion of Amnestic Mild Cognitive Impairment into Alzheimer's Disease: A Cross-Sectional Cohort Study.
    J Alzheimers Dis. 2017 Apr 3. doi: 10.3233/JAD-170007.
    PubMed     Text format     Abstract available


  268. GARCIA B, Martin C, Olivia GS, Muniz-Alonso B, et al
    Upregulated Expression of Heparanase and Heparanase 2 in the Brains of Alzheimer's Disease.
    J Alzheimers Dis. 2017 Apr 3. doi: 10.3233/JAD-161298.
    PubMed     Text format     Abstract available


  269. KEHOE PG, Hibbs E, Palmer LE, Miners JS, et al
    Angiotensin-III is Increased in Alzheimer's Disease in Association with Amyloid-beta and Tau Pathology.
    J Alzheimers Dis. 2017 Apr 3. doi: 10.3233/JAD-161265.
    PubMed     Text format     Abstract available


  270. GARCIA A, Mathur S, Kalaw MC, McAvoy E, et al
    Quantitative 3D Telomeric Imaging of Buccal Cells Reveals Alzheimer's Disease-Specific Signatures.
    J Alzheimers Dis. 2017 Apr 3. doi: 10.3233/JAD-161169.
    PubMed     Text format     Abstract available


  271. NGUYEN MF, Bonnefoy M, Adrait A, Gueugnon M, et al
    Efficacy of Hearing Aids on the Cognitive Status of Patients with Alzheimer's Disease and Hearing Loss: A Multicenter Controlled Randomized Trial.
    J Alzheimers Dis. 2017 Apr 3. doi: 10.3233/JAD-160793.
    PubMed     Text format     Abstract available


    March 2017
  272. BOHLKEN J, Jacob L, Kostev K
    Association between Anti-Dementia Treatment Persistence and Daily Dosage of the First Prescription: A Retrospective Analysis in Neuropsychiatric Practices in Germany.
    J Alzheimers Dis. 2017 Mar 29. doi: 10.3233/JAD-170091.
    PubMed     Text format     Abstract available


  273. LOPEZ-FONT I, Boix CP, Zetterberg H, Blennow K, et al
    Alterations in the Balance of Amyloid-beta Protein Precursor Species in the Cerebrospinal Fluid of Alzheimer's Disease Patients.
    J Alzheimers Dis. 2017 Mar 29. doi: 10.3233/JAD-161275.
    PubMed     Text format     Abstract available


  274. CRAFT S, Claxton A, Baker LD, Hanson AJ, et al
    Effects of Regular and Long-Acting Insulin on Cognition and Alzheimer's Disease Biomarkers: A Pilot Clinical Trial.
    J Alzheimers Dis. 2017 Mar 29. doi: 10.3233/JAD-161256.
    PubMed     Text format     Abstract available


  275. ROBB C, Udeh-Momoh C, Wagenpfeil S, Schope J, et al
    Biomarkers and Functional Decline in Prodromal Alzheimer's Disease.
    J Alzheimers Dis. 2017 Mar 29. doi: 10.3233/JAD-161162.
    PubMed     Text format     Abstract available


  276. JIANG C, Li G, Huang P, Liu Z, et al
    The Gut Microbiota and Alzheimer's Disease.
    J Alzheimers Dis. 2017 Mar 29. doi: 10.3233/JAD-161141.
    PubMed     Text format     Abstract available


  277. JIANG S, Bhaskar K
    Dynamics of the Complement, Cytokine, and Chemokine Systems in the Regulation of Synaptic Function and Dysfunction Relevant to Alzheimer's Disease.
    J Alzheimers Dis. 2017 Mar 29. doi: 10.3233/JAD-161123.
    PubMed     Text format     Abstract available


  278. WILLIAMS SM, Schulz P, Rosenberry TL, Caselli RJ, et al
    Blood-Based Oligomeric and Other Protein Variant Biomarkers to Facilitate Pre-Symptomatic Diagnosis and Staging of Alzheimer's Disease.
    J Alzheimers Dis. 2017 Mar 29. doi: 10.3233/JAD-161116.
    PubMed     Text format     Abstract available


  279. OCHMANN S, Dyrba M, Grothe MJ, Kasper E, et al
    Does Functional Connectivity Provide a Marker for Cognitive Rehabilitation Effects in Alzheimer's Disease? An Interventional Study.
    J Alzheimers Dis. 2017 Mar 29. doi: 10.3233/JAD-160773.
    PubMed     Text format     Abstract available


  280. DOREY E, Bamji-Mirza M, Najem D, Li Y, et al
    Apolipoprotein E Isoforms Differentially Regulate Alzheimer's Disease and Amyloid-beta-Induced Inflammatory Response in vivo and in vitro.
    J Alzheimers Dis. 2017 Mar 29. doi: 10.3233/JAD-160133.
    PubMed     Text format     Abstract available


  281. LIU XJ, Wei J, Shang YH, Huang HC, et al
    Modulation of AbetaPP and GSK3beta by Endoplasmic Reticulum Stress and Involvement in Alzheimer's Disease.
    J Alzheimers Dis. 2017 Mar 20. doi: 10.3233/JAD-161111.
    PubMed     Text format     Abstract available


  282. BRUEGGEN K, Kasper E, Ochmann S, Pfaff H, et al
    Cognitive Rehabilitation in Alzheimer's Disease: A Controlled Intervention Trial.
    J Alzheimers Dis. 2017 Mar 18. doi: 10.3233/JAD-170771.
    PubMed     Text format     Abstract available


  283. HUANG CC, Isidoro C
    Raman Spectrometric Detection Methods for Early and Non-Invasive Diagnosis of Alzheimer's Disease.
    J Alzheimers Dis. 2017 Mar 18. doi: 10.3233/JAD-161238.
    PubMed     Text format     Abstract available


  284. REED C, Happich M, Argimon JM, Haro JM, et al
    What Drives Country Differences in Cost of Alzheimer's Disease? An Explanation from Resource Use in the GERAS Study.
    J Alzheimers Dis. 2017 Mar 18. doi: 10.3233/JAD-160449.
    PubMed     Text format     Abstract available


  285. BRUEGGEN K, Kasper E, Ochmann S, Pfaff H, et al
    Cognitive Rehabilitation in Alzheimer's Disease: A Controlled Intervention Trial.
    J Alzheimers Dis. 2017 Mar 18. doi: 10.3233/JAD-160771.
    PubMed     Text format     Abstract available


  286. ALOSCO ML, Duskin J, Besser LM, Martin B, et al
    Modeling the Relationships Among Late-Life Body Mass Index, Cerebrovascular Disease, and Alzheimer's Disease Neuropathology in an Autopsy Sample of 1,421 Subjects from the National Alzheimer's Coordinating Center Data Set.
    J Alzheimers Dis. 2017 Mar 13. doi: 10.3233/JAD-161205.
    PubMed     Text format     Abstract available


  287. PIEVANI M, Pini L, Ferrari C, Pizzini FB, et al
    Coordinate-Based Meta-Analysis of the Default Mode and Salience Network for Target Identification in Non-Invasive Brain Stimulation of Alzheimer's Disease and Behavior Variant Frontotemporal Dementia Networks.
    J Alzheimers Dis. 2017 Mar 13. doi: 10.3233/JAD-161105.
    PubMed     Text format     Abstract available


  288. ESQUERDA-CANALS G, Montoliu-Gaya L, Guell-Bosch J, Villegas S, et al
    Mouse Models of Alzheimer's Disease.
    J Alzheimers Dis. 2017 Mar 10. doi: 10.3233/JAD-170045.
    PubMed     Text format     Abstract available


  289. BAROCCO F, Spallazzi M, Concari L, Gardini S, et al
    The Progression of Alzheimer's Disease: Are Fast Decliners Really Fast? A Four-Year Follow-Up.
    J Alzheimers Dis. 2017 Mar 10. doi: 10.3233/JAD-161264.
    PubMed     Text format     Abstract available


  290. BEYDOUN MA, Gamaldo AA, Beydoun HA, Shaked D, et al
    Trends, Predictors, and Outcomes of Healthcare Resources Used in Patients Hospitalized with Alzheimer's Disease with at Least One Procedure: The Nationwide Inpatient Sample.
    J Alzheimers Dis. 2017 Mar 10. doi: 10.3233/JAD-161225.
    PubMed     Text format     Abstract available


  291. HATASHITA S, Wakebe D
    Amyloid-beta Deposition and Long-Term Progression in Mild Cognitive Impairment due to Alzheimer's Disease Defined with Amyloid PET Imaging.
    J Alzheimers Dis. 2017 Mar 10. doi: 10.3233/JAD-161074.
    PubMed     Text format     Abstract available


  292. GARCIA-CASAL JA, Goni-Imizcoz M, Perea-Bartolome MV, Soto-Perez F, et al
    The Efficacy of Emotion Recognition Rehabilitation for People with Alzheimer's Disease.
    J Alzheimers Dis. 2017 Mar 10. doi: 10.3233/JAD-160940.
    PubMed     Text format     Abstract available


  293. MASON EJ, Hussey EP, Molitor RJ, Ko PC, et al
    Family History of Alzheimer's Disease is Associated with Impaired Perceptual Discrimination of Novel Objects.
    J Alzheimers Dis. 2017 Mar 10. doi: 10.3233/JAD-160772.
    PubMed     Text format     Abstract available


  294. DALLAIRE-THEROUX C, Callahan BL, Potvin O, Saikali S, et al
    Radiological-Pathological Correlation in Alzheimer's Disease: Systematic Review of Antemortem Magnetic Resonance Imaging Findings.
    J Alzheimers Dis. 2017 Mar 6. doi: 10.3233/JAD-161028.
    PubMed     Text format     Abstract available


  295. BOUVY WH, Kuijf HJ, Zwanenburg JJ, Koek HL, et al
    Abnormalities of Cerebral Deep Medullary Veins on 7 Tesla MRI in Amnestic Mild Cognitive Impairment and Early Alzheimer's Disease: A Pilot Study.
    J Alzheimers Dis. 2017 Mar 6. doi: 10.3233/JAD-160952.
    PubMed     Text format     Abstract available


  296. ZHANG C, Zhang Y, Shen Y, Zhao G, et al
    Anesthesia/Surgery Induces Cognitive Impairment Only in Female Alzheimer's Disease Transgenic Mice.
    J Alzheimers Dis. 2017 Mar 2. doi: 10.3233/JAD-161268.
    PubMed     Text format     Abstract available


  297. DE MARCO M, Duzzi D, Meneghello F, Venneri A, et al
    Cognitive Efficiency in Alzheimer's Disease is Associated with Increased Occipital Connectivity.
    J Alzheimers Dis. 2017 Mar 2. doi: 10.3233/JAD-161164.
    PubMed     Text format     Abstract available


  298. RUB U, Stratmann K, Heinsen H, Seidel K, et al
    Alzheimer's Disease: Characterization of the Brain Sites of the Initial Tau Cytoskeletal Pathology Will Improve the Success of Novel Immunological Anti-Tau Treatment Approaches.
    J Alzheimers Dis. 2017 Mar 2. doi: 0.3233/JAD-161102.
    PubMed     Text format     Abstract available


  299. HANE FT, Robinson M, Lee BY, Bai O, et al
    Recent Progress in Alzheimer's Disease Research, Part 3: Diagnosis and Treatment.
    J Alzheimers Dis. 2017 Mar 2. doi: 10.3233/JAD-160907.
    PubMed     Text format     Abstract available


  300. ADRAIT A, Perrot X, Nguyen MF, Gueugnon M, et al
    Do Hearing Aids Influence Behavioral and Psychological Symptoms of Dementia and Quality of Life in Hearing Impaired Alzheimer's Disease Patients and Their Caregivers?
    J Alzheimers Dis. 2017 Mar 2. doi: 10.3233/JAD-160792.
    PubMed     Text format     Abstract available


  301. VAN DER VEN A, Pape J, Hermann D, Schloesser R, et al
    Methylene Blue (Tetramethylthionine Chloride) Influences the Mobility of Adult Neural Stem Cells: A Potentially Novel Therapeutic Mechanism of a Therapeutic Approach in the Treatment of Alzheimer's Disease.
    J Alzheimers Dis. 2017 Mar 2. doi: 10.3233/JAD-160755.
    PubMed     Text format     Abstract available


  302. KETTER N, Brashear HR, Bogert J, Di J, et al
    Central Review of Amyloid-Related Imaging Abnormalities in Two Phase III Clinical Trials of Bapineuzumab in Mild-To-Moderate Alzheimer's Disease Patients.
    J Alzheimers Dis. 2017 Mar 2. doi: 10.3233/JAD-160216.
    PubMed     Text format     Abstract available


    February 2017
  303. DONG J, Qin W, Wei C, Tang Y, et al
    A Novel PSEN1 K311R Mutation Discovered in Chinese Families with Late-Onset Alzheimer's Disease Affects Amyloid-beta Production and Tau Phosphorylation.
    J Alzheimers Dis. 2017 Feb 28. doi: 10.3233/JAD-161188.
    PubMed     Text format     Abstract available


  304. ANDREWS SJ, Das D, Anstey KJ, Easteal S, et al
    Late Onset Alzheimer's Disease Risk Variants in Cognitive Decline: The PATH Through Life Study.
    J Alzheimers Dis. 2017 Feb 28. doi: 10.3233/JAD-160774.
    PubMed     Text format     Abstract available


  305. BLONIECKI V, Aarsland D, Blennow K, Cummings J, et al
    Effects of Risperidone and Galantamine Treatment on Alzheimer's Disease Biomarker Levels in Cerebrospinal Fluid.
    J Alzheimers Dis. 2017 Feb 28. doi: 10.3233/JAD-160758.
    PubMed     Text format     Abstract available


  306. OBERACHER H, Arnhard K, Linhart C, Diwo A, et al
    Targeted Metabolomic Analysis of Soluble Lysates from Platelets of Patients with Mild Cognitive Impairment and Alzheimer's Disease Compared to Healthy Controls: Is PC aeC40:4 a Promising Diagnostic Tool?
    J Alzheimers Dis. 2017 Feb 28. doi: 10.3233/JAD-160172.
    PubMed     Text format     Abstract available


  307. RIANCHO J, Vazquez-Higuera JL, Pozueta A, Lage C, et al
    MicroRNA Profile in Patients with Alzheimer's Disease: Analysis of miR-9-5p and miR-598 in Raw and Exosome Enriched Cerebrospinal Fluid Samples.
    J Alzheimers Dis. 2017 Feb 25. doi: 10.3233/JAD-161179.
    PubMed     Text format     Abstract available


  308. PREMA A, Justin Thenmozhi A, Manivasagam T, Mohamed Essa M, et al
    Fenugreek Seed Powder Attenuated Aluminum Chloride-Induced Tau Pathology, Oxidative Stress, and Inflammation in a Rat Model of Alzheimer's Disease.
    J Alzheimers Dis. 2017 Feb 25. doi: 10.3233/JAD-161103.
    PubMed     Text format     Abstract available


  309. TOEPPER M
    Dissociating Normal Aging from Alzheimer's Disease: A View from Cognitive Neuroscience.
    J Alzheimers Dis. 2017 Feb 25. doi: 10.3233/JAD-161099.
    PubMed     Text format     Abstract available


  310. DELGADO-GONZALEZ JC, Florensa-Vila J, Mansilla-Legorburo F, Insausti R, et al
    Magnetic Resonance Imaging and Anatomical Correlation of Human Temporal Lobe Landmarks, in 3D Euclidean Space: A Study of Control and Alzheimer's Disease Subjects.
    J Alzheimers Dis. 2017 Feb 25. doi: 10.3233/JAD-160944.
    PubMed     Text format     Abstract available


  311. ROBINSON M, Lee BY, Hane FT
    Recent Progress in Alzheimer's Disease Research, Part 2: Genetics and Epidemiology.
    J Alzheimers Dis. 2017 Feb 16. doi: 10.3233/JAD-161149.
    PubMed     Text format     Abstract available


  312. GONZALES EB, Sumien N
    Acidity and Acid-Sensing Ion Channels in the Normal and Alzheimer's Disease Brain.
    J Alzheimers Dis. 2017 Feb 15. doi: 10.3233/JAD-161131.
    PubMed     Text format     Abstract available


  313. KANDIMALLA R, Reddy PH
    Therapeutics of Neurotransmitters in Alzheimer's Disease.
    J Alzheimers Dis. 2017 Feb 15. doi: 10.3233/JAD-161118.
    PubMed     Text format     Abstract available


  314. EL HAJ M, Gallouj K, Antoine P
    Google Calendar Enhances Prospective Memory in Alzheimer's Disease: A Case Report.
    J Alzheimers Dis. 2017 Feb 10. doi: 10.3233/JAD-161283.
    PubMed     Text format     Abstract available


  315. YAMAZAKI K, Yoshino Y, Mori T, Yoshida T, et al
    Gene Expression and Methylation Analysis of ABCA7 in Patients with Alzheimer's Disease.
    J Alzheimers Dis. 2017 Feb 10. doi: 10.3233/JAD-161195.
    PubMed     Text format     Abstract available


  316. WANG J, Liu Y, Cheng X, Zhang X, et al
    The Effects of LW-AFC on the Hippocampus Transcriptome in Senescence-Accelerated Mouse Prone 8 Strain, a Mouse Model of Alzheimer's Disease.
    J Alzheimers Dis. 2017 Feb 10. doi: 10.3233/JAD-161079.
    PubMed     Text format     Abstract available


  317. MARIONI RE, Campbell A, Hagenaars SP, Nagy R, et al
    Genetic Stratification to Identify Risk Groups for Alzheimer's Disease.
    J Alzheimers Dis. 2017 Feb 10. doi: 10.3233/JAD-161070.
    PubMed     Text format     Abstract available


  318. LINDEMER ER, Greve DN, Fischl B, Augustinack JC, et al
    Differential Regional Distribution of Juxtacortical White Matter Signal Abnormalities in Aging and Alzheimer's Disease.
    J Alzheimers Dis. 2017 Feb 10. doi: 10.3233/JAD-161057.
    PubMed     Text format     Abstract available


  319. YANG J, Zhang R, Shi C, Mao C, et al
    AQP4 Association with Amyloid Deposition and Astrocyte Pathology in the Tg-ArcSwe Mouse Model of Alzheimer's Disease.
    J Alzheimers Dis. 2017 Feb 10. doi: 10.3233/JAD-160957.
    PubMed     Text format     Abstract available


  320. NAKAYAMA S, Suda A, Nakanishi H, Motoi Y, et al
    Galantamine Response Associates with Agitation and the Prefrontal Cortex in Patients with Alzheimer's Disease.
    J Alzheimers Dis. 2017 Feb 10. doi: 10.3233/JAD-160902.
    PubMed     Text format     Abstract available


  321. HANE FT, Lee BY, Leonenko Z
    Recent Progress in Alzheimer's Disease Research, Part 1: Pathology.
    J Alzheimers Dis. 2017 Feb 10. doi: 10.3233/JAD-160882.
    PubMed     Text format     Abstract available


  322. CARDOSO BR, Hare DJ, Bush AI, Li QX, et al
    Selenium Levels in Serum, Red Blood Cells, and Cerebrospinal Fluid of Alzheimer's Disease Patients: A Report from the Australian Imaging, Biomarker & Lifestyle Flagship Study of Ageing (AIBL).
    J Alzheimers Dis. 2017 Feb 10. doi: 10.3233/JAD-160622.
    PubMed     Text format     Abstract available


  323. MONROE TB, Beach PA, Bruehl SP, Dietrich MS, et al
    The Impact of Alzheimer's Disease on the Resting State Functional Connectivity of Brain Regions Modulating Pain: A Cross Sectional Study.
    J Alzheimers Dis. 2017 Feb 7. doi: 10.3233/JAD-161187.
    PubMed     Text format     Abstract available


  324. BALIETTI M, Giuli C, Fattoretti P, Fabbietti P, et al
    Effect of a Comprehensive Intervention on Plasma BDNF in Patients with Alzheimer's Disease.
    J Alzheimers Dis. 2017 Feb 7. doi: 10.3233/JAD-161168.
    PubMed     Text format     Abstract available


  325. IENCA M, Fabrice J, Elger B, Caon M, et al
    Intelligent Assistive Technology for Alzheimer's Disease and Other Dementias: A Systematic Review.
    J Alzheimers Dis. 2017 Feb 7. doi: 10.3233/JAD-161037.
    PubMed     Text format     Abstract available


  326. WANG Q, Li WX, Dai SX, Guo YC, et al
    Meta-Analysis of Parkinson's Disease and Alzheimer's Disease Revealed Commonly Impaired Pathways and Dysregulation of NRF2-Dependent Genes.
    J Alzheimers Dis. 2017 Feb 7. doi: 10.3233/JAD-161032.
    PubMed     Text format     Abstract available


  327. BAAZAOUI N, Flory M, Iqbal K
    Synaptic Compensation as a Probable Cause of Prolonged Mild Cognitive Impairment in Alzheimer's Disease: Implications from a Transgenic Mouse Model of the Disease.
    J Alzheimers Dis. 2017 Feb 7. doi: 10.3233/JAD-160845.
    PubMed     Text format     Abstract available


  328. KALLIO EL, Ohman H, Kautiainen H, Hietanen M, et al
    Cognitive Training Interventions for Patients with Alzheimer's Disease: A Systematic Review.
    J Alzheimers Dis. 2017 Feb 7. doi: 10.3233/JAD-160810.
    PubMed     Text format     Abstract available


  329. SANIN GN, Benke T
    Bimanual Gesture Imitation in Alzheimer's Disease.
    J Alzheimers Dis. 2017 Feb 7. doi: 10.3233/JAD-160680.
    PubMed     Text format     Abstract available


  330. STOCCORO A, Tannorella P, Salluzzo MG, Ferri R, et al
    The Methylenetetrahydrofolate Reductase C677T Polymorphism and Risk for Late-Onset Alzheimer's disease: Further Evidence in an Italian Multicenter Study.
    J Alzheimers Dis. 2017 Feb 7. doi: 10.3233/JAD-161081.
    PubMed     Text format     Abstract available


  331. CHANG KJ, Hong CH, Lee KS, Kang DR, et al
    Mortality Risk after Diagnosis of Early-Onset Alzheimer's Disease versus Late-Onset Alzheimer's Disease: A Propensity Score Matching Analysis.
    J Alzheimers Dis. 2017 Feb 1. doi: 10.3233/JAD-161181.
    PubMed     Text format     Abstract available


  332. CASTELLANO CA, Paquet N, Dionne IJ, Imbeault H, et al
    A 3-Month Aerobic Training Program Improves Brain Energy Metabolism in Mild Alzheimer's Disease: Preliminary Results from a Neuroimaging Study.
    J Alzheimers Dis. 2017 Feb 1. doi: 10.3233/JAD-161163.
    PubMed     Text format     Abstract available


  333. YU L, Wilson RS, Schneider JA, Bennett DA, et al
    Financial and Health Literacy Predict Incident Alzheimer's Disease Dementia and Pathology.
    J Alzheimers Dis. 2017 Feb 1. doi: 10.3233/JAD-161132.
    PubMed     Text format     Abstract available


  334. JIA J, Wei C, Jia L, Tang Y, et al
    Efficacy and Safety of Donepezil in Chinese Patients with Severe Alzheimer's Disease: A Randomized Controlled Trial.
    J Alzheimers Dis. 2017 Feb 1. doi: 10.3233/JAD-161117.
    PubMed     Text format     Abstract available


  335. GRANHOLM EL, Panizzon MS, Elman JA, Jak AJ, et al
    Pupillary Responses as a Biomarker of Early Risk for Alzheimer's Disease.
    J Alzheimers Dis. 2017 Feb 1. doi: 10.3233/JAD-161078.
    PubMed     Text format     Abstract available


  336. LU Y, Dong Y, Tucker D, Wang R, et al
    Treadmill Exercise Exerts Neuroprotection and Regulates Microglial Polarization and Oxidative Stress in a Streptozotocin-Induced Rat Model of Sporadic Alzheimer's Disease.
    J Alzheimers Dis. 2017 Feb 1. doi: 10.3233/JAD-160869.
    PubMed     Text format     Abstract available


  337. TIMMERS M, Barao S, Van Broeck B, Tesseur I, et al
    BACE1 Dynamics Upon Inhibition with a BACE Inhibitor and Correlation to Downstream Alzheimer's Disease Markers in Elderly Healthy Participants.
    J Alzheimers Dis. 2017 Feb 1. doi: 10.3233/JAD-160829.
    PubMed     Text format     Abstract available


  338. LI L, Xu S, Liu L, Feng R, et al
    Multifunctional Compound AD-35 Improves Cognitive Impairment and Attenuates the Production of TNF-alpha and IL-1beta in an Abeta25-35-induced Rat Model of Alzheimer's Disease.
    J Alzheimers Dis. 2017 Feb 1. doi: 10.3233/JAD-160587.
    PubMed     Text format     Abstract available


    January 2017
  339. SUHONEN NM, Hallikainen I, Hanninen T, Jokelainen J, et al
    The Modified Frontal Behavioral Inventory (FBI-mod) for Patients with Frontotemporal Lobar Degeneration, Alzheimer's Disease, and Mild Cognitive Impairment.
    J Alzheimers Dis. 2017 Jan 20. doi: 10.3233/JAD-160983.
    PubMed     Text format     Abstract available


  340. EBEL DL, Torkilsen CG, Ostrowski TD
    Blunted Respiratory Responses in the Streptozotocin-Induced Alzheimer's Disease Rat Model.
    J Alzheimers Dis. 2017 Jan 20. doi: 10.3233/JAD-160974.
    PubMed     Text format     Abstract available


  341. HORVATH A, Szucs A, Barcs G, Kamondi A, et al
    Sleep EEG Detects Epileptiform Activity in Alzheimer's Disease with High Sensitivity.
    J Alzheimers Dis. 2017 Jan 19. doi: 10.3233/JAD-160994.
    PubMed     Text format     Abstract available


  342. N'SONGO A, Carrasquillo MM, Wang X, Nguyen T, et al
    Comprehensive Screening for Disease Risk Variants in Early-Onset Alzheimer's Disease Genes in African Americans Identifies Novel PSEN Variants.
    J Alzheimers Dis. 2017 Jan 19. doi: 10.3233/JAD-161185.
    PubMed     Text format     Abstract available


  343. GOMEZ-RAMOS A, Picher AJ, Garcia E, Garrido P, et al
    Validation of Suspected Somatic Single Nucleotide Variations in the Brain of Alzheimer's Disease Patients.
    J Alzheimers Dis. 2017 Jan 19. doi: 10.3233/JAD-161053.
    PubMed     Text format     Abstract available


  344. FERRARI L, Huang SC, Magnani G, Ambrosi A, et al
    Optical Coherence Tomography Reveals Retinal Neuroaxonal Thinning in Frontotemporal Dementia as in Alzheimer's Disease.
    J Alzheimers Dis. 2017 Jan 18. doi: 10.3233/JAD-160886.
    PubMed     Text format     Abstract available


  345. LOEWENSTEIN DA, Curiel RE, Wright C, Sun X, et al
    Recovery from Proactive Semantic Interference in Mild Cognitive Impairment and Normal Aging: Relationship to Atrophy in Brain Regions Vulnerable to Alzheimer's Disease.
    J Alzheimers Dis. 2017 Jan 18. doi: 10.3233/JAD-160881.
    PubMed     Text format     Abstract available


  346. SUNDERMANN EE, Biegon A, Rubin LH, Lipton RB, et al
    Does the Female Advantage in Verbal Memory Contribute to Underestimating Alzheimer's Disease Pathology in Women versus Men?
    J Alzheimers Dis. 2017 Jan 18. doi: 10.3233/JAD-160716.
    PubMed     Text format     Abstract available


  347. HADDICK PC, Larson JL, Rathore N, Bhangale TR, et al
    A Common Variant of IL-6R is Associated with Elevated IL-6 Pathway Activity in Alzheimer's Disease Brains.
    J Alzheimers Dis. 2017 Jan 18. doi: 10.3233/JAD-160524.
    PubMed     Text format     Abstract available


  348. KHAN W, Giampietro V, Banaschewski T, Barker GJ, et al
    A Multi-Cohort Study of ApoE varepsilon4 and Amyloid-beta Effects on the Hippocampus in Alzheimer's Disease.
    J Alzheimers Dis. 2017;56:1159-1174.
    PubMed     Text format     Abstract available


  349. IWAHARA N, Hisahara S, Kawamata J, Matsumura A, et al
    Role of Suppressor of Cytokine Signaling 3 (SOCS3) in Altering Activated Microglia Phenotype in APPswe/PS1dE9 Mice.
    J Alzheimers Dis. 2017;55:1235-1247.
    PubMed     Text format     Abstract available



  350. Shi-Jiang Li, PhD, Recipient of 2017 Alzheimer Award.
    J Alzheimers Dis. 2017;59:387-388.
    PubMed     Text format    


  351. LOMBARDI G, Berti V, Tedde A, Bagnoli S, et al
    Low Florbetapir PET Uptake and Normal Abeta1-42 Cerebrospinal Fluid in an APP Ala713Thr Mutation Carrier.
    J Alzheimers Dis. 2017;57:697-703.
    PubMed     Text format     Abstract available


  352. IENCA M, Jotterand F, Elger B, Caon M, et al
    Intelligent Assistive Technology for Alzheimer's Disease and Other Dementias: A Systematic Review.
    J Alzheimers Dis. 2017;60:333.
    PubMed     Text format    



  353. Mini-Forum on Sphingolipids in Alzheimer's Disease and Related Disorders, Guest Editors: Michelle Mielke and Pilar Martinez.
    J Alzheimers Dis. 2017;60:751.
    PubMed     Text format    


  354. SERRA L, Gabrielli GB, Tuzzi E, Spano B, et al
    Damage to the Frontal Aslant Tract Accounts for Visuo-Constructive Deficits in Alzheimer's Disease.
    J Alzheimers Dis. 2017;60:1015-1024.
    PubMed     Text format     Abstract available


  355. AHMED ME, Iyer S, Thangavel R, Kempuraj D, et al
    Co-Localization of Glia Maturation Factor with NLRP3 Inflammasome and Autophagosome Markers in Human Alzheimer's Disease Brain.
    J Alzheimers Dis. 2017;60:1143-1160.
    PubMed     Text format     Abstract available


  356. HUOVINEN J, Helisalmi S, Paananen J, Laitera T, et al
    Alzheimer's Disease-Related Polymorphisms in Shunt-Responsive Idiopathic Normal Pressure Hydrocephalus.
    J Alzheimers Dis. 2017;60:1077-1085.
    PubMed     Text format     Abstract available


  357. REIJS BLR, Ramakers IHGB, Elias-Sonnenschein L, Teunissen CE, et al
    Relation of Odor Identification with Alzheimer's Disease Markers in Cerebrospinal Fluid and Cognition.
    J Alzheimers Dis. 2017;60:1025-1034.
    PubMed     Text format     Abstract available


  358. COSTA AS, Agostini S, Guerini FR, Mancuso R, et al
    Modulation of Immune Responses to Herpes Simplex Virus Type 1 by IFNL3 and IRF7 Polymorphisms: A Study in Alzheimer's Disease.
    J Alzheimers Dis. 2017;60:1055-1063.
    PubMed     Text format     Abstract available


  359. SANCHEZ SM, Abulafia C, Duarte-Abritta B, de Guevara MSL, et al
    Failure to Recover from Proactive Semantic Interference and Abnormal Limbic Connectivity in Asymptomatic, Middle-Aged Offspring of Patients with Late-Onset Alzheimer's Disease.
    J Alzheimers Dis. 2017;60:1183-1193.
    PubMed     Text format     Abstract available


  360. PALMIERI G, Cocca E, Gogliettino M, Valentino R, et al
    Low Erythrocyte Levels of Proteasome and Acyl-Peptide Hydrolase (APEH) Activities in Alzheimer's Disease: A Sign of Defective Proteostasis?
    J Alzheimers Dis. 2017;60:1097-1106.
    PubMed     Text format     Abstract available


  361. CHEN Y, Sillaire AR, Dallongeville J, Skrobala E, et al
    Low Prevalence and Clinical Effect of Vascular Risk Factors in Early-Onset Alzheimer's Disease.
    J Alzheimers Dis. 2017;60:1045-1054.
    PubMed     Text format     Abstract available


  362. VAKALOPOULOS C
    Alzheimer's Disease: The Alternative Serotonergic Hypothesis of Cognitive Decline.
    J Alzheimers Dis. 2017;60:859-866.
    PubMed     Text format     Abstract available


  363. STEVENSON A, Lopez D, Khoo P, Kalaria RN, et al
    Exploring Erythrocytes as Blood Biomarkers for Alzheimer's Disease.
    J Alzheimers Dis. 2017;60:845-857.
    PubMed     Text format     Abstract available


  364. MISE A, Yoshino Y, Yamazaki K, Ozaki Y, et al
    TOMM40 and APOE Gene Expression and Cognitive Decline in Japanese Alzheimer's Disease Subjects.
    J Alzheimers Dis. 2017;60:1107-1117.
    PubMed     Text format     Abstract available


  365. FINGER E, Zhang J, Dickerson B, Bureau Y, et al
    Disinhibition in Alzheimer's Disease is Associated with Reduced Right Frontal Pole Cortical Thickness.
    J Alzheimers Dis. 2017;60:1161-1170.
    PubMed     Text format     Abstract available


  366. DOS SANTOS MATIOLI MNP, Suemoto CK, Rodriguez RD, Farias DS, et al
    Diabetes is Not Associated with Alzheimer's Disease Neuropathology.
    J Alzheimers Dis. 2017;60:1035-1043.
    PubMed     Text format     Abstract available


  367. REIJS BLR, Ramakers IHGB, Kohler S, Teunissen CE, et al
    Memory Correlates of Alzheimer's Disease Cerebrospinal Fluid Markers: A Longitudinal Cohort Study.
    J Alzheimers Dis. 2017;60:1119-1128.
    PubMed     Text format     Abstract available


  368. DAYON L, Wojcik J, Nunez Galindo A, Corthesy J, et al
    Plasma Proteomic Profiles of Cerebrospinal Fluid-Defined Alzheimer's Disease Pathology in Older Adults.
    J Alzheimers Dis. 2017;60:1641-1652.
    PubMed     Text format     Abstract available


  369. FREEZE WM, Jacobs HI, Gronenschild EH, Jansen JF, et al
    White Matter Hyperintensities Potentiate Hippocampal Volume Reduction in Non-Demented Older Individuals with Abnormal Amyloid-beta.
    J Alzheimers Dis. 2017;55:333-342.
    PubMed     Text format     Abstract available


  370. RUSSELL CL, Mitra V, Hansson K, Blennow K, et al
    Comprehensive Quantitative Profiling of Tau and Phosphorylated Tau Peptides in Cerebrospinal Fluid by Mass Spectrometry Provides New Biomarker Candidates.
    J Alzheimers Dis. 2017;55:303-313.
    PubMed     Text format     Abstract available


    December 2016
  371. LEE HK, Kwon B, Lemere CA, de la Monte S, et al
    mTORC2 (Rictor) in Alzheimer's Disease and Reversal of Amyloid-beta Expression-Induced Insulin Resistance and Toxicity in Rat Primary Cortical Neurons.
    J Alzheimers Dis. 2016 Dec 30. doi: 10.3233/JAD-161029.
    PubMed     Text format     Abstract available


  372. YARCHOAN M, James BD, Shah RC, Arvanitakis Z, et al
    Association of Cancer History with Alzheimer's Disease Dementia and Neuropathology.
    J Alzheimers Dis. 2016 Dec 30. doi: 10.3233/JAD-160977.
    PubMed     Text format     Abstract available


  373. BRANDSCHEID C, Schuck F, Reinhardt S, Schafer KH, et al
    Altered Gut Microbiome Composition and Tryptic Activity of the 5xFAD Alzheimer's Mouse Model.
    J Alzheimers Dis. 2016 Dec 30. doi: 10.3233/JAD-160926.
    PubMed     Text format     Abstract available


  374. MIELKE MM, Haughey NJ, Han D, An Y, et al
    The Association Between Plasma Ceramides and Sphingomyelins and Risk of Alzheimer's Disease Differs by Sex and APOE in the Baltimore Longitudinal Study of Aging.
    J Alzheimers Dis. 2016 Dec 30. doi: 10.3233/JAD-160925.
    PubMed     Text format     Abstract available


  375. SUGIMOTO T, Yoshida M, Ono R, Murata S, et al
    Frontal Lobe Function Correlates with One-Year Incidence of Urinary Incontinence in Elderly with Alzheimer Disease.
    J Alzheimers Dis. 2016 Dec 30. doi: 10.3233/JAD-160923.
    PubMed     Text format     Abstract available


  376. BERGLAND AK, Dalen I, Larsen AI, Aarsland D, et al
    Effect of Vascular Risk Factors on the Progression of Mild Alzheimer's Disease and Lewy Body Dementia.
    J Alzheimers Dis. 2016 Dec 30. doi: 10.3233/JAD-160847.
    PubMed     Text format     Abstract available


  377. CHIDLOW G, Wood JP, Manavis J, Finnie J, et al
    Investigations into Retinal Pathology in the Early Stages of a Mouse Model of Alzheimer's Disease.
    J Alzheimers Dis. 2016 Dec 30. doi: 10.3233/JAD-160823.
    PubMed     Text format     Abstract available


  378. GARERI P, Castagna A, Cotroneo AM, Putignano D, et al
    The Citicholinage Study: Citicoline Plus Cholinesterase Inhibitors in Aged Patients Affected with Alzheimer's Disease Study.
    J Alzheimers Dis. 2016 Dec 30. doi: 10.3233/JAD-160808.
    PubMed     Text format     Abstract available


  379. SU F, Shu H, Ye Q, Xie C, et al
    Integration of Multilocus Genetic Risk into the Default Mode Network Longitudinal Trajectory during the Alzheimer's Disease Process.
    J Alzheimers Dis. 2016 Dec 30. doi: 10.3233/JAD-160787.
    PubMed     Text format     Abstract available


  380. CAROTENUTO A, Rea R, Traini E, Fasanaro AM, et al
    The Effect of the Association between Donepezil and Choline Alphoscerate on Behavioral Disturbances in Alzheimer's Disease: Interim Results of the ASCOMALVA Trial.
    J Alzheimers Dis. 2016 Dec 30. doi: 10.3233/JAD-160675.
    PubMed     Text format     Abstract available


  381. GAUBERT M, Villain N, Landeau B, Mezenge F, et al
    Neural Correlates of Self-Reference Effect in Early Alzheimer's Disease.
    J Alzheimers Dis. 2016 Dec 30. doi: 10.3233/JAD-160561.
    PubMed     Text format     Abstract available


  382. TAN L, Yang H, Pang W, Li H, et al
    Investigation on the Role of BDNF in the Benefits of Blueberry Extracts for the Improvement of Learning and Memory in Alzheimer's Disease Mouse Model.
    J Alzheimers Dis. 2016 Dec 30. doi: 10.3233/JAD-151108.
    PubMed     Text format     Abstract available


  383. SLOT RE, Van Harten AC, Kester MI, Jongbloed W, et al
    Apolipoprotein A1 in Cerebrospinal Fluid and Plasma and Progression to Alzheimer's Disease in Non-Demented Elderly.
    J Alzheimers Dis. 2016 Dec 30. doi: 10.3233/JAD-151068.
    PubMed     Text format     Abstract available


  384. SQUITTI R, Mendez AJ, Simonelli I, Ricordi C, et al
    Diabetes and Alzheimer's Disease: Can Elevated Free Copper Predict the Risk of the Disease?
    J Alzheimers Dis. 2016.
    PubMed     Text format     Abstract available


  385. BENUSSI L, Ghidoni R, Dal Piaz F, Binetti G, et al
    The level of 24-Hydroxycholesteryl Esters is an Early Marker of Alzheimer's Disease.
    J Alzheimers Dis. 2016.
    PubMed     Text format     Abstract available


  386. MATIAS-GUIU JA, Curiel RE, Rognoni T, Valles-Salgado M, et al
    Validation of the Spanish Version of the LASSI-L for Diagnosing Mild Cognitive Impairment and Alzheimer's Disease.
    J Alzheimers Dis. 2016.
    PubMed     Text format     Abstract available


  387. DORAN E, Keator D, Head E, Phelan MJ, et al
    Down Syndrome, Partial Trisomy 21, and Absence of Alzheimer's Disease: The Role of APP.
    J Alzheimers Dis. 2016.
    PubMed     Text format     Abstract available


  388. SABBAGH MN, Schauble B, Anand K, Richards D, et al
    Histopathology and Florbetaben PET in Patients Incorrectly Diagnosed with Alzheimer's Disease.
    J Alzheimers Dis. 2016.
    PubMed     Text format     Abstract available


  389. SIEGEL AM, Barrett MS, Bhati MT
    Deep Brain Stimulation for Alzheimer's Disease: Ethical Challenges for Clinical Research.
    J Alzheimers Dis. 2016.
    PubMed     Text format     Abstract available


  390. XIE B, Xu Y, Liu Z, Liu W, et al
    Elevation of Peripheral BDNF Promoter Methylation Predicts Conversion from Amnestic Mild Cognitive Impairment to Alzheimer's Disease: A 5-Year Longitudinal Study.
    J Alzheimers Dis. 2016.
    PubMed     Text format     Abstract available


  391. KOPONEN M, Taipale H, Lavikainen P, Tanskanen A, et al
    Risk of Mortality associated with Antipsychotic Monotherapy and Polypharmacy among Community-Dwelling Persons with Alzheimer's Disease.
    J Alzheimers Dis. 2016.
    PubMed     Text format     Abstract available


  392. HO L, Legere M, Li T, Levine S, et al
    Autonomic Nervous System Dysfunctions as a Basis for a Predictive Model of Risk of Neurological Disorders in Subjects with Prior History of Traumatic Brain Injury: Implications in Alzheimer's Disease.
    J Alzheimers Dis. 2016.
    PubMed     Text format     Abstract available


  393. SHEN L, Liao L, Chen C, Guo Y, et al
    Proteomics Analysis of Blood Serums from Alzheimer's Disease Patients Using iTRAQ Labeling Technology.
    J Alzheimers Dis. 2016.
    PubMed     Text format     Abstract available


  394. MCLIMANS KE, Willette AA
    Autotaxin is Related to Metabolic Dysfunction and Predicts Alzheimer's Disease Outcomes.
    J Alzheimers Dis. 2016.
    PubMed     Text format     Abstract available


  395. LAW LL, Schultz SA, Boots EA, Einerson JA, et al
    Chronotropic Response and Cognitive Function in a Cohort at Risk for Alzheimer's Disease.
    J Alzheimers Dis. 2016.
    PubMed     Text format     Abstract available


    November 2016
  396. BOCCARDI V, Baroni M, Smirne N, Clodomiro A, et al
    Short-Term Response is not Predictive of Long-Term Response to Acetylcholinesterase Inhibitors in Old Age Subjects with Alzheimer's Disease: A "Real World" Study.
    J Alzheimers Dis. 2016.
    PubMed     Text format     Abstract available


  397. LI X, Westman E, Thordardottir S, Stahlbom AK, et al
    The Effects of Gene Mutations on Default Mode Network in Familial Alzheimer's Disease.
    J Alzheimers Dis. 2016.
    PubMed     Text format     Abstract available


  398. SOKOLOW S, Li X, Chen L, D Taylor K, et al
    Deleterious Effect of Butyrylcholinesterase K-Variant in Donepezil Treatment of Mild Cognitive Impairment.
    J Alzheimers Dis. 2016.
    PubMed     Text format     Abstract available


  399. SANCESARIO GM, Toniolo S, Chiasserini D, Di Santo SG, et al
    The Clinical Use of Cerebrospinal Fluid Biomarkers for Alzheimer's Disease Diagnosis: The Italian Selfie.
    J Alzheimers Dis. 2016.
    PubMed     Text format     Abstract available


  400. LAMPELA P, Tolppanen AM, Tanskanen A, Tiihonen J, et al
    Anticholinergic Exposure and Risk of Pneumonia in Persons with Alzheimer's Disease: A Nested Case-Control Study.
    J Alzheimers Dis. 2016.
    PubMed     Text format     Abstract available


  401. SHEN L, Liu L, Ji HF
    Alzheimer's Disease Histological and Behavioral Manifestations in Transgenic Mice Correlate with Specific Gut Microbiome State.
    J Alzheimers Dis. 2016.
    PubMed     Text format     Abstract available


  402. CHONG JR, Chai YL, Lee JH, Howlett D, et al
    Increased Transforming Growth Factor beta2 in the Neocortex of Alzheimer's Disease and Dementia with Lewy Bodies is Correlated with Disease Severity and Soluble Abeta42 Load.
    J Alzheimers Dis. 2016.
    PubMed     Text format     Abstract available


  403. SENNIK S, Schweizer TA, Fischer CE, Munoz DG, et al
    Risk Factors and Pathological Substrates Associated with Agitation/Aggression in Alzheimer's Disease: A Preliminary Study using NACC Data.
    J Alzheimers Dis. 2016.
    PubMed     Text format     Abstract available


  404. MATSUDA T, Hisatsune T
    Cholinergic Modification of Neurogenesis and Gliosis Improves the Memory of AbetaPPswe/PSEN1dE9 Alzheimer's Disease Model Mice Fed a High-Fat Diet.
    J Alzheimers Dis. 2016.
    PubMed     Text format     Abstract available


  405. WANG E, Zhu H, Wang X, Gower A, et al
    Amylin Treatment Reduces Neuroinflammation and Ameliorates Abnormal Patterns of Gene Expression in the Cerebral Cortex of an Alzheimer's Disease Mouse Model.
    J Alzheimers Dis. 2016.
    PubMed     Text format     Abstract available


  406. FUJISHIMA M, Kawaguchi A, Maikusa N, Kuwano R, et al
    Sample Size Estimation for Alzheimer's Disease Trials from Japanese ADNI Serial Magnetic Resonance Imaging.
    J Alzheimers Dis. 2016.
    PubMed     Text format     Abstract available


  407. BOADA M, Anaya F, Ortiz P, Olazaran J, et al
    Efficacy and Safety of Plasma Exchange with 5% Albumin to Modify Cerebrospinal Fluid and Plasma Amyloid-beta Concentrations and Cognition Outcomes in Alzheimer's Disease Patients: A Multicenter, Randomized, Controlled Clinical Trial.
    J Alzheimers Dis. 2016.
    PubMed     Text format     Abstract available


  408. LOUWERSHEIMER E, Cohn-Hokke PE, Pijnenburg YA, Weiss MM, et al
    Rare Genetic Variant in SORL1 May Increase Penetrance of Alzheimer's Disease in a Family with Several Generations of APOE-varepsilon4 Homozygosity.
    J Alzheimers Dis. 2016.
    PubMed     Text format     Abstract available


  409. PANDYA S, Kuceyeski A, Raj A
    The Brain's Structural Connectome Mediates the Relationship between Regional Neuroimaging Biomarkers in Alzheimer's Disease.
    J Alzheimers Dis. 2016.
    PubMed     Text format     Abstract available


  410. GLOZMAN T, Solomon J, Pestilli F, Guibas L, et al
    Shape-Attributes of Brain Structures as Biomarkers for Alzheimer's Disease.
    J Alzheimers Dis. 2016.
    PubMed     Text format     Abstract available


  411. MORGAN AR, Touchard S, O'Hagan C, Sims R, et al
    The Correlation between Inflammatory Biomarkers and Polygenic Risk Score in Alzheimer's Disease.
    J Alzheimers Dis. 2016.
    PubMed     Text format     Abstract available


  412. SLACHEVSKY A, Guzman-Martinez L, Delgado C, Reyes P, et al
    Tau Platelets Correlate with Regional Brain Atrophy in Patients with Alzheimer's Disease.
    J Alzheimers Dis. 2016.
    PubMed     Text format     Abstract available


  413. KIM M, Nevado-Holgado A, Whiley L, Snowden SG, et al
    Association between Plasma Ceramides and Phosphatidylcholines and Hippocampal Brain Volume in Late Onset Alzheimer's Disease.
    J Alzheimers Dis. 2016.
    PubMed     Text format     Abstract available


  414. AMEN DG, Darmal B, Raji CA, Bao W, et al
    Discriminative Properties of Hippocampal Hypoperfusion in Marijuana Users Compared to Healthy Controls: Implications for Marijuana Administration in Alzheimer's Dementia.
    J Alzheimers Dis. 2016.
    PubMed     Text format     Abstract available


  415. BEHESHTI I, Maikusa N, Matsuda H, Demirel H, et al
    Histogram-Based Feature Extraction from Individual Gray Matter Similarity-Matrix for Alzheimer's Disease Classification.
    J Alzheimers Dis. 2016.
    PubMed     Text format     Abstract available


  416. ABU RUMEILEH S, Lattanzio F, Stanzani Maserati M, Rizzi R, et al
    Diagnostic Accuracy of a Combined Analysis of Cerebrospinal Fluid t-PrP, t-tau, p-tau, and Abeta42 in the Differential Diagnosis of Creutzfeldt-Jakob Disease from Alzheimer's Disease with Emphasis on Atypical Disease Variants.
    J Alzheimers Dis. 2016.
    PubMed     Text format     Abstract available


  417. CAGNIN A, Fragiacomo F, Camporese G, Turco M, et al
    Sleep-Wake Profile in Dementia with Lewy Bodies, Alzheimer's Disease, and Normal Aging.
    J Alzheimers Dis. 2016.
    PubMed     Text format     Abstract available


  418. QUARMLEY M, Moberg PJ, Mechanic-Hamilton D, Kabadi S, et al
    Odor Identification Screening Improves Diagnostic Classification in Incipient Alzheimer's Disease.
    J Alzheimers Dis. 2016.
    PubMed     Text format     Abstract available


  419. BERGERON D, Vermette A, De La Sablonniere J, Cayer AM, et al
    Finger-to-Nose Test Findings in Alzheimer's Disease.
    J Alzheimers Dis. 2016.
    PubMed     Text format     Abstract available


  420. MULLER S, Preische O, Heymann P, Elbing U, et al
    Diagnostic Value of a Tablet-Based Drawing Task for Discrimination of Patients in the Early Course of Alzheimer's Disease from Healthy Individuals.
    J Alzheimers Dis. 2016.
    PubMed     Text format     Abstract available


  421. SZABLEWSKI L
    Glucose Transporters in Brain: In Health and in Alzheimer's Disease.
    J Alzheimers Dis. 2016.
    PubMed     Text format     Abstract available


  422. CARMONA-IRAGUI M, Santos T, Videla S, Fernandez S, et al
    Feasibility of Lumbar Puncture in the Study of Cerebrospinal Fluid Biomarkers for Alzheimer's Disease in Subjects with Down Syndrome.
    J Alzheimers Dis. 2016.
    PubMed     Text format     Abstract available


  423. ALVES SARNO T, Leme Talib L, Passarelli Giroud Joaquim H, Farid Gattaz W, et al
    Protein Expression of BACE1 is Downregulated by Donepezil in Alzheimer's Disease Platelets.
    J Alzheimers Dis. 2016.
    PubMed     Text format     Abstract available


  424. ARROYO-ANLLO EM, Boustonb AT, Fargeau MN, Orgaz Baz B, et al
    Self-Consciousness Deficits in Alzheimer's Disease and Frontotemporal Dementia.
    J Alzheimers Dis. 2016.
    PubMed     Text format     Abstract available


  425. MOSS DE, Perez RG, Kobayashi H
    Cholinesterase Inhibitor Therapy in Alzheimer's Disease: The Limits and Tolerability of Irreversible CNS-Selective Acetylcholinesterase Inhibition in Primates.
    J Alzheimers Dis. 2016.
    PubMed     Text format     Abstract available


  426. GAMIR-MORRALLA A, Belbin O, Fortea J, Alcolea D, et al
    Kidins220 Correlates with Tau in Alzheimer's Disease Brain and Cerebrospinal Fluid.
    J Alzheimers Dis. 2016.
    PubMed     Text format     Abstract available


  427. MONACELLI F, Cea M, Borghi R, Odetti P, et al
    Do Cancer Drugs Counteract Neurodegeneration? Repurposing for Alzheimer's Disease.
    J Alzheimers Dis. 2016.
    PubMed     Text format     Abstract available


  428. REITER K, Nielson KA, Durgerian S, Woodard JL, et al
    Five-Year Longitudinal Brain Volume Change in Healthy Elders at Genetic Risk for Alzheimer's Disease.
    J Alzheimers Dis. 2016.
    PubMed     Text format     Abstract available


  429. CHAU SA, Herrmann N, Sherman C, Chung J, et al
    Visual Selective Attention Toward Novel Stimuli Predicts Cognitive Decline in Alzheimer's Disease Patients.
    J Alzheimers Dis. 2016.
    PubMed     Text format     Abstract available


  430. LUSARDI TA, Phillips JI, Wiedrick JT, Harrington CA, et al
    MicroRNAs in Human Cerebrospinal Fluid as Biomarkers for Alzheimer's Disease.
    J Alzheimers Dis. 2016.
    PubMed     Text format     Abstract available


  431. DENGLER-CRISH CM, Smith MA, Wilson GN
    Early Evidence of Low Bone Density and Decreased Serotonergic Synthesis in the Dorsal Raphe of a Tauopathy Model of Alzheimer's Disease.
    J Alzheimers Dis. 2016.
    PubMed     Text format     Abstract available


  432. BEESLEY S, Olcese J, Saunders C, Bienkiewicz EA, et al
    Combinatorial Treatment Effects in a Cell Culture Model of Alzheimer's Disease.
    J Alzheimers Dis. 2016.
    PubMed     Text format     Abstract available


  433. NUNOMURA A, Zhu X, Perry G
    Modulation of Parkinson's Disease Associated Protein Rescues Alzheimer's Disease Degeneration.
    J Alzheimers Dis. 2016;55:73-75.
    PubMed     Text format     Abstract available


    October 2016
  434. OCHOA JF, Alonso JF, Duque JE, Tobon CA, et al
    Successful Scene Encoding Induces Increased Directed Connectivity in Presymptomatic Early-Onset Alzheimer's Disease.
    J Alzheimers Dis. 2016.
    PubMed     Text format     Abstract available


  435. LEE M, Guo JP, Kennedy K, McGeer EG, et al
    A Method for Diagnosing Alzheimer's Disease Based on Salivary Amyloid-beta Protein 42 Levels.
    J Alzheimers Dis. 2016.
    PubMed     Text format     Abstract available


  436. MENDIOLA-PRECOMA J, Padilla K, Rodriguez-Cruz A, Berumen LC, et al
    Theobromine-Induced Changes in A1 Purinergic Receptor Gene Expression and Distribution in a Rat Brain Alzheimer's Disease Model.
    J Alzheimers Dis. 2016.
    PubMed     Text format     Abstract available


  437. DE LA RUBIA ORTI JE, Castillo SS, Benlloch M, Rochina MJ, et al
    Impact of the Relationship of Stress and the Immune System in the Appearance of Alzheimer's Disease.
    J Alzheimers Dis. 2016.
    PubMed     Text format     Abstract available


  438. CUMMINGS J, Scheltens P, McKeith I, Blesa R, et al
    Effect Size Analyses of Souvenaid in Patients with Alzheimer's Disease.
    J Alzheimers Dis. 2016.
    PubMed     Text format     Abstract available


  439. CAI Q, Tammineni P
    Mitochondrial Aspects of Synaptic Dysfunction in Alzheimer's Disease.
    J Alzheimers Dis. 2016.
    PubMed     Text format     Abstract available


  440. SERINO S, Riva G
    The Proactive Self in Space: How Egocentric and Allocentric Spatial Impairments Contribute to Anosognosia in Alzheimer's Disease.
    J Alzheimers Dis. 2016.
    PubMed     Text format     Abstract available


  441. CEBERS G, Alexander RC, Haeberlein SB, Han D, et al
    AZD3293: Pharmacokinetic and Pharmacodynamic Effects in Healthy Subjects and Patients with Alzheimer's Disease.
    J Alzheimers Dis. 2016.
    PubMed     Text format     Abstract available


  442. ANDERSON M, Xu F, Ou-Yang MH, Davis J, et al
    Intensive 'Brain Training' Intervention Fails to Reduce Amyloid Pathologies or Cognitive Deficits in Transgenic Mouse Models of Alzheimer's Disease.
    J Alzheimers Dis. 2016.
    PubMed     Text format     Abstract available


  443. ZHUANG X, Chen Y, Zhuang X, Xing T, et al
    Impaired Center-Surround Suppression in Patients with Alzheimer's Disease.
    J Alzheimers Dis. 2016.
    PubMed     Text format     Abstract available



  444. Upcoming Meetings Related to Alzheimer's Disease.
    J Alzheimers Dis. 2016;54:1687-1690.
    PubMed     Text format    


  445. LEWCZUK P, Matzen A, Blennow K, Parnetti L, et al
    Cerebrospinal Fluid Abeta42/40 Corresponds Better than Abeta42 to Amyloid PET in Alzheimer's Disease.
    J Alzheimers Dis. 2016.
    PubMed     Text format     Abstract available


  446. DE LA MONTE SM, Tong M, Schiano I, Didsbury J, et al
    Improved Brain Insulin/IGF Signaling and Reduced Neuroinflammation with T3D-959 in an Experimental Model of Sporadic Alzheimer's Disease.
    J Alzheimers Dis. 2016.
    PubMed     Text format     Abstract available


  447. CRISPOLTONI L, Stabile AM, Pistilli A, Venturelli M, et al
    Changes in Plasma beta-NGF and Its Receptors Expression on Peripheral Blood Monocytes During Alzheimer's Disease Progression.
    J Alzheimers Dis. 2016.
    PubMed     Text format     Abstract available


  448. TONG Z, Wang W, Luo W, Lv J, et al
    Urine Formaldehyde Predicts Cognitive Impairment in Post-Stroke Dementia and Alzheimer's Disease.
    J Alzheimers Dis. 2016.
    PubMed     Text format     Abstract available


  449. ANDREOTTI J, Dierks T, Wahlund LO, Grieder M, et al
    Diverging Progression of Network Disruption and Atrophy in Alzheimer's Disease and Semantic Dementia.
    J Alzheimers Dis. 2016.
    PubMed     Text format     Abstract available


  450. MCCLURE R, Ong H, Janve V, Barton S, et al
    Aerosol Delivery of Curcumin Reduced Amyloid-beta Deposition and Improved Cognitive Performance in a Transgenic Model of Alzheimer's Disease.
    J Alzheimers Dis. 2016.
    PubMed     Text format     Abstract available


  451. NOGUCHI-SHINOHARA M, Komatsu J, Samuraki M, Matsunari I, et al
    Cerebral Amyloid Angiopathy-Related Microbleeds and Cerebrospinal Fluid Biomarkers in Alzheimer's Disease.
    J Alzheimers Dis. 2016.
    PubMed     Text format     Abstract available


  452. MARTINS IV, Rivers-Auty J, Allan SM, Lawrence CB, et al
    Mitochondrial Abnormalities and Synaptic Loss Underlie Memory Deficits Seen in Mouse Models of Obesity and Alzheimer's Disease.
    J Alzheimers Dis. 2016.
    PubMed     Text format     Abstract available


  453. LAITERA T, Paananen J, Helisalmi S, Sarajarvi T, et al
    Effects of Alzheimer's Disease-Associated Risk Loci on Amyloid-beta Accumulation in the Brain of Idiopathic Normal Pressure Hydrocephalus Patients.
    J Alzheimers Dis. 2016.
    PubMed     Text format     Abstract available


  454. DRONSE J, Fliessbach K, Bischof GN, von Reutern B, et al
    In vivo Patterns of Tau Pathology, Amyloid-beta Burden, and Neuronal Dysfunction in Clinical Variants of Alzheimer's Disease.
    J Alzheimers Dis. 2016.
    PubMed     Text format     Abstract available


  455. COSKUN P, Helguera P, Nemati Z, Bohannan RC, et al
    Metabolic and Growth Rate Alterations in Lymphoblastic Cell Lines Discriminate Between Down Syndrome and Alzheimer's Disease.
    J Alzheimers Dis. 2016.
    PubMed     Text format     Abstract available


  456. SHEN Y, Xia Y, Meng S, Lim NK, et al
    SH2B1 is Involved in the Accumulation of Amyloid-beta42 in Alzheimer's Disease.
    J Alzheimers Dis. 2016.
    PubMed     Text format     Abstract available


  457. HUEY ED, Lee S, Cheran G, Grafman J, et al
    Brain Regions Involved in Arousal and Reward Processing are Associated with Apathy in Alzheimer's Disease and Frontotemporal Dementia.
    J Alzheimers Dis. 2016.
    PubMed     Text format     Abstract available


  458. ULSTEIN I, Bohmer T
    Normal Vitamin Levels and Nutritional Indices in Alzheimer's Disease Patients with Mild Cognitive Impairment or Dementia with Normal Body Mass Indexes.
    J Alzheimers Dis. 2016.
    PubMed     Text format     Abstract available


  459. DEKENS DW, Naude PJ, Engelborghs S, Vermeiren Y, et al
    Neutrophil Gelatinase-Associated Lipocalin and its Receptors in Alzheimer's Disease (AD) Brain Regions: Differential Findings in AD with and without Depression.
    J Alzheimers Dis. 2016.
    PubMed     Text format     Abstract available


  460. DUGGER BN, Whiteside CM, Maarouf CL, Walker DG, et al
    The Presence of Select Tau Species in Human Peripheral Tissues and Their Relation to Alzheimer's Disease.
    J Alzheimers Dis. 2016;54:1249.
    PubMed     Text format    



  461. Upcoming Meetings Related to Alzheimer's Disease.
    J Alzheimers Dis. 2016;54:1253-1257.
    PubMed     Text format    


  462. MCGEER PL, Rogers J, McGeer EG
    Inflammation, Antiinflammatory Agents, and Alzheimer's Disease: The Last 22 Years.
    J Alzheimers Dis. 2016;54:853-857.
    PubMed     Text format     Abstract available


  463. LIN F, Ren P, Lo RY, Chapman BP, et al
    Insula and Inferior Frontal Gyrus' Activities Protect Memory Performance Against Alzheimer's Disease Pathology in Old Age.
    J Alzheimers Dis. 2016.
    PubMed     Text format     Abstract available


  464. VARMA VR, Watts A
    Daily Physical Activity Patterns During the Early Stage of Alzheimer's Disease.
    J Alzheimers Dis. 2016.
    PubMed     Text format     Abstract available


  465. RIVERO-SANTANA A, Ferreira D, Perestelo-Perez L, Westman E, et al
    Cerebrospinal Fluid Biomarkers for the Differential Diagnosis between Alzheimer's Disease and Frontotemporal Lobar Degeneration: Systematic Review, HSROC Analysis, and Confounding Factors.
    J Alzheimers Dis. 2016.
    PubMed     Text format     Abstract available


  466. AN H, Choi B, Park KW, Kim DH, et al
    The Effect of Escitalopram on Mood and Cognition in Depressive Alzheimer's Disease Subjects.
    J Alzheimers Dis. 2016.
    PubMed     Text format     Abstract available


  467. MIRANDA LF, Gomes KB, Tito PA, Silveira JN, et al
    Clinical Response to Donepezil in Mild and Moderate Dementia: Relationship to Drug Plasma Concentration and CYP2D6 and APOE Genetic Polymorphisms.
    J Alzheimers Dis. 2016.
    PubMed     Text format     Abstract available


    September 2016
  468. WANG R, Reddy PH
    Role of Glutamate and NMDA Receptors in Alzheimer's Disease.
    J Alzheimers Dis. 2016.
    PubMed     Text format     Abstract available


  469. LEGER D, Elbaz M, Dubois A, Rio S, et al
    Alzheimer's Disease Severity is Not Significantly Associated with Short Sleep: Survey by Actigraphy on 208 Mild and Moderate Alzheimer's Disease Patients.
    J Alzheimers Dis. 2016.
    PubMed     Text format     Abstract available


  470. DUCLOS H, de La Sayette V, Bonnet AL, Viard A, et al
    Social Cognition in the Frontal Variant of Alzheimer's Disease: A Case Study.
    J Alzheimers Dis. 2016.
    PubMed     Text format     Abstract available


  471. JHA SK, Jha NK, Kumar D, Sharma R, et al
    Stress-Induced Synaptic Dysfunction and Neurotransmitter Release in Alzheimer's Disease: Can Neurotransmitters and Neuromodulators be Potential Therapeutic Targets?
    J Alzheimers Dis. 2016.
    PubMed     Text format     Abstract available


  472. KEPP KP
    Ten Challenges of the Amyloid Hypothesis of Alzheimer's Disease.
    J Alzheimers Dis. 2016.
    PubMed     Text format     Abstract available


  473. CUCCARO D, De Marco EV, Cittadella R, Cavallaro S, et al
    Copy Number Variants in Alzheimer's Disease.
    J Alzheimers Dis. 2016.
    PubMed     Text format     Abstract available


  474. XIE B, Liu Z, Jiang L, Liu W, et al
    Increased Serum miR-206 Level Predicts Conversion from Amnestic Mild Cognitive Impairment to Alzheimer's Disease: A 5-Year Follow-up Study.
    J Alzheimers Dis. 2016.
    PubMed     Text format     Abstract available


  475. HAFKEMEIJER A, Moller C, Dopper EG, Jiskoot LC, et al
    A Longitudinal Study on Resting State Functional Connectivity in Behavioral Variant Frontotemporal Dementia and Alzheimer's Disease.
    J Alzheimers Dis. 2016.
    PubMed     Text format     Abstract available


  476. SERRA L, Mancini M, Cercignani M, Di Domenico C, et al
    Network-Based Substrate of Cognitive Reserve in Alzheimer's Disease.
    J Alzheimers Dis. 2016.
    PubMed     Text format     Abstract available


  477. KITAMURA Y, Inden M, Kimoto Y, Takata K, et al
    Effects of a DJ-1-Binding Compound on Spatial Learning and Memory Impairment in a Mouse Model of Alzheimer's Disease.
    J Alzheimers Dis. 2016.
    PubMed     Text format     Abstract available


  478. ARNERIC SP, Batrla-Utermann R, Beckett L, Bittner T, et al
    Cerebrospinal Fluid Biomarkers for Alzheimer's Disease: A View of the Regulatory Science Qualification Landscape from the Coalition Against Major Diseases CSF Biomarker Team.
    J Alzheimers Dis. 2016.
    PubMed     Text format     Abstract available


  479. DINKINS MB, Wang G, Bieberich E
    Sphingolipid-Enriched Extracellular Vesicles and Alzheimer's Disease: A Decade of Research.
    J Alzheimers Dis. 2016.
    PubMed     Text format     Abstract available


  480. KIM J, Schweizer TA, Fischer CE, Munoz DG, et al
    The Role of Cerebrovascular Disease on Cognitive and Functional Status and Psychosis in Severe Alzheimer's Disease.
    J Alzheimers Dis. 2016.
    PubMed     Text format     Abstract available


  481. DARST BF, Koscik RL, Racine AM, Oh JM, et al
    Pathway-Specific Polygenic Risk Scores as Predictors of Amyloid-beta Deposition and Cognitive Function in a Sample at Increased Risk for Alzheimer's Disease.
    J Alzheimers Dis. 2016.
    PubMed     Text format     Abstract available


  482. GUO L, Tian J, Du H
    Mitochondrial Dysfunction and Synaptic Transmission Failure in Alzheimer's Disease.
    J Alzheimers Dis. 2016.
    PubMed     Text format     Abstract available


  483. PHILIPPENS IH, Ormel PR, Baarends G, Johansson M, et al
    Acceleration of Amyloidosis by Inflammation in the Amyloid-Beta Marmoset Monkey Model of Alzheimer's Disease.
    J Alzheimers Dis. 2016.
    PubMed     Text format     Abstract available


  484. RAHA AA, Henderson JW, Stott SR, Vuono R, et al
    Neuroprotective Effect of TREM-2 in Aging and Alzheimer's Disease Model.
    J Alzheimers Dis. 2016.
    PubMed     Text format     Abstract available


  485. BETHEA CL, Reddy AP, Christian FL
    How Studies of the Serotonin System in Macaque Models of Menopause Relate to Alzheimer's Disease1.
    J Alzheimers Dis. 2016.
    PubMed     Text format     Abstract available


  486. ARDEKANI BA, Bermudez E, Mubeen AM, Bachman AH, et al
    Prediction of Incipient Alzheimer's Disease Dementia in Patients with Mild Cognitive Impairment.
    J Alzheimers Dis. 2016.
    PubMed     Text format     Abstract available


  487. RODRIGUEZ CRUZ Y, Strehaiano M, Rodriguez Obaya T, Garcia Rodriguez JC, et al
    An Intranasal Formulation of Erythropoietin (Neuro-EPO) Prevents Memory Deficits and Amyloid Toxicity in the APPSwe Transgenic Mouse Model of Alzheimer's Disease.
    J Alzheimers Dis. 2016.
    PubMed     Text format     Abstract available


  488. LEWCZUK P, Lelental N, Lachmann I, Holzer M, et al
    Non-Phosphorylated Tau as a Potential Biomarker of Alzheimer's Disease: Analytical and Diagnostic Characterization.
    J Alzheimers Dis. 2016.
    PubMed     Text format     Abstract available


  489. ZIMETTI F, Caffarra P, Ronda N, Favari E, et al
    Increased PCSK9 Cerebrospinal Fluid Concentrations in Alzheimer's Disease.
    J Alzheimers Dis. 2016.
    PubMed     Text format     Abstract available


  490. DAL-PAN A, Dudonne S, Bourassa P, Bourdoulous M, et al
    Cognitive-Enhancing Effects of a Polyphenols-Rich Extract from Fruits without Changes in Neuropathology in an Animal Model of Alzheimer's Disease.
    J Alzheimers Dis. 2016.
    PubMed     Text format     Abstract available


  491. MYUNG W, Lee C, Park JH, Woo SY, et al
    Occupational Attainment as Risk Factor for Progression from Mild Cognitive Impairment to Alzheimer's Disease: A CREDOS Study.
    J Alzheimers Dis. 2016.
    PubMed     Text format     Abstract available


  492. DOMINGUEZ-PRIETO M, Velasco A, Vega L, Tabernero A, et al
    Aberrant Co-Localization of Synaptic Proteins Promoted by Alzheimer's Disease Amyloid-beta Peptides: Protective Effect of Human Serum Albumin.
    J Alzheimers Dis. 2016.
    PubMed     Text format     Abstract available


  493. BRUGGENJURGEN B, Andersohn F, Burkowitz J, Ezzat N, et al
    Cohort Study on Predictors of Need for Nursing Care in Alzheimer's Disease: An Analysis of Healthcare Data.
    J Alzheimers Dis. 2016.
    PubMed     Text format     Abstract available


  494. SAINAGHI PP, Bellan M, Lombino F, Alciato F, et al
    Growth Arrest Specific 6 Concentration is Increased in the Cerebrospinal Fluid of Patients with Alzheimer's Disease.
    J Alzheimers Dis. 2016.
    PubMed     Text format     Abstract available


  495. ROBILLARD JM, Feng TL
    Health Advice in a Digital World: Quality and Content of Online Information about the Prevention of Alzheimer's Disease.
    J Alzheimers Dis. 2016.
    PubMed     Text format     Abstract available


  496. TURRO-GARRIGA O, Garre-Olmo J, Rene-Ramirez R, Calvo-Perxas L, et al
    Consequences of Anosognosia on the Cost of Caregivers' Care in Alzheimer's Disease.
    J Alzheimers Dis. 2016.
    PubMed     Text format     Abstract available


  497. MUSUNURI S, Khoonsari PE, Mikus M, Wetterhall M, et al
    Increased Levels of Extracellular Microvesicle Markers and Decreased Levels of Endocytic/Exocytic Proteins in the Alzheimer's Disease Brain.
    J Alzheimers Dis. 2016.
    PubMed     Text format     Abstract available


  498. TOMBINI M, Sicari M, Pellegrino G, Ursini F, et al
    Nutritional Status of Patients with Alzheimer's Disease and Their Caregivers.
    J Alzheimers Dis. 2016.
    PubMed     Text format     Abstract available


  499. MUELLER KD, Koscik RL, Turkstra LS, Riedeman SK, et al
    Connected Language in Late Middle-Aged Adults at Risk for Alzheimer's Disease.
    J Alzheimers Dis. 2016.
    PubMed     Text format     Abstract available


  500. GOOSSENS J, Laton J, Van Schependom J, Gielen J, et al
    EEG Dominant Frequency Peak Differentiates Between Alzheimer's Disease and Frontotemporal Lobar Degeneration.
    J Alzheimers Dis. 2016.
    PubMed     Text format     Abstract available



  501. Upcoming Meetings Related to Alzheimer's Disease.
    J Alzheimers Dis. 2016;54:847-52.
    PubMed     Text format    


  502. CESTARI JA, Fabri GM, Kalil J, Nitrini R, et al
    Oral Infections and Cytokine Levels in Patients with Alzheimer's Disease and Mild Cognitive Impairment Compared with Controls.
    J Alzheimers Dis. 2016;54:845.
    PubMed     Text format    


  503. MAGNIN E, Demonet JF, Wallon D, Dumurgier J, et al
    Primary Progressive Aphasia in the Network of French Alzheimer Plan Memory Centers.
    J Alzheimers Dis. 2016.
    PubMed     Text format     Abstract available


  504. RACINE AM, Clark LR, Berman SE, Koscik RL, et al
    Associations between Performance on an Abbreviated CogState Battery, Other Measures of Cognitive Function, and Biomarkers in People at Risk for Alzheimer's Disease.
    J Alzheimers Dis. 2016.
    PubMed     Text format     Abstract available


  505. MUKHAMEDYAROV MA, Rizvanov AA, Yakupov EZ, Zefirov AL, et al
    Transcriptional Analysis of Blood Lymphocytes and Skin Fibroblasts, Keratinocytes, and Endothelial Cells as a Potential Biomarker for Alzheimer's Disease.
    J Alzheimers Dis. 2016.
    PubMed     Text format     Abstract available


  506. WIJESINGHE P, Shankar SK, Yasha TC, Gorrie C, et al
    Vascular Contributions in Alzheimer's Disease-Related Neuropathological Changes: First Autopsy Evidence from a South Asian Aging Population.
    J Alzheimers Dis. 2016.
    PubMed     Text format     Abstract available


  507. BRODY M, Liu E, Di J, Lu M, et al
    A Phase II, Randomized, Double-Blind, Placebo-Controlled Study of Safety, Pharmacokinetics, and Biomarker Results of Subcutaneous Bapineuzumab in Patients with mild to moderate Alzheimer's disease.
    J Alzheimers Dis. 2016.
    PubMed     Text format     Abstract available


  508. MAZZEO S, Santangelo R, Bernasconi MP, Cecchetti G, et al
    Combining Cerebrospinal Fluid Biomarkers and Neuropsychological Assessment: A Simple and Cost-Effective Algorithm to Predict the Progression from Mild Cognitive Impairment to Alzheimer's Disease Dementia.
    J Alzheimers Dis. 2016.
    PubMed     Text format     Abstract available


    August 2016
  509. BENGOETXEA X, de Cerain AL, Azqueta A, Ramirez MJ, et al
    Purported Interactions of Amyloid-beta and Glucocorticoids in Cytotoxicity and Genotoxicity: Implications in Alzheimer's Disease.
    J Alzheimers Dis. 2016.
    PubMed     Text format     Abstract available


  510. FARR SA, Sandoval KE, Niehoff ML, Witt KA, et al
    Peripheral Administration of GSK-3beta Antisense Oligonucleotide Improves Learning and Memory in SAMP8 and Tg2576 Mouse Models of Alzheimer's Disease.
    J Alzheimers Dis. 2016.
    PubMed     Text format     Abstract available


  511. FRIED I
    Brain Stimulation in Alzheimer's Disease.
    J Alzheimers Dis. 2016.
    PubMed     Text format     Abstract available


  512. RAJMOHAN R, Reddy PH
    Amyloid-Beta and Phosphorylated Tau Accumulations Cause Abnormalities at Synapses of Alzheimer's disease Neurons.
    J Alzheimers Dis. 2016.
    PubMed     Text format     Abstract available


  513. YOSHINO Y, Mori T, Yoshida T, Yamazaki K, et al
    Elevated mRNA Expression and Low Methylation of SNCA in Japanese Alzheimer's Disease Subjects.
    J Alzheimers Dis. 2016.
    PubMed     Text format     Abstract available


  514. RENARD D, Gabelle A, Hirtz C, Demattei C, et al
    Cerebrospinal Fluid Alzheimer's Disease Biomarkers in Isolated Supratentorial Cortical Superficial Siderosis.
    J Alzheimers Dis. 2016.
    PubMed     Text format     Abstract available


  515. LEVY B, Tsoy E, Gable S
    Developing Cognitive Markers of Alzheimer's Disease for Primary Care: Implications for Behavioral and Global Prevention.
    J Alzheimers Dis. 2016.
    PubMed     Text format     Abstract available


  516. ESTRADA LD, Chamorro D, Yanez MJ, Gonzalez M, et al
    Reduction of Blood Amyloid-beta Oligomers in Alzheimer's Disease Transgenic Mice by c-Abl Kinase Inhibition.
    J Alzheimers Dis. 2016.
    PubMed     Text format     Abstract available


  517. MARESOVA P, Klimova B, Novotny M, Kuca K, et al
    Alzheimer's and Parkinson's Diseases: Expected Economic Impact on Europe- A Call for a Uniform European Strategy.
    J Alzheimers Dis. 2016.
    PubMed     Text format     Abstract available


  518. RAI N, Kumar R, Desai GR, Venugopalan G, et al
    Relative Alterations in Blood-Based Levels of Sestrin in Alzheimer's Disease and Mild Cognitive Impairment Patients.
    J Alzheimers Dis. 2016.
    PubMed     Text format     Abstract available


  519. WOLFSGRUBER S, Kleineidam L, Wagner M, Mosch E, et al
    Differential Risk of Incident Alzheimer's Disease Dementia in Stable Versus Unstable Patterns of Subjective Cognitive Decline.
    J Alzheimers Dis. 2016.
    PubMed     Text format     Abstract available


  520. TAHERI S, Yu J, Zhu H, Kindy MS, et al
    High-Sodium Diet Has Opposing Effects on Mean Arterial Blood Pressure and Cerebral Perfusion in a Transgenic Mouse Model of Alzheimer's Disease.
    J Alzheimers Dis. 2016.
    PubMed     Text format     Abstract available


  521. SHANKLE WR, Hara J, Barrentine LW, Curole MV, et al
    CerefolinNAC Therapy of Hyperhomocysteinemia Delays Cortical and White Matter Atrophy in Alzheimer's Disease and Cerebrovascular Disease.
    J Alzheimers Dis. 2016.
    PubMed     Text format     Abstract available



  522. Upcoming Meetings Related to Alzheimer's Disease.
    J Alzheimers Dis. 2016;54:411-5.
    PubMed     Text format    



  523. Mark W. Bondi, PhD, Recipient of 2016 Alzheimer Award.
    J Alzheimers Dis. 2016;54:1-2.
    PubMed     Text format    


  524. SCHARRE DW, Chang SI, Nagaraja HN, Park A, et al
    Paired Studies Comparing Clinical Profiles of Lewy Body Dementia with Alzheimer's and Parkinson's Diseases.
    J Alzheimers Dis. 2016.
    PubMed     Text format     Abstract available


  525. LIMA S, Gago M, Garrett C, Pereira MG, et al
    Predictors and Moderators of Quality of Life in Alzheimer's Disease Patients.
    J Alzheimers Dis. 2016.
    PubMed     Text format     Abstract available


  526. SEPE-MONTI M, Vanacore N, Bartorelli L, Tognetti A, et al
    The Savvy Caregiver Program: A Probe Multicenter Randomized Controlled Pilot Trial in Caregivers of Patients Affected by Alzheimer's Disease.
    J Alzheimers Dis. 2016.
    PubMed     Text format     Abstract available


  527. YU Q, Fang D, Swerdlow RH, Yu H, et al
    Antioxidants Rescue Mitochondrial Transport in Differentiated Alzheimer's Disease Trans-Mitochondrial Cybrid Cells.
    J Alzheimers Dis. 2016.
    PubMed     Text format     Abstract available


  528. CHAPLEAU M, Aldebert J, Montembeault M, Brambati SM, et al
    Atrophy in Alzheimer's Disease and Semantic Dementia: An ALE Meta-Analysis of Voxel-Based Morphometry Studies.
    J Alzheimers Dis. 2016.
    PubMed     Text format     Abstract available


  529. DE BEAUMONT L, Pelleieux S, Lamarre-Theroux L, Dea D, et al
    Butyrylcholinesterase K and Apolipoprotein E-varepsilon4 Reduce the Age of Onset of Alzheimer's Disease, Accelerate Cognitive Decline, and Modulate Donepezil Response in Mild Cognitively Impaired Subjects.
    J Alzheimers Dis. 2016.
    PubMed     Text format     Abstract available


  530. MAHESHWARI P, Eslick GD
    Bacterial Infection Increases the Risk of Alzheimer's Disease: An Evidence-Based Assessment.
    J Alzheimers Dis. 2016.
    PubMed     Text format     Abstract available


  531. VAN STEENOVEN I, Aarsland D, Weintraub D, Londos E, et al
    Cerebrospinal Fluid Alzheimer's Disease Biomarkers Across the Spectrum of Lewy Body Diseases: Results from a Large Multicenter Cohort.
    J Alzheimers Dis. 2016;54:287-95.
    PubMed     Text format     Abstract available


  532. GERTJE EC, Pluta J, Das S, Mancuso L, et al
    Clinical Application of Automatic Segmentation of Medial Temporal Lobe Subregions in Prodromal and Dementia-Level Alzheimer's Disease.
    J Alzheimers Dis. 2016.
    PubMed     Text format     Abstract available


  533. SELIVANOVA OM, Surin AK, Marchenkov VV, Dzhus UF, et al
    The Mechanism Underlying Amyloid Polymorphism is Opened for Alzheimer's Disease Amyloid-beta Peptide.
    J Alzheimers Dis. 2016.
    PubMed     Text format     Abstract available


  534. CHEN G, Shu H, Chen G, Ward BD, et al
    Staging Alzheimer's Disease Risk by Sequencing Brain Function and Structure, Cerebrospinal Fluid, and Cognition Biomarkers.
    J Alzheimers Dis. 2016.
    PubMed     Text format     Abstract available


  535. VIJAYAN M, Reddy PH
    Stroke, Vascular Dementia, and Alzheimer's Disease: Molecular Links.
    J Alzheimers Dis. 2016.
    PubMed     Text format     Abstract available


  536. EL HAJ M, Antoine P
    Death Preparation and Boredom Reduction as Functions of Reminiscence in Alzheimer's Disease.
    J Alzheimers Dis. 2016.
    PubMed     Text format     Abstract available


  537. CALDERON-GARCIDUENAS L, Avila-Ramirez J, Calderon-Garciduenas A, Gonzalez-Heredia T, et al
    Cerebrospinal Fluid Biomarkers in Highly Exposed PM2.5 Urbanites: The Risk of Alzheimer's and Parkinson's Diseases in Young Mexico City Residents.
    J Alzheimers Dis. 2016.
    PubMed     Text format     Abstract available


  538. HAKOBYAN S, Harding K, Aiyaz M, Hye A, et al
    Complement Biomarkers as Predictors of Disease Progression in Alzheimer's Disease.
    J Alzheimers Dis. 2016.
    PubMed     Text format     Abstract available


  539. KANG JM, Yeon BK, Cho SJ, Suh YH, et al
    Stem Cell Therapy for Alzheimer's Disease: A Review of Recent Clinical Trials.
    J Alzheimers Dis. 2016.
    PubMed     Text format     Abstract available


  540. VILLARREAL AE, Grajales S, O'Bryant SE, Edwards M, et al
    Characterization of Alzheimer's Disease and Mild Cognitive Impairment in Older Adults in Panama.
    J Alzheimers Dis. 2016.
    PubMed     Text format     Abstract available


  541. SEO EH, Kim SH, Park SH, Kang SH, et al
    Topographical APOE varepsilon4 Genotype Influence on Cerebral Metabolism in the Continuum of Alzheimer's Disease: Amyloid Burden Adjusted Analysis.
    J Alzheimers Dis. 2016.
    PubMed     Text format     Abstract available


  542. HO BL, Kao YH, Chou MC, Yang YH, et al
    Cerebral White Matter Changes on Therapeutic Response to Rivastigmine in Alzheimer's Disease.
    J Alzheimers Dis. 2016;54:351-7.
    PubMed     Text format     Abstract available


  543. WANG H, Wang Y, Hong X, Li S, et al
    Quantitative Proteomics Reveals the Mechanism of Oxygen Treatment on Lenses of Alzheimer's Disease Model Mice.
    J Alzheimers Dis. 2016;54:275-86.
    PubMed     Text format     Abstract available


  544. JAAKKIMAINEN RL, Bronskill SE, Tierney MC, Herrmann N, et al
    Identification of Physician-Diagnosed Alzheimer's Disease and Related Dementias in Population-Based Administrative Data: A Validation Study Using Family Physicians' Electronic Medical Records.
    J Alzheimers Dis. 2016;54:337-49.
    PubMed     Text format     Abstract available


  545. LIU S, Ong YT, Hilal S, Loke YM, et al
    The Association Between Retinal Neuronal Layer and Brain Structure is Disrupted in Patients with Cognitive Impairment and Alzheimer's Disease.
    J Alzheimers Dis. 2016.
    PubMed     Text format     Abstract available


  546. BECKELMAN BC, Day S, Zhou X, Donohue M, et al
    Dysregulation of Elongation Factor 1A Expression is Correlated with Synaptic Plasticity Impairments in Alzheimer's Disease.
    J Alzheimers Dis. 2016.
    PubMed     Text format     Abstract available


  547. ROSENBERG PB, Lanctot KL, Herrmann N, Mintzer JE, et al
    Changes in Neuropsychiatric Inventory Associated with Semagacestat Treatment of Alzheimer's Disease.
    J Alzheimers Dis. 2016;54:373-81.
    PubMed     Text format     Abstract available


  548. SOMERS C, Struyfs H, Goossens J, Niemantsverdriet E, et al
    A Decade of Cerebrospinal Fluid Biomarkers for Alzheimer's Disease in Belgium.
    J Alzheimers Dis. 2016;54:383-95.
    PubMed     Text format     Abstract available


  549. MARTIRE S, Fuso A, Mosca L, Forte E, et al
    Bioenergetic Impairment in Animal and Cellular Models of Alzheimer's Disease: PARP-1 Inhibition Rescues Metabolic Dysfunctions.
    J Alzheimers Dis. 2016;54:307-24.
    PubMed     Text format     Abstract available



  550. Upcoming Meetings Related to Alzheimer's Disease.
    J Alzheimers Dis. 2016;53:1653-7.
    PubMed     Text format    



  551. Upcoming Meetings Related to Alzheimer's Disease.
    J Alzheimers Dis. 2016;53:1231-5.
    PubMed     Text format    


  552. ITZHAKI RF
    Herpes and Alzheimer's Disease: Subversion in the Central Nervous System and How It Might Be Halted.
    J Alzheimers Dis. 2016.
    PubMed     Text format     Abstract available


  553. AROSIO B, Casati M, Gussago C, Ferri E, et al
    Adenosine Type A2A Receptor in Peripheral Cell from Patients with Alzheimer's Disease, Vascular Dementia, and Idiopathic Normal Pressure Hydrocephalus: A New/Old Potential Target.
    J Alzheimers Dis. 2016.
    PubMed     Text format     Abstract available


  554. GOLDWASER EL, Acharya NK, Sarkar A, Godsey G, et al
    Breakdown of the Cerebrovasculature and Blood-Brain Barrier: A Mechanistic Link Between Diabetes Mellitus and Alzheimer's Disease.
    J Alzheimers Dis. 2016.
    PubMed     Text format     Abstract available


    July 2016
  555. GRINBERG LT, Anghinah R, Nascimento CF, Amaro E, et al
    Chronic Traumatic Encephalopathy Presenting as Alzheimer's Disease in a Retired Soccer Player.
    J Alzheimers Dis. 2016.
    PubMed     Text format     Abstract available


  556. MANDECKA M, Budziszewska M, Barczak A, Peplonska B, et al
    Association between Cerebrospinal Fluid Biomarkers for Alzheimer's Disease: APOE Genotypes and Auditory Verbal Learning Task in Subjective Cognitive Decline, Mild Cognitive Impairment, and Alzheimer's Disease.
    J Alzheimers Dis. 2016.
    PubMed     Text format     Abstract available


  557. ULAMEK-KOZIOL M, Kocki J, Bogucka-Kocka A, Petniak A, et al
    Dysregulation of Autophagy, Mitophagy, and Apoptotic Genes in the Medial Temporal Lobe Cortex in an Ischemic Model of Alzheimer's Disease.
    J Alzheimers Dis. 2016.
    PubMed     Text format     Abstract available


  558. HULSEMANN M, Zafiu C, Kuhbach K, Luhmann N, et al
    Biofunctionalized Silica Nanoparticles: Standards in Amyloid-beta Oligomer-Based Diagnosis of Alzheimer's Disease.
    J Alzheimers Dis. 2016.
    PubMed     Text format     Abstract available


  559. MIDORIKAWA A, Leyton CE, Foxe D, Landin-Romero R, et al
    All Is Not Lost: Positive Behaviors in Alzheimer's Disease and Behavioral-Variant Frontotemporal Dementia with Disease Severity.
    J Alzheimers Dis. 2016.
    PubMed     Text format     Abstract available


  560. DURAZZO TC, Korecka M, Trojanowski JQ, Weiner MW, et al
    Active Cigarette Smoking in Cognitively-Normal Elders and Probable Alzheimer's Disease is Associated with Elevated Cerebrospinal Fluid Oxidative Stress Biomarkers.
    J Alzheimers Dis. 2016.
    PubMed     Text format     Abstract available


  561. MALPAS CB, Vivash L, Genc S, Saling MM, et al
    A Phase IIa Randomized Control Trial of VEL015 (Sodium Selenate) in Mild-Moderate Alzheimer's Disease.
    J Alzheimers Dis. 2016.
    PubMed     Text format     Abstract available


  562. CHIASSERINI D, Biscetti L, Farotti L, Eusebi P, et al
    Performance Evaluation of an Automated ELISA System for Alzheimer's Disease Detection in Clinical Routine.
    J Alzheimers Dis. 2016.
    PubMed     Text format     Abstract available


  563. LOZANO AM, Fosdick L, Chakravarty MM, Leoutsakos JM, et al
    A Phase II Study of Fornix Deep Brain Stimulation in Mild Alzheimer's Disease.
    J Alzheimers Dis. 2016.
    PubMed     Text format     Abstract available


  564. VENTURELLI M, Sollima A, Ce E, Limonta E, et al
    Effectiveness of Exercise- and Cognitive-Based Treatments on Salivary Cortisol Levels and Sundowning Syndrome Symptoms in Patients with Alzheimer's Disease.
    J Alzheimers Dis. 2016;53:1631-40.
    PubMed     Text format     Abstract available


  565. JAKOBSEN JE, Johansen MG, Schmidt M, Liu Y, et al
    Expression of the Alzheimer's Disease Mutations AbetaPP695sw and PSEN1M146I in Double-Transgenic Gottingen Minipigs.
    J Alzheimers Dis. 2016;53:1617-30.
    PubMed     Text format     Abstract available


  566. LI X, Jia S, Zhou Z, Hou C, et al
    The Gesture Imitation in Alzheimer's Disease Dementia and Amnestic Mild Cognitive Impairment.
    J Alzheimers Dis. 2016;53:1577-84.
    PubMed     Text format     Abstract available


  567. ROSSINI PM, Di Iorio R, Granata G, Miraglia F, et al
    From Mild Cognitive Impairment to Alzheimer's Disease: A New Perspective in the "Land" of Human Brain Reactivity and Connectivity.
    J Alzheimers Dis. 2016;53:1389-93.
    PubMed     Text format     Abstract available


  568. ETTCHETO M, Petrov D, Pedros I, Alva N, et al
    Evaluation of Neuropathological Effects of a High-Fat Diet in a Presymptomatic Alzheimer's Disease Stage in APP/PS1 Mice.
    J Alzheimers Dis. 2016;54:233-51.
    PubMed     Text format     Abstract available



  569. Upcoming Meetings Related to Alzheimer's Disease.
    J Alzheimers Dis. 2016;53:747-51.
    PubMed     Text format    


  570. JAHNG GH, Oh J, Lee DW, Kim HG, et al
    Glutamine and Glutamate Complex, as Measured by Functional Magnetic Resonance Spectroscopy, Alters During Face-Name Association Task in Patients with Mild Cognitive Impairment and Alzheimer's Disease.
    J Alzheimers Dis. 2016;53:745.
    PubMed     Text format    


  571. PENNINKILAMPI R, Brothers HM, Eslick GD
    Pharmacological Agents Targeting gamma-Secretase Increase Risk of Cancer and Cognitive Decline in Alzheimer's Disease Patients: A Systematic Review and Meta-Analysis.
    J Alzheimers Dis. 2016.
    PubMed     Text format     Abstract available


  572. DE VOS A, Struyfs H, Jacobs D, Fransen E, et al
    The Cerebrospinal Fluid Neurogranin/BACE1 Ratio is a Potential Correlate of Cognitive Decline in Alzheimer's Disease.
    J Alzheimers Dis. 2016.
    PubMed     Text format     Abstract available


  573. BANGEN KJ, Himali JJ, Beiser AS, Nation DA, et al
    Interaction Between Midlife Blood Glucose and APOE Genotype Predicts Later Alzheimer's Disease Pathology.
    J Alzheimers Dis. 2016.
    PubMed     Text format     Abstract available


  574. KANG S, Jeong H, Baek JH, Lee SJ, et al
    PiB-PET Imaging-Based Serum Proteome Profiles Predict Mild Cognitive Impairment and Alzheimer's Disease.
    J Alzheimers Dis. 2016.
    PubMed     Text format     Abstract available


  575. ADIELE RC, Adiele CA
    Mitochondrial Regulatory Pathways in the Pathogenesis of Alzheimer's Disease.
    J Alzheimers Dis. 2016.
    PubMed     Text format     Abstract available


  576. SALEM H, Rocha NP, Colpo GD, Teixeira AL, et al
    Moving from the Dish to the Clinical Practice: A Decade of Lessons and Perspectives from the Pre-Clinical and Clinical Stem Cell Studies for Alzheimer's Disease.
    J Alzheimers Dis. 2016.
    PubMed     Text format     Abstract available


  577. DAVID R, Manera V, Fabre R, Pradier C, et al
    Evolution of the Rate of Antidepressant Prescriptions in Alzheimer's Disease and Related Disorders Between 2010 and 2014: Results from the French National Database on Alzheimer's Disease (BNA).
    J Alzheimers Dis. 2016.
    PubMed     Text format     Abstract available


  578. IDRIZBEGOVIC E, Hederstierna C, Rosenhall U
    Mismatch Negativity and Ear Laterality in Alzheimer's Disease and in Mild Cognitive Impairment.
    J Alzheimers Dis. 2016.
    PubMed     Text format     Abstract available


  579. ANDERSSON CH, Hansson O, Minthon L, Andreasen N, et al
    A Genetic Variant of the Sortilin 1 Gene is Associated with Reduced Risk of Alzheimer's Disease.
    J Alzheimers Dis. 2016.
    PubMed     Text format     Abstract available


  580. AMBROSE CT
    The Role of Capillaries in the Lesser Ailments of Old Age and in Alzheimer's Disease and Vascular Dementia: The Potential of Pro-Therapeutic Angiogenesis.
    J Alzheimers Dis. 2016.
    PubMed     Text format     Abstract available


  581. GROSSI E, Stoccoro A, Tannorella P, Migliore L, et al
    Artificial Neural Networks Link One-Carbon Metabolism to Gene-Promoter Methylation in Alzheimer's Disease.
    J Alzheimers Dis. 2016.
    PubMed     Text format     Abstract available


    June 2016
  582. BRONNICK K, Breitve MH, Rongve A, Aarsland D, et al
    Neurocognitive Deficits Distinguishing Mild Dementia with Lewy Bodies from Mild Alzheimer's Disease are Associated with Parkinsonism.
    J Alzheimers Dis. 2016.
    PubMed     Text format     Abstract available


  583. ZIMMERER VC, Wibrow M, Varley RA
    Formulaic Language in People with Probable Alzheimer's Disease: A Frequency-Based Approach.
    J Alzheimers Dis. 2016.
    PubMed     Text format     Abstract available


  584. PIETTO M, Parra MA, Trujillo N, Flores F, et al
    Behavioral and Electrophysiological Correlates of Memory Binding Deficits in Patients at Different Risk Levels for Alzheimer's Disease.
    J Alzheimers Dis. 2016.
    PubMed     Text format     Abstract available


  585. BIELLA G, Fusco F, Nardo E, Bernocchi O, et al
    Sirtuin 2 Inhibition Improves Cognitive Performance and Acts on Amyloid-beta Protein Precursor Processing in Two Alzheimer's Disease Mouse Models.
    J Alzheimers Dis. 2016.
    PubMed     Text format     Abstract available


  586. DENG Y, Wei J, Cheng J, Zhong P, et al
    Partial Amelioration of Synaptic and Cognitive Deficits by Inhibiting Cofilin Dephosphorylation in an Animal Model of Alzheimer's Disease.
    J Alzheimers Dis. 2016.
    PubMed     Text format     Abstract available


  587. ALLEN HB
    Alzheimer's Disease: Assessing the Role of Spirochetes, Biofilms, the Immune System, and Amyloid-beta with Regard to Potential Treatment and Prevention.
    J Alzheimers Dis. 2016.
    PubMed     Text format     Abstract available



  588. Upcoming Meetings Related to Alzheimer's Disease.
    J Alzheimers Dis. 2016;53:363-6.
    PubMed     Text format    


  589. MAKOVAC E, Serra L, Spano B, Giulietti G, et al
    Different Patterns of Correlation between Grey and White Matter Integrity Account for Behavioral and Psychological Symptoms in Alzheimer's Disease.
    J Alzheimers Dis. 2016;50:591-604.
    PubMed     Text format     Abstract available


  590. PRETORIUS E, Bester J, Kell DB
    A Bacterial Component to Alzheimer's-Type Dementia Seen via a Systems Biology Approach that Links Iron Dysregulation and Inflammagen Shedding to Disease.
    J Alzheimers Dis. 2016.
    PubMed     Text format     Abstract available


  591. MOHSENI HK, Cowan D, Chettle DR, Milic AP, et al
    A Pilot Study Measuring Aluminum in Bone in Alzheimer's Disease and control Subjects Using in vivo Neutron Activation Analysis.
    J Alzheimers Dis. 2016.
    PubMed     Text format     Abstract available


  592. WANG J, Ye F, Cheng X, Zhang X, et al
    The Effects of LW-AFC on Intestinal Microbiome in Senescence-Accelerated Mouse Prone 8 Strain, a Mouse Model of Alzheimer's Disease.
    J Alzheimers Dis. 2016.
    PubMed     Text format     Abstract available


  593. HAWKINS KM, Sergio LE
    Adults at Increased Alzheimer's Disease Risk Display Cognitive-Motor Integration Impairment Associated with Changes in Resting-State Functional Connectivity: A Preliminary Study.
    J Alzheimers Dis. 2016.
    PubMed     Text format     Abstract available


  594. LIN CY, Cheng YS, Liao TY, Lin C, et al
    Intranasal Administration of a Polyethylenimine-Conjugated Scavenger Peptide Reduces Amyloid-beta Accumulation in a Mouse Model of Alzheimer's Disease.
    J Alzheimers Dis. 2016.
    PubMed     Text format     Abstract available


  595. CHOURAKI V, Reitz C, Maury F, Bis JC, et al
    Evaluation of a Genetic Risk Score to Improve Risk Prediction for Alzheimer's Disease.
    J Alzheimers Dis. 2016.
    PubMed     Text format     Abstract available


  596. VAN LANGENHOVE T, Leyton CE, Piguet O, Hodges JR, et al
    Comparing Longitudinal Behavior Changes in the Primary Progressive Aphasias.
    J Alzheimers Dis. 2016;53:1033-42.
    PubMed     Text format     Abstract available


  597. VERMEIREN Y, Janssens J, Aerts T, Martin JJ, et al
    Brain Serotonergic and Noradrenergic Deficiencies in Behavioral Variant Frontotemporal Dementia Compared to Early-Onset Alzheimer's Disease.
    J Alzheimers Dis. 2016.
    PubMed     Text format     Abstract available


  598. OLSEN I, Singhrao SK
    Inflammasome Involvement in Alzheimer's Disease.
    J Alzheimers Dis. 2016.
    PubMed     Text format     Abstract available


  599. ZHAI Y, Yamashita T, Nakano Y, Sun Z, et al
    Chronic Cerebral Hypoperfusion Accelerates Alzheimer's Disease Pathology with Cerebrovascular Remodeling in a Novel Mouse Model.
    J Alzheimers Dis. 2016.
    PubMed     Text format     Abstract available



  600. Upcoming Meetings Related to Alzheimer's Disease.
    J Alzheimers Dis. 2016;52:1515-9.
    PubMed     Text format    


    May 2016
  601. HOFRICHTER J, Krohn M, Schumacher T, Lange C, et al
    Sideritis spp. Extracts Enhance Memory and Learning in Alzheimer's beta-Amyloidosis Mouse Models and Aged C57Bl/6 Mice.
    J Alzheimers Dis. 2016.
    PubMed     Text format     Abstract available


  602. ALLUE JA, Sarasa L, Izco M, Perez-Grijalba V, et al
    Outstanding Phenotypic Differences in the Profile of Amyloid-beta between Tg2576 and APPswe/PS1dE9 Transgenic Mouse Models of Alzheimer's Disease.
    J Alzheimers Dis. 2016.
    PubMed     Text format     Abstract available


  603. CAMPANARI ML, Navarrete F, Ginsberg SD, Manzanares J, et al
    Increased Expression of Readthrough Acetylcholinesterase Variants in the Brains of Alzheimer's Disease Patients.
    J Alzheimers Dis. 2016.
    PubMed     Text format     Abstract available


  604. DERMODY N, Wong S, Ahmed R, Piguet O, et al
    Uncovering the Neural Bases of Cognitive and Affective Empathy Deficits in Alzheimer's Disease and the Behavioral-Variant of Frontotemporal Dementia.
    J Alzheimers Dis. 2016.
    PubMed     Text format     Abstract available


  605. ARENDASH GW
    Review of the Evidence that Transcranial Electromagnetic Treatment will be a Safe and Effective Therapeutic Against Alzheimer's Disease.
    J Alzheimers Dis. 2016.
    PubMed     Text format     Abstract available


  606. EUGENIN J, Vecchiola A, Murgas P, Arroyo P, et al
    Expression Pattern of Scavenger Receptors and Amyloid-beta Phagocytosis of Astrocytes and Microglia in Culture are Modified by Acidosis: Implications for Alzheimer's Disease.
    J Alzheimers Dis. 2016.
    PubMed     Text format     Abstract available


  607. OBOSHI Y, Kikuchi M, Terada T, Yoshikawa E, et al
    Alterations in Phase-Related Prefrontal Activation During Cognitive Tasks and Nicotinic alpha4beta2 Receptor Availability in Alzheimer's Disease.
    J Alzheimers Dis. 2016.
    PubMed     Text format     Abstract available



  608. Upcoming Meetings Related to Alzheimer's Disease.
    J Alzheimers Dis. 2016;52:1151-1155.
    PubMed     Text format    


  609. DEL VALLE E, Navarro A, Martinez-Pinilla E, Torices S, et al
    Apo J and Apo D: Complementary or Antagonistic Roles in Alzheimer's Disease?
    J Alzheimers Dis. 2016.
    PubMed     Text format     Abstract available


  610. HIRD MA, Egeto P, Fischer CE, Naglie G, et al
    A Systematic Review and Meta-Analysis of On-Road Simulator and Cognitive Driving Assessment in Alzheimer's Disease and Mild Cognitive Impairment.
    J Alzheimers Dis. 2016.
    PubMed     Text format     Abstract available


  611. TAIPA R, Sousa AL, Melo Pires M, Sousa N, et al
    Does the Interplay Between Aging and Neuroinflammation Modulate Alzheimer's Disease Clinical Phenotypes? A Clinico-Pathological Perspective.
    J Alzheimers Dis. 2016.
    PubMed     Text format     Abstract available


  612. LANDEL V, Annweiler C, Millet P, Morello M, et al
    Vitamin D, Cognition, and Alzheimer's Disease: The Therapeutic Benefit is in the D-Tails.
    J Alzheimers Dis. 2016.
    PubMed     Text format     Abstract available



  613. Upcoming Meetings Related to Alzheimer's Disease.
    J Alzheimers Dis. 2016;52:775-779.
    PubMed     Text format    


  614. DI MECO A, Pratico D
    MicroRNAs as Therapeutic Targets for Alzheimer's Disease.
    J Alzheimers Dis. 2016.
    PubMed     Text format     Abstract available


  615. TAJEDDINN W, Persson T, Calvo-Garrido J, Seed Ahmed M, et al
    Pharmacological Modulations of the Serotonergic System in a Cell-Model of Familial Alzheimer's Disease.
    J Alzheimers Dis. 2016.
    PubMed     Text format     Abstract available


  616. SZALARDY L, Zadori D, Klivenyi P, Vecsei L, et al
    The Role of Cerebrospinal Fluid Biomarkers in the Evolution of Diagnostic Criteria in Alzheimer's Disease: Shortcomings in Prodromal Diagnosis.
    J Alzheimers Dis. 2016.
    PubMed     Text format     Abstract available


  617. KASZA A, Hunya A, Frank Z, Fulop F, et al
    Dihydropyridine Derivatives Modulate Heat Shock Responses and have a Neuroprotective Effect in a Transgenic Mouse Model of Alzheimer's Disease.
    J Alzheimers Dis. 2016.
    PubMed     Text format     Abstract available


  618. FARNSWORTH B, Peuckert C, Zimmermann B, Jazin E, et al
    Gene Expression of Quaking in Sporadic Alzheimer's Disease Patients is Both Upregulated and Related to Expression Levels of Genes Involved in Amyloid Plaque and Neurofibrillary Tangle Formation.
    J Alzheimers Dis. 2016.
    PubMed     Text format     Abstract available


  619. WANG MJ, Yi S, Han JY, Park SY, et al
    Analysis of Cerebrospinal Fluid and [11C]PIB PET Biomarkers for Alzheimer's Disease with Updated Protocols.
    J Alzheimers Dis. 2016.
    PubMed     Text format     Abstract available


  620. HAPPICH M, Kirson NY, Desai U, King S, et al
    Excess Costs Associated with Possible Misdiagnosis of Alzheimer's Disease Among Patients with Vascular Dementia in a UK CPRD Population.
    J Alzheimers Dis. 2016.
    PubMed     Text format     Abstract available


  621. MALISZEWSKA-CYNA E, Xhima K, Aubert I
    A Comparative Study Evaluating the Impact of Physical Exercise on Disease Progression in a Mouse Model of Alzheimer's Disease.
    J Alzheimers Dis. 2016.
    PubMed     Text format     Abstract available


  622. VERMA N, Ly H, Liu M, Chen J, et al
    Intraneuronal Amylin Deposition Peroxidative Membrane Injury and Increased IL-1beta Synthesis in Brains of Alzheimer's Disease Patients with Type-2 Diabetes and in Diabetic HIP Rats.
    J Alzheimers Dis. 2016.
    PubMed     Text format     Abstract available


  623. BOLIVAR JC, Saladie DG
    Redefining Amnestic Mild Cognitive Impairment as an Early Form of Alzheimer's Disease Based on Assessment of Memory Systems.
    J Alzheimers Dis. 2016.
    PubMed     Text format     Abstract available


  624. TAJEDDINN W, Fereshtehnejad SM, Seed Ahmed M, Yoshitake T, et al
    Association of Platelet Serotonin Levels in Alzheimer's Disease with Clinical and Cerebrospinal Fluid Markers.
    J Alzheimers Dis. 2016.
    PubMed     Text format     Abstract available


  625. RUSSU A, Samtani MN, Xu S, Adedokun OJ, et al
    Biomarker Exposure-Response Analysis in Mild-To-Moderate Alzheimer's Disease Trials of Bapineuzumab.
    J Alzheimers Dis. 2016.
    PubMed     Text format     Abstract available


    April 2016

  626. Upcoming Meetings Related to Alzheimer's Disease.
    J Alzheimers Dis. 2016;52:385-9.
    PubMed     Text format    


  627. MARIN-MUNOZ J, Noguera-Perea MF, Gomez-Tortosa E, Lopez-Motos D, et al
    Novel Mutation (Gly212Val) in the PS2 Gene Associated with Early-Onset Familial Alzheimer's Disease.
    J Alzheimers Dis. 2016.
    PubMed     Text format     Abstract available


  628. EL GAAMOUCH F, Jing P, Xia J, Cai D, et al
    Alzheimer's Disease Risk Genes and Lipid Regulators.
    J Alzheimers Dis. 2016.
    PubMed     Text format     Abstract available


  629. UEKAWA K, Hasegawa Y, Senju S, Nakagata N, et al
    Intracerebroventricular Infusion of Angiotensin-(1-7) Ameliorates Cognitive Impairment and Memory Dysfunction in a Mouse Model of Alzheimer's Disease.
    J Alzheimers Dis. 2016.
    PubMed     Text format     Abstract available


  630. YE BS, Lee Y, Kwak K, Park YH, et al
    Posterior Ventricular Enlargement to Differentiate Dementia with Lewy Bodies from Alzheimer's Disease.
    J Alzheimers Dis. 2016.
    PubMed     Text format     Abstract available


  631. TROJANO L, Gainotti G
    Drawing Disorders in Alzheimer's Disease and Other Forms of Dementia.
    J Alzheimers Dis. 2016.
    PubMed     Text format     Abstract available


  632. CESTARI JA, Fabri GM, Kalil J, Nitrini R, et al
    Oral Infections and Cytokine Levels in Patients with Alzheimer's Disease and Mild Cognitive Impairment Compared with Controls.
    J Alzheimers Dis. 2016.
    PubMed     Text format     Abstract available


  633. HAN P, Shi J
    A Theoretical Analysis of the Synergy of Amyloid and Tau in Alzheimer's Disease.
    J Alzheimers Dis. 2016.
    PubMed     Text format     Abstract available


  634. MULLER S, Mychajliw C, Reichert C, Melcher T, et al
    Autobiographical Memory Performance in Alzheimer's Disease Depends on Retrieval Frequency.
    J Alzheimers Dis. 2016.
    PubMed     Text format     Abstract available


  635. CRETIN B, Sellal F, Philippi N, Bousiges O, et al
    Epileptic Prodromal Alzheimer's Disease, a Retrospective Study of 13 New Cases: Expanding the Spectrum of Alzheimer's Disease to an Epileptic Variant?
    J Alzheimers Dis. 2016.
    PubMed     Text format     Abstract available


  636. CLARELLI F, Mascia E, Santangelo R, Mazzeo S, et al
    CHRNA7 Gene and Response to Cholinesterase Inhibitors in an Italian Cohort of Alzheimer's Disease Patients.
    J Alzheimers Dis. 2016.
    PubMed     Text format     Abstract available


  637. INGBER AP, Hassenstab J, Fagan AM, Benzinger TL, et al
    Cerebrospinal Fluid Biomarkers and Reserve Variables as Predictors of Future "Non-Cognitive" Outcomes of Alzheimer's Disease.
    J Alzheimers Dis. 2016.
    PubMed     Text format     Abstract available


  638. HENSLEY K, Kursula P
    Collapsin Response Mediator Protein-2 (CRMP2) is a Plausible Etiological Factor and Potential Therapeutic Target in Alzheimer's Disease: Comparison and Contrast with Microtubule-Associated Protein Tau.
    J Alzheimers Dis. 2016.
    PubMed     Text format     Abstract available


  639. BERGER M, Nadler JW, Friedman A, McDonagh DL, et al
    The Effect of Propofol Versus Isoflurane Anesthesia on Human Cerebrospinal Fluid Markers of Alzheimer's Disease: Results of a Randomized Trial.
    J Alzheimers Dis. 2016.
    PubMed     Text format     Abstract available



  640. Upcoming Meetings Related to Alzheimer's Disease.
    J Alzheimers Dis. 2016;51:1291-5.
    PubMed     Text format    


  641. OTA K, Oishi N, Ito K, Fukuyama H, et al
    Prediction of Alzheimer's Disease in Amnestic Mild Cognitive Impairment Subtypes: Stratification Based on Imaging Biomarkers.
    J Alzheimers Dis. 2016.
    PubMed     Text format     Abstract available


  642. ZHAI Y, Yamashita T, Nakano Y, Sun Z, et al
    Disruption of White Matter Integrity by Chronic Cerebral Hypoperfusion in an Alzheimer's Disease Mouse Model.
    J Alzheimers Dis. 2016.
    PubMed     Text format     Abstract available


  643. HOSCHEIDT SM, Starks EJ, Oh JM, Zetterberg H, et al
    Insulin Resistance is Associated with Increased Alzheimer's Disease Pathology and Reduced Memory Function in At-Risk Healthy Middle-Aged Adults.
    J Alzheimers Dis. 2016.
    PubMed     Text format     Abstract available


  644. CONDE-SALA JL, Turro-Garriga O, Portellano-Ortiz C, Vinas-Diez V, et al
    Self-Perceived Quality of Life Among Patients with Alzheimer's Disease: Two Longitudinal Models of Analysis.
    J Alzheimers Dis. 2016.
    PubMed     Text format     Abstract available


  645. WANG W, Lu L, Wu QQ, Jia JP, et al
    Brain Amyloid-beta Plays an Initiating Role in the Pathophysiological Process of the PS1V97L-Tg Mouse Model of Alzheimer's Disease.
    J Alzheimers Dis. 2016.
    PubMed     Text format     Abstract available


  646. REGO A, Viana SD, Ribeiro CA, Rodrigues-Santos P, et al
    Monophosphoryl Lipid-A: A Promising Tool for Alzheimer's Disease Toll.
    J Alzheimers Dis. 2016.
    PubMed     Text format     Abstract available


  647. XING Y, Tang Y, Zhao L, Wang Q, et al
    Plasma Ceramides and Neuropsychiatric Symptoms of Alzheimer's Disease.
    J Alzheimers Dis. 2016.
    PubMed     Text format     Abstract available


  648. NILSSON ED, Melander O, Elmstahl S, Lethagen E, et al
    Copeptin, a Marker of Vasopressin, Predicts Vascular Dementia but not Alzheimer's Disease.
    J Alzheimers Dis. 2016.
    PubMed     Text format     Abstract available


  649. TEIPEL S, Grothe MJ
    Association Between Smoking and Cholinergic Basal Forebrain Volume in Healthy Aging and Prodromal and Dementia Stages of Alzheimer's Disease.
    J Alzheimers Dis. 2016.
    PubMed     Text format     Abstract available


  650. HENNEGES C, Reed C, Chen YF, Dell'Agnello G, et al
    Describing the Sequence of Cognitive Decline in Alzheimer's Disease Patients: Results from an Observational Study.
    J Alzheimers Dis. 2016.
    PubMed     Text format     Abstract available


  651. WARAGAI M, Adame A, Trinh I, Sekiyama K, et al
    Possible Involvement of Adiponectin, the Anti-Diabetes Molecule, in the Pathogenesis of Alzheimer's Disease.
    J Alzheimers Dis. 2016.
    PubMed     Text format     Abstract available


  652. ZHAN Y, Ma J, Alexander-Bloch AF, Xu K, et al
    Longitudinal Study of Impaired Intra- and Inter-Network Brain Connectivity in Subjects at High Risk for Alzheimer's Disease.
    J Alzheimers Dis. 2016.
    PubMed     Text format     Abstract available


  653. BEHESHTI I, Olya HG, Demirel H
    Risk Assessment of Alzheimer's Disease using the Information Diffusion Model from Structural Magnetic Resonance Imaging.
    J Alzheimers Dis. 2016.
    PubMed     Text format     Abstract available


  654. HUANG HC, Zheng BW, Guo Y, Zhao J, et al
    Antioxidative and Neuroprotective Effects of Curcumin in an Alzheimer's Disease Rat Model Co-Treated with Intracerebroventricular Streptozotocin and Subcutaneous D-Galactose.
    J Alzheimers Dis. 2016.
    PubMed     Text format     Abstract available


  655. JAYNE T, Newman M, Verdile G, Sutherland G, et al
    Evidence for and Against a Pathogenic Role of Reduced gamma-Secretase Activity in Familial Alzheimer's Disease.
    J Alzheimers Dis. 2016.
    PubMed     Text format     Abstract available


    March 2016
  656. ZHAI Y, Yin S, Zhang D
    Association between Antipsychotic Drugs and Mortality in Older Persons with Alzheimer's Disease: A Systematic Review and Meta-Analysis.
    J Alzheimers Dis. 2016.
    PubMed     Text format     Abstract available


  657. EBRAHIMIE E, Moussavi-Nik SH, Newman M, Van Der Hoek M, et al
    The Zebrafish Equivalent of Alzheimer's Disease-Associated PRESENILIN Isoform PS2V Regulates Inflammatory and Other Responses to Hypoxic Stress.
    J Alzheimers Dis. 2016.
    PubMed     Text format     Abstract available



  658. Upcoming Meetings Related to Alzheimer's Disease.
    J Alzheimers Dis. 2016;51:929-934.
    PubMed     Text format    


  659. PIAZZA F, Winblad B
    Amyloid-Related Imaging Abnormalities (ARIA) in Immunotherapy Trials for Alzheimer's Disease: Need for Prognostic Biomarkers?
    J Alzheimers Dis. 2016.
    PubMed     Text format     Abstract available


  660. VIDAL JS, Hanon O, Funalot B, Brunel N, et al
    Low Serum Insulin-Like Growth Factor-I Predicts Cognitive Decline in Alzheimer's Disease.
    J Alzheimers Dis. 2016.
    PubMed     Text format     Abstract available


  661. KUSTER OC, Kosel J, Spohn S, Schurig N, et al
    Cognitive Reserve in Alzheimer's Dementia: Diagnostic Accuracy of a Testing-the-Limits Paradigm.
    J Alzheimers Dis. 2016.
    PubMed     Text format     Abstract available


  662. HEFFERNAN M, Mather KA, Xu J, Assareh AA, et al
    Alcohol Consumption and Incident Dementia: Evidence from the Sydney Memory and Ageing Study.
    J Alzheimers Dis. 2016;52:529-38.
    PubMed     Text format     Abstract available


  663. CUCHILLO-IBANEZ I, Balmaceda V, Mata-Balaguer T, Lopez-Font I, et al
    Reelin in Alzheimer's Disease, Increased Levels but Impaired Signaling: When More is Less.
    J Alzheimers Dis. 2016.
    PubMed     Text format     Abstract available


  664. HIRNI DI, Kivisaari SL, Krumm S, Monsch AU, et al
    Neuropsychological Markers of Medial Perirhinal and Entorhinal Cortex Functioning are Impaired Twelve Years Preceding Diagnosis of Alzheimer's Dementia.
    J Alzheimers Dis. 2016.
    PubMed     Text format     Abstract available


  665. CLEMENTS-CORTES A, Ahonen H, Evans M, Freedman M, et al
    Short-Term Effects of Rhythmic Sensory Stimulation in Alzheimer's Disease: An Exploratory Pilot Study.
    J Alzheimers Dis. 2016.
    PubMed     Text format     Abstract available


  666. YANG C, Huang X, Huang X, Mai H, et al
    Aquaporin-4 and Alzheimer's Disease.
    J Alzheimers Dis. 2016.
    PubMed     Text format     Abstract available


  667. HU Q, Teng W, Li J, Hao F, et al
    Homocysteine and Alzheimer's Disease: Evidence for a Causal Link from Mendelian Randomization.
    J Alzheimers Dis. 2016.
    PubMed     Text format     Abstract available


  668. ONTIVEROS-TORRES MA, Labra-Barrios ML, Diaz-Cintra S, Aguilar-Vazquez AR, et al
    Fibrillar Amyloid-beta Accumulation Triggers an Inflammatory Mechanism Leading to Hyperphosphorylation of the Carboxyl-Terminal End of Tau Polypeptide in the Hippocampal Formation of the 3xTg-AD Transgenic Mouse.
    J Alzheimers Dis. 2016;52:243-69.
    PubMed     Text format     Abstract available


  669. MIN JY, Min KB
    The Folate-Vitamin B12 Interaction, Low Hemoglobin, and the Mortality Risk from Alzheimer's Disease.
    J Alzheimers Dis. 2016.
    PubMed     Text format     Abstract available


  670. ZHAO QF, Wan Y, Wang HF, Sun FR, et al
    ABCA7 Genotypes Confer Alzheimer's Disease Risk by Modulating Amyloid-beta Pathology.
    J Alzheimers Dis. 2016.
    PubMed     Text format     Abstract available


  671. EL HAJ M, Kapogiannis D, Antoine P
    Phenomenological Reliving and Visual Imagery During Autobiographical Recall in Alzheimer's Disease.
    J Alzheimers Dis. 2016.
    PubMed     Text format     Abstract available



  672. Upcoming Meetings Related to Alzheimer's Disease.
    J Alzheimers Dis. 2016;51:631-5.
    PubMed     Text format    


  673. NHO K, Saykin AJ, Nelson PT
    Hippocampal Sclerosis of Aging, a Common Alzheimer's Disease 'Mimic': Risk Genotypes are Associated with Brain Atrophy Outside the Temporal Lobe.
    J Alzheimers Dis. 2016.
    PubMed     Text format     Abstract available


  674. SCHUTT T, Helboe L, Ostergaard Pedersen L, Waldemar G, et al
    Dogs with Cognitive Dysfunction as a Spontaneous Model for Early Alzheimer's Disease: A Translational Study of Neuropathological and Inflammatory Markers.
    J Alzheimers Dis. 2016.
    PubMed     Text format     Abstract available


  675. WANG HF, Wan Y, Hao XK, Cao L, et al
    Bridging Integrator 1 (BIN1) Genotypes Mediate Alzheimer's Disease Risk by Altering Neuronal Degeneration.
    J Alzheimers Dis. 2016.
    PubMed     Text format     Abstract available


  676. HOMMA A, Atarashi H, Kubota N, Nakai K, et al
    Efficacy and Safety of Sustained Release Donepezil High Dose versus Immediate Release Donepezil Standard Dose in Japanese Patients with Severe Alzheimer's Disease: A Randomized, Double-Blind Trial.
    J Alzheimers Dis. 2016.
    PubMed     Text format     Abstract available


  677. ITZHAKI RF, Lathe R, Balin BJ, Ball MJ, et al
    Microbes and Alzheimer's Disease.
    J Alzheimers Dis. 2016.
    PubMed     Text format    


  678. YE Q, Bai F, Zhang Z
    Shared Genetic Risk Factors for Late-Life Depression and Alzheimer's Disease.
    J Alzheimers Dis. 2016.
    PubMed     Text format     Abstract available


  679. SPILMAN PR, Corset V, Gorostiza O, Poksay KS, et al
    Netrin-1 Interrupts Amyloid-beta Amplification, Increases sAbetaPPalpha in vitro and in vivo, and Improves Cognition in a Mouse Model of Alzheimer's Disease.
    J Alzheimers Dis. 2016.
    PubMed     Text format     Abstract available


  680. LINGLER JH, Butters MA, Gentry AL, Hu L, et al
    Development of a Standardized Approach to Disclosing Amyloid Imaging Research Results in Mild Cognitive Impairment.
    J Alzheimers Dis. 2016;52:17-24.
    PubMed     Text format     Abstract available


  681. FERNANDEZ-BLAZQUEZ MA, Avila-Villanueva M, Maestu F, Medina M, et al
    Specific Features of Subjective Cognitive Decline Predict Faster Conversion to Mild Cognitive Impairment.
    J Alzheimers Dis. 2016;52:271-81.
    PubMed     Text format     Abstract available


  682. JEFFERSON AL, Gifford KA, Acosta LM, Bell SP, et al
    The Vanderbilt Memory & Aging Project: Study Design and Baseline Cohort Overview.
    J Alzheimers Dis. 2016;52:539-59.
    PubMed     Text format     Abstract available


  683. SHANG J, Yamashita T, Zhai Y, Nakano Y, et al
    Strong Impact of Chronic Cerebral Hypoperfusion on Neurovascular Unit, Cerebrovascular Remodeling, and Neurovascular Trophic Coupling in Alzheimer's Disease Model Mouse.
    J Alzheimers Dis. 2016.
    PubMed     Text format     Abstract available


  684. LOPEZ ME, Turrero A, Cuesta P, Lopez-Sanz D, et al
    Searching for Primary Predictors of Conversion from Mild Cognitive Impairment to Alzheimer's Disease: A Multivariate Follow-Up Study.
    J Alzheimers Dis. 2016.
    PubMed     Text format     Abstract available


  685. JAHNG GH, Oh J, Lee DW, Kim HG, et al
    Glutamine and Glutamate Complex, as Measured by Functional Magnetic Resonance Spectroscopy, Alters During Face-Name Association Task in Patients with Mild Cognitive Impairment and Alzheimer's Disease.
    J Alzheimers Dis. 2016.
    PubMed     Text format     Abstract available


  686. FEMMINELLA GD, Ninan S, Atkinson R, Fan Z, et al
    Does Microglial Activation Influence Hippocampal Volume and Neuronal Function in Alzheimer's Disease and Parkinson's Disease Dementia?
    J Alzheimers Dis. 2016;51:1275-89.
    PubMed     Text format     Abstract available


  687. YOON B, Yang DW, Hong YJ, Choi SH, et al
    Differences in Depressive Patterns According to Disease Severityin Early-Onset Alzheimer's Disease.
    J Alzheimers Dis. 2016.
    PubMed     Text format     Abstract available


  688. TIIHONEN M, Taipale H, Tanskanen A, Tiihonen J, et al
    Incidence and Duration of Cumulative Bisphosphonate Use among Community-Dwelling Persons with or without Alzheimer's Disease.
    J Alzheimers Dis. 2016.
    PubMed     Text format     Abstract available


  689. PASQUIER F, Sadowsky C, Holstein A, Leterme GL, et al
    Two Phase 2 Multiple Ascending-Dose Studies of Vanutide Cridificar (ACC-001) and QS-21 Adjuvant in Mild-to-Moderate Alzheimer's Disease.
    J Alzheimers Dis. 2016.
    PubMed     Text format     Abstract available


    February 2016
  690. REMINGTON R, Bechtel C, Larsen D, Samar A, et al
    Maintenance of Cognitive Performance and Mood for Individuals with Alzheimer's Disease Following Consumption of a Nutraceutical Formulation: A One-Year, Open-Label Study.
    J Alzheimers Dis. 2016.
    PubMed     Text format     Abstract available


  691. FLORIAN H, Meier A, Gauthier S, Lipschitz S, et al
    Efficacy and Safety of ABT-126 in Subjects with Mild-to-Moderate Alzheimer's Disease on Stable Doses of Acetylcholinesterase Inhibitors: A Randomized, Double-Blind, Placebo-Controlled Study.
    J Alzheimers Dis. 2016.
    PubMed     Text format     Abstract available



  692. Upcoming Meetings Related to Alzheimer's Disease.
    J Alzheimers Dis. 2016;51:327-331.
    PubMed     Text format    


  693. PECK K, Girard TA, Russo F, Fiocco AJ, et al
    Music and Memory in Alzheimer's Disease and The Potential Underlying Mechanisms.
    J Alzheimers Dis. 2016.
    PubMed     Text format     Abstract available


  694. SCHILLING MA
    Unraveling Alzheimer's: Making Sense of the Relationship between Diabetes and Alzheimer's Disease1.
    J Alzheimers Dis. 2016.
    PubMed     Text format     Abstract available


  695. SANDERS C, Behrens S, Schwartz S, Wengreen H, et al
    Nutritional Status is Associated with Faster Cognitive Decline and Worse Functional Impairment in the Progression of Dementia: The Cache County Dementia Progression Study1.
    J Alzheimers Dis. 2016;52:33-42.
    PubMed     Text format     Abstract available


  696. TAN CC, Wan Y, Tan MS, Zhang W, et al
    Association of Frontotemporal Dementia GWAS Loci with Late-Onset Alzheimer's Disease in a Northern Han Chinese Population.
    J Alzheimers Dis. 2016.
    PubMed     Text format     Abstract available


  697. LAVALLEE MM, Gandini D, Rouleau I, Vallet GT, et al
    A Qualitative Impairment in Face Perception in Alzheimer's Disease: Evidence from a Reduced Face Inversion Effect.
    J Alzheimers Dis. 2016.
    PubMed     Text format     Abstract available


  698. GOMAR JJ, Conejero-Goldberg C, Davies P, Goldberg TE, et al
    Anti-Correlated Cerebrospinal Fluid Biomarker Trajectories in Preclinical Alzheimer's Disease.
    J Alzheimers Dis. 2016.
    PubMed     Text format     Abstract available


  699. MASOUD AM, Bihaqi SW, Machan JT, Zawia NH, et al
    Early-Life Exposure to Lead (Pb) Alters the Expression of microRNA that Target Proteins Associated with Alzheimer's Disease.
    J Alzheimers Dis. 2016.
    PubMed     Text format     Abstract available


  700. WONG S, Bertoux M, Savage G, Hodges JR, et al
    Comparison of Prefrontal Atrophy and Episodic Memory Performance in Dysexecutive Alzheimer's Disease and Behavioral-Variant Frontotemporal Dementia.
    J Alzheimers Dis. 2016.
    PubMed     Text format     Abstract available


  701. MONTESANTO A, Crocco P, Anfossi M, Smirne N, et al
    The Genetic Variability of UCP4 Affects the Individual Susceptibility to Late-Onset Alzheimer's Disease and Modifies the Disease's Risk in APOE-varepsilon4 Carriers.
    J Alzheimers Dis. 2016.
    PubMed     Text format     Abstract available


  702. GUILLOT F, Kemppainen S, Lavasseur G, Miettinen PO, et al
    Brain-Specific Basal and Novelty-Induced Alternations in PI3K-Akt and MAPK/ERK Signaling in a Middle-Aged AbetaPP/PS1 Mouse Model of Alzheimer's Disease.
    J Alzheimers Dis. 2016.
    PubMed     Text format     Abstract available


  703. ONGALI B, Nicolakakis N, Tong XK, Aboulkassim T, et al
    Enalapril Alone or Co-Administered with Losartan Rescues Cerebrovascular Dysfunction, but not Mnemonic Deficits or Amyloidosis in a Mouse Model of Alzheimer's Disease.
    J Alzheimers Dis. 2016.
    PubMed     Text format     Abstract available


  704. BOUSIGES O, Cretin B, Lavaux T, Philippi N, et al
    Diagnostic Value of Cerebrospinal Fluid Biomarkers (Phospho-Tau181, total-Tau, Abeta42, and Abeta40) in Prodromal Stage of Alzheimer's Disease and Dementia with Lewy Bodies.
    J Alzheimers Dis. 2016.
    PubMed     Text format     Abstract available



  705. Upcoming Meetings Related to Alzheimer's Disease.
    J Alzheimers Dis. 2016;50:1257-61.
    PubMed     Text format    


  706. SAKAI K, Senda T, Hata R, Kuroda M, et al
    Patients that have Undergone Hemodialysis Exhibit Lower Amyloid Deposition in the Brain: Evidence Supporting a Therapeutic Strategy for Alzheimer's Disease by Removal of Blood Amyloid.
    J Alzheimers Dis. 2016.
    PubMed     Text format     Abstract available


  707. BARTHELEMY NR, Gabelle A, Hirtz C, Fenaille F, et al
    Differential Mass Spectrometry Profiles of Tau Protein in the Cerebrospinal Fluid of Patients with Alzheimer's Disease, Progressive Supranuclear Palsy, and Dementia with Lewy Bodies.
    J Alzheimers Dis. 2016.
    PubMed     Text format     Abstract available


  708. CHAI YL, Yeo HK, Wang J, Hilal S, et al
    Apolipoprotein varepsilon4 is Associated with Dementia and Cognitive Impairment Predominantly Due to Alzheimer's Disease and Not with Vascular Cognitive Impairment: A Singapore-Based Cohort.
    J Alzheimers Dis. 2016.
    PubMed     Text format     Abstract available


  709. SANCHEZ-VALLE R, Monte GC, Sala-Llonch R, Bosch B, et al
    White Matter Abnormalities Track Disease Progression in PSEN1 Autosomal Dominant Alzheimer's Disease.
    J Alzheimers Dis. 2016.
    PubMed     Text format     Abstract available


  710. SUPPA P, Hampel H, Kepp T, Lange C, et al
    Performance of Hippocampus Volumetry with FSL-FIRST for Prediction of Alzheimer's Disease Dementia in at Risk Subjects with Amnestic Mild Cognitive Impairment.
    J Alzheimers Dis. 2016.
    PubMed     Text format     Abstract available


  711. SINGHRAO SK, Harding A, Chukkapalli S, Olsen I, et al
    Apolipoprotein E Related Co-Morbidities and Alzheimer's Disease.
    J Alzheimers Dis. 2016.
    PubMed     Text format     Abstract available


  712. PLUTA R, Kocki J, Ulamek-Koziol M, Petniak A, et al
    Discrepancy in Expression of beta-Secretase and Amyloid-beta Protein Precursor in Alzheimer-Related Genes in the Rat Medial Temporal Lobe Cortex Following Transient Global Brain Ischemia.
    J Alzheimers Dis. 2016.
    PubMed     Text format     Abstract available


  713. CHAU SA, Chung J, Herrmann N, Eizenman M, et al
    Apathy and Attentional Biases in Alzheimer's Disease.
    J Alzheimers Dis. 2016.
    PubMed     Text format     Abstract available


  714. LYOO CH, Cho H, Choi JY, Hwang MS, et al
    Tau Accumulation in Primary Motor Cortex of Variant Alzheimer's Disease with Spastic Paraparesis.
    J Alzheimers Dis. 2016.
    PubMed     Text format     Abstract available


  715. LOU G, Zhang Q, Xiao F, Xiang Q, et al
    Intranasal TAT-haFGF Improves Cognition and Amyloid-beta Pathology in an AbetaPP/PS1 Mouse Model of Alzheimer's Disease.
    J Alzheimers Dis. 2016.
    PubMed     Text format     Abstract available


  716. SOUTHAM KA, Vincent AJ, Small DH
    Do Microglia Default on Network Maintenance in Alzheimer's Disease?
    J Alzheimers Dis. 2016.
    PubMed     Text format     Abstract available


  717. DINGOVA D, Fazekas T, Okuliarova P, Strbova J, et al
    Low Plasma Cholinesterase Activities are associated with Deficits in Spatial Orientation, Reduced Ability to Perform Basic Activities of Daily Living, and Low Body Mass Index in Patients with Progressed Alzheimer's Disease.
    J Alzheimers Dis. 2016.
    PubMed     Text format     Abstract available


  718. MOON Y, Han SH, Moon WJ
    Patterns of Brain Iron Accumulation in Vascular Dementia and Alzheimer's Dementia Using Quantitative Susceptibility Mapping Imaging.
    J Alzheimers Dis. 2016.
    PubMed     Text format     Abstract available


  719. BONET-COSTA V, Herranz-Perez V, Blanco-Gandia M, Mas-Bargues C, et al
    Clearing Amyloid-beta through PPARgamma/ApoE Activation by Genistein is a Treatment of Experimental Alzheimer's Disease.
    J Alzheimers Dis. 2016.
    PubMed     Text format     Abstract available


  720. GODEFROY O, Bakchine S, Verny M, Delabrousse-Mayoux JP, et al
    Characteristics of Alzheimer's Disease Patients with Severe Executive Disorders.
    J Alzheimers Dis. 2016.
    PubMed     Text format     Abstract available


  721. FANG D, Zhang Z, Li H, Yu Q, et al
    Increased Electron Paramagnetic Resonance Signal Correlates with Mitochondrial Dysfunction and Oxidative Stress in an Alzheimer's disease Mouse Brain.
    J Alzheimers Dis. 2016.
    PubMed     Text format     Abstract available


  722. HESSMANN P, Seeberg G, Reese JP, Dams J, et al
    Health-Related Quality of Life in Patients with Alzheimer's Disease in Different German Health Care Settings.
    J Alzheimers Dis. 2016.
    PubMed     Text format     Abstract available


  723. SCHUBERT S, Leyton CE, Hodges JR, Piguet O, et al
    Longitudinal Memory Profiles in Behavioral-Variant Frontotemporal Dementia and Alzheimer's Disease.
    J Alzheimers Dis. 2016.
    PubMed     Text format     Abstract available


  724. GRANGER MW, Franko B, Taylor MW, Messier C, et al
    A TgCRND8 Mouse Model of Alzheimer's Disease Exhibits Sexual Dimorphisms in Behavioral Indices of Cognitive Reserve.
    J Alzheimers Dis. 2016.
    PubMed     Text format     Abstract available


  725. ALLISON SL, Fagan AM, Morris JC, Head D, et al
    Spatial Navigation in Preclinical Alzheimer's Disease.
    J Alzheimers Dis. 2016.
    PubMed     Text format     Abstract available


  726. CHEN HY, Panegyres PK
    The Role of Ethnicity in Alzheimer's Disease: Findings From The C-PATH Online Data Repository.
    J Alzheimers Dis. 2016.
    PubMed     Text format     Abstract available


  727. WHITE MT, Shaw LM, Xie SX
    Evaluation of Cerebrospinal Fluid Assay Variability in Alzheimer's Disease.
    J Alzheimers Dis. 2016.
    PubMed     Text format     Abstract available


  728. SERRA L, Cercignani M, Mastropasqua C, Torso M, et al
    Longitudinal Changes in Functional Brain Connectivity Predicts Conversionto Alzheimer's Disease.
    J Alzheimers Dis. 2016.
    PubMed     Text format     Abstract available


  729. ASO E, Andres-Benito P, Carmona M, Maldonado R, et al
    Cannabinoid Receptor 2 Participates in Amyloid-beta Processing in a Mouse Model of Alzheimer's Disease but Plays a Minor Role in the Therapeutic Properties of a Cannabis-Based Medicine.
    J Alzheimers Dis. 2016.
    PubMed     Text format     Abstract available


  730. D'ONOFRIO G, Panza F, Sancarlo D, Paris FF, et al
    Delusions in Patients with Alzheimer's Disease: A Multidimensional Approach.
    J Alzheimers Dis. 2016.
    PubMed     Text format     Abstract available


  731. LOUWERSHEIMER E, Keulen MA, Steenwijk MD, Wattjes MP, et al
    Heterogeneous Language Profiles in Patients with Primary Progressive Aphasiadue to Alzheimer's Disease.
    J Alzheimers Dis. 2016.
    PubMed     Text format     Abstract available


  732. LI WX, Dai SX, Liu JQ, Wang Q, et al
    Integrated Analysis of Alzheimer's Disease and Schizophrenia Dataset Revealed Different Expression Pattern in Learningand Memory.
    J Alzheimers Dis. 2016.
    PubMed     Text format     Abstract available


  733. WRUCK W, Schroter F, Adjaye J
    Meta-Analysis of Transcriptome Data Related to Hippocampus Biopsiesand iPSC-Derived Neuronal Cells from Alzheimer's Disease Patients Revealsan Association with FOXA1 and FOXA2 Gene Regulatory Networks.
    J Alzheimers Dis. 2016.
    PubMed     Text format     Abstract available


  734. KIDA J, Nemoto K, Ikejima C, Bun S, et al
    Impact of Depressive Symptomson Conversion from Mild Cognitive Impairment Subtypes to Alzheimer's Disease: A Community-Based Longitudinal Study.
    J Alzheimers Dis. 2016.
    PubMed     Text format     Abstract available


  735. LACALLE-AURIOLES M, Javier Navas-Sanchez F, Aleman-Gomez Y, Olazaran J, et al
    The Disconnection Hypothesis in Alzheimer's Disease Studied Through Multimodal Magnetic Resonance Imaging: Structural, Perfusion, and Diffusion Tensor Imaging.
    J Alzheimers Dis. 2016.
    PubMed     Text format     Abstract available


  736. DUGGER BN, Whiteside CM, Maarouf CL, Walker DG, et al
    The Presence of Select Tau Speciesin Human Peripheral Tissues and Their Relation to Alzheimer's Disease.
    J Alzheimers Dis. 2016.
    PubMed     Text format     Abstract available



  737. Upcoming Meetings Related to Alzheimer's Disease.
    J Alzheimers Dis. 2016;50:907-911.
    PubMed     Text format    


    January 2016
  738. BOCCHETTA M, Mega A, Bernardi L, Di Maria E, et al
    Genetic Counseling and Testing for Alzheimer's Disease and Frontotemporal Lobar Degeneration: An Italian Consensus Protocol.
    J Alzheimers Dis. 2016.
    PubMed     Text format     Abstract available


  739. EUSTACHE P, Nemmi F, Saint-Aubert L, Pariente J, et al
    Multimodal Magnetic Resonance Imaging in Alzheimer's Disease Patients at Prodromal Stage.
    J Alzheimers Dis. 2016.
    PubMed     Text format     Abstract available


  740. TONG M, Deochand C, Didsbury J, de la Monte SM, et al
    T3D-959: A Multi-Faceted Disease Remedial Drug Candidate for the Treatment of Alzheimer's Disease.
    J Alzheimers Dis. 2016.
    PubMed     Text format     Abstract available


  741. MELAH KE, Lu SY, Hoscheidt SM, Alexander AL, et al
    Cerebrospinal Fluid Markers of Alzheimer's Disease Pathology and Microglial Activation are Associated with Altered White Matter Microstructure in Asymptomatic Adults at Risk for Alzheimer's Disease.
    J Alzheimers Dis. 2016.
    PubMed     Text format     Abstract available


  742. LANGLOIS R, Joubert S, Benoit S, Dostie V, et al
    Memory for Public Events in Mild Cognitive Impairment and Alzheimer's Disease:The Importance of Rehearsal.
    J Alzheimers Dis. 2016.
    PubMed     Text format     Abstract available


  743. ROBILLARD JM
    The Online Environment: A Key Variable in the Ethical Response to Complementary and Alternative Medicine for Alzheimer's Disease.
    J Alzheimers Dis. 2016.
    PubMed     Text format     Abstract available


  744. DODICH A, Cerami C, Crespi C, Canessa N, et al
    Differential Impairment of Cognitive and Affective Mentalizing Abilities in Neurodegenerative Dementias: Evidence from Behavioral Variant of Frontotemporal Dementia, Alzheimer's Disease, and Mild Cognitive Impairment.
    J Alzheimers Dis. 2016.
    PubMed     Text format     Abstract available


  745. RACINE E, Forlini C, Aspler J, Chandler J, et al
    Complementary and Alternative Medicine in the Context of Earlier Diagnoses of Alzheimer's Disease: Opening the Conversation to Prepare Ethical Responses.
    J Alzheimers Dis. 2016.
    PubMed     Text format     Abstract available


  746. TURRO-GARRIGA O, Garre-Olmo J, Calvo-Perxas L, Rene-Ramirez R, et al
    Course and Determinants of Anosognosia in Alzheimer's Disease: A 12-Month Follow-up.
    J Alzheimers Dis. 2016.
    PubMed     Text format     Abstract available



  747. Upcoming Meetings Related to Alzheimer's Disease.
    J Alzheimers Dis. 2016;50:617-21.
    PubMed     Text format    


  748. MANOUSOPOULOU A, Saito S, Yamamoto Y, Al-Daghri NM, et al
    Hemisphere Asymmetry of Response to Pharmacologic Treatment in an Alzheimer's Disease Mouse Model.
    J Alzheimers Dis. 2016.
    PubMed     Text format     Abstract available


  749. SMITH R, Wibom M, Olsson T, Hagerstrom D, et al
    Posterior Accumulation of Tau and Concordant Hypometabolism in an Early-Onset Alzheimer's Disease Patient with Presenilin-1 Mutation.
    J Alzheimers Dis. 2016.
    PubMed     Text format     Abstract available


  750. NAGATA T, Shinagawa S, Nakajima S, Plitman E, et al
    Classification of Neuropsychiatric Symptoms Requiring Antipsychotic Treatment in Patients with Alzheimer's Disease: Analysis of the CATIE-AD Study.
    J Alzheimers Dis. 2016.
    PubMed     Text format     Abstract available


  751. WANG HF, Tan L, Cao L, Zhu XC, et al
    Application of the IWG-2 Diagnostic Criteria for Alzheimer's Disease to the ADNI.
    J Alzheimers Dis. 2016.
    PubMed     Text format     Abstract available


  752. PASQUINI L, Scherr M, Tahmasian M, Myers NE, et al
    Increased Intrinsic Activity of Medial-Temporal Lobe Subregions is Associated with Decreased Cortical Thickness of Medial-Parietal Areas in Patients with Alzheimer's Disease Dementia.
    J Alzheimers Dis. 2016.
    PubMed     Text format     Abstract available


  753. GALLUCCI M, Spagnolo P, Arico M, Grossi E, et al
    Predictors of Response to Cholinesterase Inhibitors Treatment of Alzheimer's Disease: Date Mining from the TREDEM Registry.
    J Alzheimers Dis. 2016.
    PubMed     Text format     Abstract available


  754. RODRIGUEZ-PERDIGON M, Solas M, Javier Ramirez M
    JNK: A Putative Link Between Insulin Signaling and VGLUT1 in Alzheimer's Disease.
    J Alzheimers Dis. 2016.
    PubMed     Text format     Abstract available


  755. ZHANG Y, Wang S, Phillips P, Yang J, et al
    Three-Dimensional Eigenbrain for the Detection of Subjects and Brain Regions Related with Alzheimer's Disease.
    J Alzheimers Dis. 2016.
    PubMed     Text format     Abstract available


  756. MORIN JP, Ceron-Solano G, Velazquez-Campos G, Pacheco-Lopez G, et al
    Spatial Memory Impairment is Associated with Intraneural Amyloid-beta Immunoreactivity and Dysfunctional Arc Expression in the Hippocampal-CA3 Region of a Transgenic Mouse Model of Alzheimer's Disease.
    J Alzheimers Dis. 2016.
    PubMed     Text format     Abstract available


  757. NUNEZ K, Kay J, Krotow A, Tong M, et al
    Cigarette Smoke-Induced Alterations in Frontal White Matter Lipid Profiles Demonstrated by MALDI-Imaging Mass Spectrometry: Relevance to Alzheimer's Disease.
    J Alzheimers Dis. 2016.
    PubMed     Text format     Abstract available


  758. MANSO Y, Comes G, Lopez-Ramos JC, Belfiore M, et al
    Overexpression of Metallothionein-1 Modulates the Phenotype of the Tg2576 Mouse Model of Alzheimer's Disease.
    J Alzheimers Dis. 2016.
    PubMed     Text format     Abstract available


  759. NIEMANTSVERDRIET E, Goossens J, Struyfs H, Martin JJ, et al
    Diagnostic Impact of Cerebrospinal Fluid Biomarker (Pre-)Analytical Variability in Alzheimer's Disease.
    J Alzheimers Dis. 2016.
    PubMed     Text format     Abstract available


  760. WANG J, Tan L, Yu JT
    Prevention Trials in Alzheimer's Disease: Current Status and Future Perspectives.
    J Alzheimers Dis. 2016.
    PubMed     Text format     Abstract available


  761. BABIC LEKO M, Borovecki F, Dejanovic N, Hof PR, et al
    Predictive Value of Cerebrospinal Fluid Visinin-Like Protein-1 Levels for Alzheimer's Disease Early Detection and Differential Diagnosis in Patients with Mild Cognitive Impairment.
    J Alzheimers Dis. 2016.
    PubMed     Text format     Abstract available


  762. SIOTTO M, Simonelli I, Pasqualetti P, Mariani S, et al
    Association Between Serum Ceruloplasmin Specific Activity and Risk of Alzheimer's Disease.
    J Alzheimers Dis. 2016.
    PubMed     Text format     Abstract available


  763. BOCCARDI V, Ruggiero C, Patriti A, Marano L, et al
    Diagnostic Assessment and Management of Dysphagia in Patients with Alzheimer's Disease.
    J Alzheimers Dis. 2016.
    PubMed     Text format     Abstract available


  764. WANG HL, Wang YY, Liu XG, Kuo SH, et al
    Cholesterol, 24-Hydroxycholesterol, and 27-Hydroxycholesterol as Surrogate Biomarkers in Cerebrospinal Fluid in Mild Cognitive Impairment and Alzheimer's Disease: A Meta-Analysis.
    J Alzheimers Dis. 2016.
    PubMed     Text format     Abstract available


  765. FERNANDEZ G, Manes F, Politi LE, Orozco D, et al
    Patients with Mild Alzheimer's Disease Fail When Using Their Working Memory: Evidence from the Eye Tracking Technique.
    J Alzheimers Dis. 2016.
    PubMed     Text format     Abstract available


  766. QIU H, Zhong R, Liu H, Zhang F, et al
    Chronic Sleep Deprivation Exacerbates Learning-Memory Disability and Alzheimer's Disease-Like Pathologies in AbetaPPswe/PS1DeltaE9 Mice.
    J Alzheimers Dis. 2016.
    PubMed     Text format     Abstract available


  767. MAES A, Anthonissen R, Wambacq S, Simons K, et al
    The Cytome Assay as a Tool to Investigate the Possible Association Between Exposure to Extremely Low Frequency Magnetic Fields and an Increased Risk for Alzheimer's Disease.
    J Alzheimers Dis. 2016.
    PubMed     Text format     Abstract available


  768. KIM HJ, Cha J, Lee JM, Shin JS, et al
    Distinctive Resting State Network Disruptions Among Alzheimer's Disease, Subcortical Vascular Dementia, and Mixed Dementia Patients.
    J Alzheimers Dis. 2016.
    PubMed     Text format     Abstract available


  769. KOCH G, Di Lorenzo F, Del Olmo MF, Bonni S, et al
    Reversal of LTP-Like Cortical Plasticity in Alzheimer's Disease Patients with Tau-Related Faster Clinical Progression.
    J Alzheimers Dis. 2016.
    PubMed     Text format     Abstract available


  770. ROHER AE, Maarouf CL, Kokjohn TA
    Familial Presenilin Mutations and Sporadic Alzheimer's Disease Pathology: Is the Assumption of Biochemical Equivalence Justified?
    J Alzheimers Dis. 2016.
    PubMed     Text format     Abstract available


  771. VIJAYARAGHAVAN S, Darreh-Shori T, Rongve A, Berge G, et al
    Association of Butyrylcholinesterase-K Allele and Apolipoprotein E varepsilon4 Allele with Cognitive Decline in Dementia with Lewy Bodies and Alzheimer's Disease.
    J Alzheimers Dis. 2016.
    PubMed     Text format     Abstract available


  772. HUANG F, Shang Y, Luo Y, Wu P, et al
    Lower Prevalence of Alzheimer's Disease among Tibetans: Association with Religious and Genetic Factors.
    J Alzheimers Dis. 2016.
    PubMed     Text format     Abstract available


  773. RENARD D, Wacongne A, Ayrignac X, Charif M, et al
    Cerebrospinal Fluid Alzheimer's Disease Biomarkers in Cerebral Amyloid Angiopathy-Related Inflammation.
    J Alzheimers Dis. 2016.
    PubMed     Text format     Abstract available


  774. DZIEDZIC T, Pera J, Klimkowicz-Mrowiec A, Mroczko B, et al
    Biochemical and Radiological Markers of Alzheimer's Disease Progression.
    J Alzheimers Dis. 2016.
    PubMed     Text format     Abstract available


  775. IBARRIA M, Alegret M, Valero S, Morera A, et al
    Beneficial Effects of an Integrated Psychostimulation Program in Patients with Alzheimer's Disease.
    J Alzheimers Dis. 2016.
    PubMed     Text format     Abstract available



  776. Upcoming Meetings Related to Alzheimer's Disease.
    J Alzheimers Dis. 2016;50:297-300.
    PubMed     Text format    


  777. MOHSENI HK, Chettle DR
    A History of In Vivo Neutron Activation Analysis in Measurement of Aluminum in Human Subjects.
    J Alzheimers Dis. 2016;50:913-26.
    PubMed     Text format     Abstract available


  778. KENNEDY RE, Cutter GR, Wang G, Schneider LS, et al
    Post Hoc Analyses of ApoE Genotype-Defined Subgroups in Clinical Trials.
    J Alzheimers Dis. 2016;50:1205-15.
    PubMed     Text format     Abstract available


  779. LEINONEN H, Lipponen A, Gurevicius K, Tanila H, et al
    Normal Amplitude of Electroretinography and Visual Evoked Potential Responses in AbetaPP/PS1 Mice.
    J Alzheimers Dis. 2016;51:21-6.
    PubMed     Text format     Abstract available


  780. GRAMUNT N, Sanchez-Benavides G, Buschke H, Lipton RB, et al
    Psychometric Properties of the Memory Binding Test: Test-Retest Reliability and Convergent Validity.
    J Alzheimers Dis. 2016;50:999-1010.
    PubMed     Text format     Abstract available


  781. KUMFOR F, Teo D, Miller L, Lah S, et al
    Examining the Relationship Between Autobiographical Memory Impairment and Carer Burden in Dementia Syndromes.
    J Alzheimers Dis. 2016;51:237-48.
    PubMed     Text format     Abstract available


  782. ANDRIUTA D, Moullart V, Schraen S, Devendeville A, et al
    What are the Most Frequently Impaired Markers of Neurodegeneration in ADNI Subjects?
    J Alzheimers Dis. 2016;51:793-800.
    PubMed     Text format     Abstract available


  783. GRANGEON L, Paquet C, Bombois S, Quillard-Muraine M, et al
    Differential Diagnosis of Dementia with High Levels of Cerebrospinal Fluid Tau Protein.
    J Alzheimers Dis. 2016;51:905-13.
    PubMed     Text format     Abstract available


  784. SIERKSMA AS, de Nijs L, Hoogland G, Vanmierlo T, et al
    Fluoxetine Treatment Induces Seizure Behavior and Premature Death in APPswe/PS1dE9 Mice.
    J Alzheimers Dis. 2016;51:677-82.
    PubMed     Text format     Abstract available


  785. KRISHNA K, Behnisch T, Sajikumar S
    Inhibition of Histone Deacetylase 3 Restores Amyloid-beta Oligomer-Induced Plasticity Deficit in Hippocampal CA1 Pyramidal Neurons.
    J Alzheimers Dis. 2016;51:783-91.
    PubMed     Text format     Abstract available


  786. RAMANAN S, Flanagan E, Leyton CE, Villemagne VL, et al
    Non-Verbal Episodic Memory Deficits in Primary Progressive Aphasias are Highly Predictive of Underlying Amyloid Pathology.
    J Alzheimers Dis. 2016;51:367-76.
    PubMed     Text format     Abstract available


  787. SON SM, Shin HJ, Byun J, Kook SY, et al
    Metformin Facilitates Amyloid-beta Generation by beta- and gamma-Secretases via Autophagy Activation.
    J Alzheimers Dis. 2016;51:1197-208.
    PubMed     Text format     Abstract available


  788. XU L, Wu X, Li R, Chen K, et al
    Prediction of Progressive Mild Cognitive Impairment by Multi-Modal Neuroimaging Biomarkers.
    J Alzheimers Dis. 2016;51:1045-56.
    PubMed     Text format     Abstract available


  789. MIGLIACCIO R, Gallea C, Kas A, Perlbarg V, et al
    Functional Connectivity of Ventral and Dorsal Visual Streams in Posterior Cortical Atrophy.
    J Alzheimers Dis. 2016;51:1119-30.
    PubMed     Text format     Abstract available


  790. TRAMUTOLA A, Pupo G, Di Domenico F, Barone E, et al
    Activation of p53 in Down Syndrome and in the Ts65Dn Mouse Brain is Associated with a Pro-Apoptotic Phenotype.
    J Alzheimers Dis. 2016;52:359-71.
    PubMed     Text format     Abstract available


  791. RAJI CA, Merrill DA, Eyre H, Mallam S, et al
    Longitudinal Relationships between Caloric Expenditure and Gray Matter in the Cardiovascular Health Study.
    J Alzheimers Dis. 2016;52:719-29.
    PubMed     Text format     Abstract available


    December 2015

  792. Upcoming Meetings Related to Alzheimer's Disease.
    J Alzheimers Dis. 2015;49:1193-6.
    PubMed     Text format    



  793. Upcoming Meetings Related to Alzheimer's Disease.
    J Alzheimers Dis. 2015;49:889-92.
    PubMed     Text format    


  794. LEWCZUK P, Kornhuber J, Toledo JB, Trojanowski JQ, et al
    Validation of the Erlangen Score Algorithm for the Prediction of the Development of Dementia due to Alzheimer's Disease in Pre-Dementia Subjects.
    J Alzheimers Dis. 2015;49:887.
    PubMed     Text format    


  795. BENNETT J, Burns J, Welch P, Bothwell R, et al
    Safety and Tolerability of R(+) Pramipexole in Mild-to-Moderate Alzheimer's Disease.
    J Alzheimers Dis. 2015.
    PubMed     Text format     Abstract available


  796. DERMODY N, Hornberger M, Piguet O, Hodges JR, et al
    Prospective Memory Impairments in Alzheimer's Disease and Behavioral Variant Frontotemporal Dementia: Clinical and Neural Correlates.
    J Alzheimers Dis. 2015.
    PubMed     Text format     Abstract available


  797. HOFFMANN K, Sobol NA, Frederiksen KS, Beyer N, et al
    Moderate-to-High Intensity Physical Exercise in Patients with Alzheimer's Disease: A Randomized Controlled Trial.
    J Alzheimers Dis. 2015.
    PubMed     Text format     Abstract available


  798. YAMASHITA S, Kiko T, Fujiwara H, Hashimoto M, et al
    Alterations in the Levels of Amyloid-beta, Phospholipid Hydroperoxide, and Plasmalogen in the Blood of Patients with Alzheimer's Disease: Possible Interactions between Amyloid-beta and These Lipids.
    J Alzheimers Dis. 2015.
    PubMed     Text format     Abstract available


  799. CHAKRABARTI M, McDonald AJ, Will Reed J, Moss MA, et al
    Molecular Signaling Mechanisms of Natural and Synthetic Retinoids for Inhibition of Pathogenesis in Alzheimer's Disease.
    J Alzheimers Dis. 2015.
    PubMed     Text format     Abstract available


  800. WANG S, Zhang Y, Liu G, Phillips P, et al
    Detection of Alzheimer's Disease by Three-Dimensional Displacement Field Estimation in Structural Magnetic Resonance Imaging.
    J Alzheimers Dis. 2015.
    PubMed     Text format     Abstract available


  801. GARDENER SL, Rainey-Smith SR, Martins RN
    Diet and Inflammation in Alzheimer's Disease and Related Chronic Diseases: A Review.
    J Alzheimers Dis. 2015.
    PubMed     Text format     Abstract available


  802. EZRA A, Rabinovich-Nikitin I, Rabinovich-Toidman P, Solomon B, et al
    Multifunctional Effect of Human Serum Albumin Reduces Alzheimer's Disease Related Pathologies in the 3xTg Mouse Model.
    J Alzheimers Dis. 2015.
    PubMed     Text format     Abstract available


  803. BARTOLOTTI N, Segura L, Lazarov O
    Diminished CRE-Induced Plasticity is Linked to Memory Deficits in Familial Alzheimer's Disease Mice.
    J Alzheimers Dis. 2015.
    PubMed     Text format     Abstract available


    November 2015
  804. MALISHKEVICH A, Marshall GA, Schultz AP, Sperling RA, et al
    Blood-Borne Activity-Dependent Neuroprotective Protein (ADNP) is Correlated with Premorbid Intelligence, Clinical Stage, and Alzheimer's Disease Biomarkers.
    J Alzheimers Dis. 2015.
    PubMed     Text format     Abstract available


  805. WEISSMANN R, Huttenrauch M, Kacprowski T, Bouter Y, et al
    Gene Expression Profiling in the APP/PS1KI Mouse Model of Familial Alzheimer's Disease.
    J Alzheimers Dis. 2015.
    PubMed     Text format     Abstract available


  806. STOCKBURGER C, Miano D, Baeumlisberger M, Pallas T, et al
    A Mitochondrial Role of SV2a Protein in Aging and Alzheimer's Disease: Studies with Levetiracetam.
    J Alzheimers Dis. 2015.
    PubMed     Text format     Abstract available


  807. CHANG YL, Yen YS, Chen TF, Yan SH, et al
    Clinical Dementia Rating Scale Detects White Matter Changes in Older Adults at Risk for Alzheimer's Disease.
    J Alzheimers Dis. 2015.
    PubMed     Text format     Abstract available


  808. QUINTANA-HERNANDEZ DJ, Miro-Barrachina MT, Ibanez-Fernandez IJ, Pino AS, et al
    Mindfulness in the Maintenance of Cognitive Capacities in Alzheimer's Disease: A Randomized Clinical Trial.
    J Alzheimers Dis. 2015.
    PubMed     Text format     Abstract available


  809. FISCHER CE, Qian W, Schweizer TA, Millikin CP, et al
    Lewy Bodies, Vascular Risk Factors, and Subcortical Arteriosclerotic Leukoencephalopathy, but not Alzheimer Pathology, are Associated with Development of Psychosis in Alzheimer's Disease.
    J Alzheimers Dis. 2015.
    PubMed     Text format     Abstract available


  810. STEENLAND K, Goldstein FC, Levey A, Wharton W, et al
    A Meta-Analysis of Alzheimer's Disease Incidence and Prevalence Comparing African-Americans and Caucasians.
    J Alzheimers Dis. 2015.
    PubMed     Text format     Abstract available


  811. GAO L, Cui Z, Shen L, Ji HF, et al
    Shared Genetic Etiology between Type 2 Diabetes and Alzheimer's Disease Identified by Bioinformatics Analysis.
    J Alzheimers Dis. 2015.
    PubMed     Text format     Abstract available


  812. AVONDINO E, Antoine P
    Heterogeneity of Cognitive Anosognosia and its Variation with the Severity of Dementia in Patients with Alzheimer's Disease.
    J Alzheimers Dis. 2015.
    PubMed     Text format     Abstract available


  813. MARRA C, Gainotti G, Fadda L, Perri R, et al
    Usefulness of an Integrated Analysis of Different Memory Tasks to Predict the Progression from Mild Cognitive Impairment to Alzheimer's Disease: The Episodic Memory Score (EMS).
    J Alzheimers Dis. 2015.
    PubMed     Text format     Abstract available


  814. SANTOS CY, Lim YY, Wu WC, Machan JT, et al
    Resting-State Cardiac Workload is Related to Both Increased Neocortical Aggregation of Amyloid-beta and Relative Impairments in Spatial Working Memory in Pre-Clinical Alzheimer's Disease.
    J Alzheimers Dis. 2015.
    PubMed     Text format     Abstract available


  815. GABELLE A, Gutierrez LA, Dartigues JF, Ritchie K, et al
    Palmomental Reflex a Relevant Sign in Early Alzheimer's Disease Diagnosis?
    J Alzheimers Dis. 2015.
    PubMed     Text format     Abstract available


  816. NOVAK G, Fox N, Clegg S, Nielsen C, et al
    Changes in Brain Volume with Bapineuzumab in Mild to Moderate Alzheimer's Disease.
    J Alzheimers Dis. 2015.
    PubMed     Text format     Abstract available


  817. LIU J, Zhang X, Yu C, Duan Y, et al
    Impaired Parahippocampus Connectivity in Mild Cognitive Impairment and Alzheimer's Disease.
    J Alzheimers Dis. 2015.
    PubMed     Text format     Abstract available


  818. DUKART J, Sambataro F, Bertolino A
    Accurate Prediction of Conversion to Alzheimer's Disease using Imaging, Genetic, and Neuropsychological Biomarkers.
    J Alzheimers Dis. 2015.
    PubMed     Text format     Abstract available


  819. SATTLECKER M, Khondoker M, Proitsi P, Williams S, et al
    Longitudinal Protein Changes in Blood Plasma Associated with the Rate of Cognitive Decline in Alzheimer's Disease.
    J Alzheimers Dis. 2015.
    PubMed     Text format     Abstract available


  820. TOSTO G, Monsell SE, Hawes SE, Giuseppe B, et al
    Progression of Extrapyramidal Signs in Alzheimer's Disease: Clinical and Neuropathological Correlates.
    J Alzheimers Dis. 2015.
    PubMed     Text format     Abstract available



  821. Upcoming Meetings Related to Alzheimer's Disease.
    J Alzheimers Dis. 2015;49:583-7.
    PubMed     Text format    


  822. BERTOUX M, de Souza Lc LC, O'Callaghan C, Greve A, et al
    Social Cognition Deficits: The Key to Discriminate Behavioral Variant Frontotemporal Dementia from Alzheimer's Disease Regardless of Amnesia?
    J Alzheimers Dis. 2015;49:1065-74.
    PubMed     Text format     Abstract available


  823. RHODIUS-MEESTER HF, Koikkalainen J, Mattila J, Teunissen CE, et al
    Integrating Biomarkers for Underlying Alzheimer's Disease in Mild Cognitive Impairment in Daily Practice: Comparison of a Clinical Decision Support System with Individual Biomarkers.
    J Alzheimers Dis. 2015.
    PubMed     Text format     Abstract available


  824. LANGE C, Suppa P, Frings L, Brenner W, et al
    Optimization of Statistical Single Subject Analysis of Brain FDG PET for the Prognosis of Mild Cognitive Impairment-to-Alzheimer's Disease Conversion.
    J Alzheimers Dis. 2015.
    PubMed     Text format     Abstract available


  825. STOGMANN E, Moser D, Klug S, Gleiss A, et al
    Activities of Daily Living and Depressive Symptoms in Patients with Subjective Cognitive Decline, Mild Cognitive Impairment, and Alzheimer's Disease.
    J Alzheimers Dis. 2015.
    PubMed     Text format     Abstract available



  826. Upcoming Meetings Related to Alzheimer's Disease.
    J Alzheimers Dis. 2015;49:267-70.
    PubMed     Text format    


    October 2015
  827. ROSENBERGER AF, Hilhorst R, Coart E, Garcia Barrado L, et al
    Protein Kinase Activity Decreases with Higher Braak Stages of Alzheimer's Disease Pathology.
    J Alzheimers Dis. 2015.
    PubMed     Text format     Abstract available



  828. Upcoming Meetings Related to Alzheimer's Disease.
    J Alzheimers Dis. 2015;48:1129-32.
    PubMed     Text format    


  829. DIAZ M, Fabelo N, Casanas-Sanchez V, Marin R, et al
    Hippocampal Lipid Homeostasis in APP/PS1 Mice is Modulated by a Complex Interplay Between Dietary DHA and Estrogens: Relevance for Alzheimer's Disease.
    J Alzheimers Dis. 2015.
    PubMed     Text format     Abstract available


  830. JOHNEN A, Frommeyer J, Modes F, Wiendl H, et al
    Dementia Apraxia Test (DATE): A Brief Tool to Differentiate Behavioral Variant Frontotemporal Dementia from Alzheimer's Dementia based on Apraxia Profiles.
    J Alzheimers Dis. 2015.
    PubMed     Text format     Abstract available


  831. BERGE G, Lauridsen C, Sando SB, Holder D, et al
    Effect of Tween-20 on Core Biomarkers Measured in Cerebrospinal Fluid from Patients with Alzheimer's Disease, Mild Cognitive Impairment, or Healthy Control Individuals.
    J Alzheimers Dis. 2015.
    PubMed     Text format     Abstract available


  832. WU HZ, Ong KL, Seeher K, J Armstrong N, et al
    Circulating microRNAs as Biomarkers of Alzheimer's Disease: A Systematic Review.
    J Alzheimers Dis. 2015.
    PubMed     Text format     Abstract available


  833. MADHAVAN A, Schwarz CG, Duffy JR, Strand EA, et al
    Characterizing White Matter Tract Degeneration in Syndromic Variants of Alzheimer's Disease: A Diffusion Tensor Imaging Study.
    J Alzheimers Dis. 2015.
    PubMed     Text format     Abstract available


  834. DUBOIS B, Padovani A, Scheltens P, Rossi A, et al
    Timely Diagnosis for Alzheimer's Disease: A Literature Review on Benefits and Challenges.
    J Alzheimers Dis. 2015.
    PubMed     Text format     Abstract available


  835. SAARELAINEN L, Taipale H, Koponen M, Tanskanen A, et al
    The Incidence of Benzodiazepine and Related Drug Use in Persons with and without Alzheimer's Disease.
    J Alzheimers Dis. 2015.
    PubMed     Text format     Abstract available


  836. FA M, Zhang H, Staniszewski A, Saeed F, et al
    Novel Selective Calpain 1 Inhibitors as Potential Therapeutics in Alzheimer's Disease.
    J Alzheimers Dis. 2015.
    PubMed     Text format     Abstract available


  837. BANERJEE P, Sahoo A, Anand S, Bir A, et al
    The Oral Iron Chelator, Deferasirox, Reverses the Age-Dependent Alterations in Iron and Amyloid-beta Homeostasis in Rat Brain: Implications in the Therapy of Alzheimer's Disease.
    J Alzheimers Dis. 2015.
    PubMed     Text format     Abstract available


  838. PINNOCK EC, Jovanovic K, Pinto MG, Ferreira E, et al
    LRP/LR Antibody Mediated Rescuing of Amyloid-beta-Induced Cytotoxicity is Dependent on PrPc in Alzheimer's Disease.
    J Alzheimers Dis. 2015.
    PubMed     Text format     Abstract available


  839. KOPPARA A, Wolfsgruber S, Kleineidam L, Schmidtke K, et al
    The Latent Dementia Phenotype delta is Associated with Cerebrospinal Fluid Biomarkers of Alzheimer's Disease and Predicts Conversion to Dementia in Subjects with Mild Cognitive Impairment.
    J Alzheimers Dis. 2015.
    PubMed     Text format     Abstract available


  840. YE BS, Jang EY, Kim SY, Kim EJ, et al
    Unstable Body Mass Index and Progression to Probable Alzheimer's Disease Dementia in Patients with Amnestic Mild Cognitive Impairment.
    J Alzheimers Dis. 2015.
    PubMed     Text format     Abstract available


  841. FRASER KC, Meltzer JA, Rudzicz F
    Linguistic Features Identify Alzheimer's Disease in Narrative Speech.
    J Alzheimers Dis. 2015.
    PubMed     Text format     Abstract available


  842. VOYLE N, Keohane A, Newhouse S, Lunnon K, et al
    A Pathway Based Classification Method for Analyzing Gene Expression for Alzheimer's Disease Diagnosis.
    J Alzheimers Dis. 2015.
    PubMed     Text format     Abstract available


  843. SHAH DJ, Rohlfing F, Anand S, Johnson WE, et al
    Discovery and Subsequent Confirmation of Novel Serum Biomarkers Diagnosing Alzheimer's Disease.
    J Alzheimers Dis. 2015.
    PubMed     Text format     Abstract available


  844. GARCIA BARRADO L, Coart E, Vanderstichele HM, Burzykowski T, et al
    Transferring Cut-off Values between Assays for Cerebrospinal Fluid Alzheimer's Disease Biomarkers.
    J Alzheimers Dis. 2015.
    PubMed     Text format     Abstract available


  845. PAN Y, Terpstra E, Wang Y, Qiao F, et al
    Dysregulation and Diagnostic Potential of microRNA in Alzheimer's Disease.
    J Alzheimers Dis. 2015.
    PubMed     Text format     Abstract available


  846. MINH DO T, Dodacki A, Alata W, Calon F, et al
    Age-Dependent Regulation of the Blood-Brain Barrier Influx/Efflux Equilibrium of Amyloid-beta Peptide in a Mouse Model of Alzheimer's Disease (3xTg-AD).
    J Alzheimers Dis. 2015.
    PubMed     Text format     Abstract available


  847. JOUSSAIN P, Bessy M, Fournel A, Ferdenzi C, et al
    Altered Affective Evaluations of Smells in Alzheimer's Disease.
    J Alzheimers Dis. 2015.
    PubMed     Text format     Abstract available


  848. LEVAULT KR, Tischkau SA, Brewer GJ
    Circadian Disruption Reveals a Correlation of an Oxidative GSH/GSSG Redox Shift with Learning and Impaired Memory in an Alzheimer's Disease Mouse Model.
    J Alzheimers Dis. 2015.
    PubMed     Text format     Abstract available


  849. ARAB L, Sabbagh MN
    Are Certain Lifestyle Habits Associated with Lower Alzheimer's Disease Risk?
    J Alzheimers Dis. 2015;48:877.
    PubMed     Text format    



  850. Upcoming Meetings Related to Alzheimer's Disease.
    J Alzheimers Dis. 2015;48:871-4.
    PubMed     Text format    


  851. GUO Z, Liu X, Jia X, Hou H, et al
    Regional Coherence Changes in Alzheimer's Disease Patients with Depressive Symptoms: A Resting-State Functional MRI Study.
    J Alzheimers Dis. 2015;48:603-11.
    PubMed     Text format     Abstract available


    September 2015
  852. PASTOR P, Moreno F, Clarimon J, Ruiz A, et al
    MAPT H1 Haplotype is Associated with Late-Onset Alzheimer's Disease Risk in APOEvarepsilon4 Noncarriers: Results from the Dementia Genetics Spanish Consortium.
    J Alzheimers Dis. 2015.
    PubMed     Text format     Abstract available


  853. COUTU JP, Goldblatt A, Rosas HD, Salat DH, et al
    White Matter Changes are Associated with Ventricular Expansion in Aging, Mild Cognitive Impairment, and Alzheimer's Disease.
    J Alzheimers Dis. 2015.
    PubMed     Text format     Abstract available


  854. GAVETT BE, John SE, Gurnani AS, Bussell CA, et al
    The Role of Alzheimer's and Cerebrovascular Pathology in Mediating the Effects of Age, Race, and Apolipoprotein E Genotype on Dementia Severity in Pathologically-Confirmed Alzheimer's Disease.
    J Alzheimers Dis. 2015.
    PubMed     Text format     Abstract available


  855. AGOSTINI S, Mancuso R, Baglio F, Cabinio M, et al
    Lack of Evidence for a Role of HHV-6 in the Pathogenesis of Alzheimer's Disease.
    J Alzheimers Dis. 2015.
    PubMed     Text format     Abstract available


  856. PIERROT N, Lhommel R, Quenon L, Hanseeuw B, et al
    Targretin Improves Cognitive and Biological Markers in a Patient with Alzheimer's Disease.
    J Alzheimers Dis. 2015.
    PubMed     Text format     Abstract available


  857. CONEJERO-GOLDBERG C, Hyde TM, Chen S, Herman MM, et al
    Cortical Transcriptional Profiles in APOE4 Carriers with Alzheimer's Disease: Patterns of Protection and Degeneration.
    J Alzheimers Dis. 2015.
    PubMed     Text format     Abstract available


  858. LIZIO R, Del Percio C, Marzano N, Soricelli A, et al
    Neurophysiological Assessment of Alzheimer's Disease Individuals by a Single Electroencephalographic Marker.
    J Alzheimers Dis. 2015.
    PubMed     Text format     Abstract available


  859. VALECH N, Mollica MA, Olives J, Tort A, et al
    Informants' Perception of Subjective Cognitive Decline Helps to Discriminate Preclinical Alzheimer's Disease from Normal Aging.
    J Alzheimers Dis. 2015;48 Suppl 1:S87-98.
    PubMed     Text format     Abstract available


  860. WHITEHOUSE PJ, George DR
    A Tale of Two Reports: What Recent Publications from the Alzheimer's Association and Institute of Medicine say about the State of the Field.
    J Alzheimers Dis. 2015.
    PubMed     Text format    


  861. SUN X, Ma R, Yao X, Shang X, et al
    Concanavalin Agglutinin Levels are Decreased in Peripheral Blood of Alzheimer's Disease Patients.
    J Alzheimers Dis. 2015.
    PubMed     Text format     Abstract available


  862. YOON B, Shim YS, Park HK, Park S, et al
    Predictive Factors for Disease Progression in Patients With Early-Onset Alzheimer's Disease.
    J Alzheimers Dis. 2015.
    PubMed     Text format     Abstract available


  863. SAVASTANO A, Klafki H, Haussmann U, Oberstein TJ, et al
    N-Truncated Abeta 2-X Starting with Position Two in Sporadic Alzheimer's Disease Cases and Two Alzheimer Mouse Models.
    J Alzheimers Dis. 2015.
    PubMed     Text format     Abstract available


  864. SPIEGEL J, Pirraglia E, Li Y, Tsui W, et al
    Greater Specificity for Cerebrospinal Fluid P-tau231 over P-tau181 in the Differentiation of Healthy Controls from Alzheimer's Disease.
    J Alzheimers Dis. 2015.
    PubMed     Text format     Abstract available


  865. KIM HJ, Park KW, Kim TE, Im JY, et al
    Elevation of the Plasma Abeta40/Abeta 42 Ratio as a Diagnostic Marker of Sporadic Early-Onset Alzheimer's Disease.
    J Alzheimers Dis. 2015.
    PubMed     Text format     Abstract available


  866. SAVASTANO A, Klafki H, Haussmann U, Oberstein TJ, et al
    N-Truncated Abeta2-X Starting with Position Two in Sporadic Alzheimer's Disease Cases and Two Alzheimer Mouse Models.
    J Alzheimers Dis. 2015;49:101-10.
    PubMed     Text format     Abstract available


  867. BRYNDIS EINARSDOTTIR A, Hardarson SH, Kristjansdottir JV, Bragason DT, et al
    Retinal Oximetry Imaging in Alzheimer's Disease.
    J Alzheimers Dis. 2015.
    PubMed     Text format     Abstract available


  868. TRIPLETT JC, Swomley AM, Cai J, Klein JB, et al
    Quantitative Phosphoproteomic Analyses of the Inferior Parietal Lobule from Three Different Pathological Stages of Alzheimer's Disease.
    J Alzheimers Dis. 2015.
    PubMed     Text format     Abstract available


  869. LIU H, Qiu H, Xiao Q, Le W, et al
    Chronic Hypoxia-Induced Autophagy Aggravates the Neuropathology of Alzheimer's Disease through AMPK-mTOR Signaling in the APPSwe/PS1dE9 Mouse Model.
    J Alzheimers Dis. 2015.
    PubMed     Text format     Abstract available


  870. SPARRE-SORENSEN M, Kristensen G
    Alzheimer's Disease in the Danish Malnutrition Period 1999-2007.
    J Alzheimers Dis. 2015.
    PubMed     Text format     Abstract available


  871. MOON SW, Dinov ID, Kim J, Zamanyan A, et al
    Structural Neuroimaging Genetics Interactions in Alzheimer's Disease.
    J Alzheimers Dis. 2015.
    PubMed     Text format     Abstract available


  872. ZHENG W, Yao Z, Hu B, Gao X, et al
    Novel Cortical Thickness Pattern for Accurate Detection of Alzheimer's Disease.
    J Alzheimers Dis. 2015.
    PubMed     Text format     Abstract available


  873. TORMALEHTO SM, Martikainen JA, Vaatainen ST, Hallikainen IT, et al
    Use of Anti-Dementia Drugs in Relation to Change in Cognition, Behavior, and Functioning in Alzheimer's Disease over a Three-Year Period: Kuopio ALSOVA Study.
    J Alzheimers Dis. 2015.
    PubMed     Text format     Abstract available


  874. CALDERON-GARCIDUENAS L, Mora-Tiscareno A, Sanchez GM, Rodriguez-Diaz J, et al
    A Critical Proton MR Spectroscopy Marker of Alzheimer's Disease Early Neurodegenerative Change: Low Hippocampal NAA/Cr Ratio Impacts APOE varepsilon4 Mexico City Children and Their Parents.
    J Alzheimers Dis. 2015.
    PubMed     Text format     Abstract available


  875. PRICE CC, Tanner JJ, Schmalfuss IM, Brumback B, et al
    Dissociating Statistically-Determined Alzheimer's Disease/Vascular Dementia Neuropsychological Syndromes Using White and Gray Neuroradiological Parameters.
    J Alzheimers Dis. 2015.
    PubMed     Text format     Abstract available


  876. BIELARCZYK H, Jankowska-Kulawy A, Hofling C, Ronowska A, et al
    AbetaPP-Transgenic 2576 Mice Mimic Cell Type-Specific Aspects of Acetyl-CoA-Linked Metabolic Deficits in Alzheimer's Disease.
    J Alzheimers Dis. 2015.
    PubMed     Text format     Abstract available


  877. MISTRIDIS P, Krumm S, Monsch AU, Berres M, et al
    The 12 Years Preceding Mild Cognitive Impairment Due to Alzheimer's Disease: The Temporal Emergence of Cognitive Decline.
    J Alzheimers Dis. 2015.
    PubMed     Text format     Abstract available


  878. JHA NK, Jha SK, Kumar D, Kejriwal N, et al
    Impact of Insulin Degrading Enzyme and Neprilysin in Alzheimer's Disease Biology: Characterization of Putative Cognates for Therapeutic Applications.
    J Alzheimers Dis. 2015.
    PubMed     Text format     Abstract available


  879. GIACCONE G
    The Existence of Primary Age-Related Tauopathy Suggests that not all the Cases with Early Braak Stages of Neurofibrillary Pathology are Alzheimer's Disease.
    J Alzheimers Dis. 2015.
    PubMed     Text format     Abstract available


  880. DIEHL-WIESENECKER E, von Armin CA, Dupuis L, Muller HP, et al
    Adipose Tissue Distribution in Patients with Alzheimer's Disease: A Whole Body MRI Case-Control Study.
    J Alzheimers Dis. 2015.
    PubMed     Text format     Abstract available



  881. Upcoming Meetings Related to Alzheimer's Disease.
    J Alzheimers Dis. 2015;48:557-61.
    PubMed     Text format    


  882. REDDY PH, Blackmon J, Molinar-Lopez V, Ament C, et al
    Garrison Institute on Aging: A New Hope for Elderly Individuals and Patients with Alzheimer's Disease.
    J Alzheimers Dis. 2015;48:547-55.
    PubMed     Text format     Abstract available


  883. WOOD PL, Medicherla S, Sheikh N, Terry B, et al
    Targeted Lipidomics of Fontal Cortex and Plasma Diacylglycerols (DAG) in Mild Cognitive Impairment and Alzheimer's Disease: Validation of DAG Accumulation Early in the Pathophysiology of Alzheimer's Disease.
    J Alzheimers Dis. 2015;48:537-46.
    PubMed     Text format     Abstract available


  884. EL HAJ M, Gely-Nargeot MC, Raffard S
    Destination Memory and Cognitive Theory of Mind in Alzheimer's Disease.
    J Alzheimers Dis. 2015;48:529-36.
    PubMed     Text format     Abstract available


  885. SAMURAKI M, Matsunari I, Yoshita M, Shima K, et al
    Cerebral Amyloid Angiopathy-Related Microbleeds Correlate with Glucose Metabolism and Brain Volume in Alzheimer's Disease.
    J Alzheimers Dis. 2015;48:517-28.
    PubMed     Text format     Abstract available


  886. SARAJARVI T, Marttinen M, Natunen T, Kauppinen T, et al
    Genetic Variation in delta-Opioid Receptor Associates with Increased beta- and gamma-Secretase Activity in the Late Stages of Alzheimer's Disease.
    J Alzheimers Dis. 2015;48:507-16.
    PubMed     Text format     Abstract available


  887. SARLUS H, Eyjolfsdottir H, Eriksdotter M, Oprica M, et al
    Influence of Allergy on Immunoglobulins and Amyloid-beta in the Cerebrospinal Fluid of Patients with Alzheimer's Disease.
    J Alzheimers Dis. 2015;48:495-505.
    PubMed     Text format     Abstract available


  888. GAUTHIER S, Rountree S, Finn B, LaPlante B, et al
    Effects of the Acetylcholine Release Agent ST101 with Donepezil in Alzheimer's Disease: A Randomized Phase 2 Study.
    J Alzheimers Dis. 2015;48:473-81.
    PubMed     Text format     Abstract available


  889. LIAO X, Li G, Wang A, Liu T, et al
    Repetitive Transcranial Magnetic Stimulation as an Alternative Therapy for Cognitive Impairment in Alzheimer's Disease: A Meta-Analysis.
    J Alzheimers Dis. 2015;48:463-72.
    PubMed     Text format     Abstract available


  890. LEIFERT WR, Nguyen T, Rembach A, Martins R, et al
    Buccal Cell Cytokeratin 14 Correlates with Multiple Blood Biomarkers of Alzheimer's Disease Risk.
    J Alzheimers Dis. 2015;48:443-52.
    PubMed     Text format     Abstract available


  891. LEWCZUK P, Kornhuber J, Toledo JB, Trojanowski JQ, et al
    Validation of the Erlangen Score Algorithm for the Prediction of the Development of Dementia due to Alzheimer's Disease in Pre-Dementia Subjects.
    J Alzheimers Dis. 2015;48:433-41.
    PubMed     Text format     Abstract available


  892. WEISE D, Tiepolt S, Awissus C, Hoffmann KT, et al
    Critical Comparison of Different Biomarkers for Alzheimer's Disease in a Clinical Setting.
    J Alzheimers Dis. 2015;48:425-32.
    PubMed     Text format     Abstract available


  893. KEENEY JT, Ibrahimi S, Zhao L
    Human ApoE Isoforms Differentially Modulate Glucose and Amyloid Metabolic Pathways in Female Brain: Evidence of the Mechanism of Neuroprotection by ApoE2 and Implications for Alzheimer's Disease Prevention and Early Intervention.
    J Alzheimers Dis. 2015;48:411-24.
    PubMed     Text format     Abstract available


  894. MATSUNAGA S, Kishi T, Annas P, Basun H, et al
    Lithium as a Treatment for Alzheimer's Disease: A Systematic Review and Meta-Analysis.
    J Alzheimers Dis. 2015;48:403-10.
    PubMed     Text format     Abstract available


  895. SERVELLO A, Fioretti A, Gualdi G, Di Biasi C, et al
    Olfactory Dysfunction, Olfactory Bulb Volume and Alzheimer's Disease: Is There a Correlation? A Pilot Study1.
    J Alzheimers Dis. 2015;48:395-402.
    PubMed     Text format     Abstract available


  896. REA R, Carotenuto A, Traini E, Fasanaro AM, et al
    Apathy Treatment in Alzheimer's Disease: Interim Results of the ASCOMALVA Trial.
    J Alzheimers Dis. 2015;48:377-83.
    PubMed     Text format     Abstract available


  897. BEYDOUN MA, Beydoun HA, Gamaldo AA, Rostant OS, et al
    Nationwide Inpatient Prevalence, Predictors, and Outcomes of Alzheimer's Disease among Older Adults in the United States, 2002-2012.
    J Alzheimers Dis. 2015;48:361-75.
    PubMed     Text format     Abstract available


  898. HARRIS SA, Harris EA
    Herpes Simplex Virus Type 1 and Other Pathogens are Key Causative Factors in Sporadic Alzheimer's Disease.
    J Alzheimers Dis. 2015;48:319-53.
    PubMed     Text format     Abstract available


  899. PISTOLLATO F, Cano SS, Elio I, Vergara MM, et al
    The Use of Neuroimaging to Assess Associations Among Diet, Nutrients, Metabolic Syndrome, and Alzheimer's Disease.
    J Alzheimers Dis. 2015;48:303-18.
    PubMed     Text format     Abstract available


  900. DUBNER L, Wang J, Ho L, Ward L, et al
    Recommendations for Development of New Standardized Forms of Cocoa Breeds and Cocoa Extract Processing for the Prevention of Alzheimer's Disease: Role of Cocoa in Promotion of Cognitive Resilience and Healthy Brain Aging.
    J Alzheimers Dis. 2015.
    PubMed     Text format     Abstract available


  901. POPOVA SN, Pesala S, Alafuzoff I
    To Stage Alzheimer's Disease Related Neurodegeneration Using one Section of Hippocampus.
    J Alzheimers Dis. 2015.
    PubMed     Text format     Abstract available


  902. DI STEFANO F, Epelbaum S, Coley N, Cantet C, et al
    Prediction of Alzheimer's Disease Dementia: Data from the GuidAge Prevention Trial.
    J Alzheimers Dis. 2015.
    PubMed     Text format     Abstract available


  903. DUITS FH, Hernandez-Guillamon M, Montaner J, Goos JD, et al
    Matrix Metalloproteinases in Alzheimer's Disease and Concurrent Cerebral Microbleeds.
    J Alzheimers Dis. 2015.
    PubMed     Text format     Abstract available


  904. ERIKSDOTTER M, Vedin I, Falahati F, Freund-Levi Y, et al
    Plasma Fatty Acid Profiles in Relation to Cognition and Gender in Alzheimer's Disease Patients During Oral Omega-3 Fatty Acid Supplementation: The OmegAD Study.
    J Alzheimers Dis. 2015.
    PubMed     Text format     Abstract available


  905. YOU SC, Walsh CM, Chiodo LA, Ketelle R, et al
    Neuropsychiatric Symptoms Predict Functional Status in Alzheimer's Disease.
    J Alzheimers Dis. 2015.
    PubMed     Text format     Abstract available


  906. FORAKER J, Millard SP, Leong L, Thomson Z, et al
    The APOE Gene is Differentially Methylated in Alzheimer's Disease.
    J Alzheimers Dis. 2015.
    PubMed     Text format     Abstract available


  907. BILELLO M, Doshi J, Nabavizadeh SA, Toledo JB, et al
    Correlating Cognitive Decline with White Matter Lesion and Brain Atrophy Magnetic Resonance Imaging Measurements in Alzheimer's Disease.
    J Alzheimers Dis. 2015.
    PubMed     Text format     Abstract available


  908. MAGISTRI M, Velmeshev D, Makhmutova M, Faghihi MA, et al
    Transcriptomics Profiling of Alzheimer's Disease Reveal Neurovascular Defects, Altered Amyloid-beta Homeostasis, and Deregulated Expression of Long Noncoding RNAs.
    J Alzheimers Dis. 2015.
    PubMed     Text format     Abstract available


  909. KUBO M, Kishi T, Matsunaga S, Iwata N, et al
    Histamine H3 Receptor Antagonists for Alzheimer's Disease: A Systematic Review and Meta-Analysis of Randomized Placebo-Controlled Trials.
    J Alzheimers Dis. 2015.
    PubMed     Text format     Abstract available


  910. HONG HS, Maezawa I, Petrlova J, Zhao XY, et al
    Tomoregulin (TMEFF2) Binds Alzheimer's Disease Amyloid-beta (Abeta) Oligomer and AbetaPP and Protects Neurons from Abeta-Induced Toxicity.
    J Alzheimers Dis. 2015.
    PubMed     Text format     Abstract available


  911. MEIER S, Bell M, Lyons DN, Ingram A, et al
    Identification of Novel Tau Interactions with Endoplasmic Reticulum Proteins in Alzheimer's Disease Brain.
    J Alzheimers Dis. 2015.
    PubMed     Text format     Abstract available


  912. GRAMUNT N, Buschke H, Sanchez-Benavides G, Lipton RB, et al
    Reference Data of the Spanish Memory Binding Test in a Midlife Population from the ALFA STUDY (Alzheimer's and Family).
    J Alzheimers Dis. 2015.
    PubMed     Text format     Abstract available


  913. MENENDEZ-GONZALEZ M, de Celis Alonso B, Salas-Pacheco J, Arias-Carrion O, et al
    Structural Neuroimaging of the Medial Temporal Lobe in Alzheimer's Disease Clinical Trials.
    J Alzheimers Dis. 2015.
    PubMed     Text format     Abstract available


  914. MATSUZONO K, Sato K, Kono S, Hishikawa N, et al
    Clinical Benefits of Rivastigmine in the Real World Dementia Clinics of the Okayama Rivastigmine Study (ORS).
    J Alzheimers Dis. 2015.
    PubMed     Text format     Abstract available


    August 2015

  915. Upcoming Meetings Related to Alzheimer's Disease.
    J Alzheimers Dis. 2015;48:287-91.
    PubMed     Text format    


  916. MATSUZONO K, Hishikawa N, Yamashita T, Ohta Y, et al
    Comprehensive Clinical Evaluations of Frontotemporal Dementia Contrasting to Alzheimer's Disease (oFTD Study).
    J Alzheimers Dis. 2015;48:279-86.
    PubMed     Text format     Abstract available


  917. ANDERKOVA L, Eliasova I, Marecek R, Janousova E, et al
    Distinct Pattern of Gray Matter Atrophy in Mild Alzheimer's Disease Impacts on Cognitive Outcomes of Noninvasive Brain Stimulation.
    J Alzheimers Dis. 2015;48:251-60.
    PubMed     Text format     Abstract available


  918. HEISKANEN J, Hartikainen S, Roine RP, Tolppanen AM, et al
    30-Day Mortality after Cardiovascular Events in Persons with or without Alzheimer's Disease.
    J Alzheimers Dis. 2015;48:241-9.
    PubMed     Text format     Abstract available


  919. BRUEGGEN K, Dyrba M, Barkhof F, Hausner L, et al
    Basal Forebrain and Hippocampus as Predictors of Conversion to Alzheimer's Disease in Patients with Mild Cognitive Impairment - A Multicenter DTI and Volumetry Study.
    J Alzheimers Dis. 2015;48:197-204.
    PubMed     Text format     Abstract available


  920. SCHMIDT C, Gerlach N, Schmitz M, Thom T, et al
    Baseline CSF/Serum-Ratio of Apolipoprotein E and Rate of Differential Decline in Alzheimer's Disease.
    J Alzheimers Dis. 2015;48:189-96.
    PubMed     Text format     Abstract available


  921. LI QX, Villemagne VL, Doecke JD, Rembach A, et al
    Alzheimer's Disease Normative Cerebrospinal Fluid Biomarkers Validated in PET Amyloid-beta Characterized Subjects from the Australian Imaging, Biomarkers and Lifestyle (AIBL) study.
    J Alzheimers Dis. 2015;48:175-87.
    PubMed     Text format     Abstract available


  922. PAPUC E, Kurys-Denis E, Krupski W, Tatara M, et al
    Can Antibodies Against Glial Derived Antigens be Early Biomarkers of Hippocampal Demyelination and Memory Loss in Alzheimer's Disease?
    J Alzheimers Dis. 2015;48:115-21.
    PubMed     Text format     Abstract available


  923. ZHANG XF, Zhao YF, Zhu SW, Huang WJ, et al
    CXCL1 Triggers Caspase-3 Dependent Tau Cleavage in Long-Term Neuronal Cultures and in the Hippocampus of Aged Mice: Implications in Alzheimer's Disease.
    J Alzheimers Dis. 2015;48:89-104.
    PubMed     Text format     Abstract available


  924. SNIR JA, Suchy M, Lawrence KS, Hudson RH, et al
    Prolonged In Vivo Retention of a Cathepsin D Targeted Optical Contrast Agent in a Mouse Model of Alzheimer's Disease.
    J Alzheimers Dis. 2015;48:73-87.
    PubMed     Text format     Abstract available


  925. SOLLVANDER S, Ekholm-Pettersson F, Brundin RM, Westman G, et al
    Increased Number of Plasma B Cells Producing Autoantibodies Against Abeta42 Protofibrils in Alzheimer's Disease.
    J Alzheimers Dis. 2015;48:63-72.
    PubMed     Text format     Abstract available


  926. SIARKOS KT, Katirtzoglou EA, Politis AM
    A Review of Pharmacological Treatments for Depression in Alzheimer's Disease.
    J Alzheimers Dis. 2015;48:15-34.
    PubMed     Text format     Abstract available


  927. WESSON ASHFORD J, Mahoney L, Burkett T
    A Role for Complementary and Integrative Medicine in Alzheimer's Disease Prevention.
    J Alzheimers Dis. 2015;48:13-4.
    PubMed     Text format     Abstract available


  928. KHALSA DS
    Stress, Meditation, and Alzheimer's Disease Prevention: Where The Evidence Stands.
    J Alzheimers Dis. 2015;48:1-12.
    PubMed     Text format     Abstract available


  929. SPALLETTA G, Long JD, Robinson RG, Trequattrini A, et al
    Longitudinal Neuropsychiatric Predictors of Death in Alzheimer's Disease.
    J Alzheimers Dis. 2015.
    PubMed     Text format     Abstract available


  930. ABERG D, Johansson P, Isgaard J, Wallin A, et al
    Increased Cerebrospinal Fluid Level of Insulin-like Growth Factor-II in Male Patients with Alzheimer's Disease.
    J Alzheimers Dis. 2015.
    PubMed     Text format     Abstract available



  931. Upcoming Meetings Related to Alzheimer's Disease.
    J Alzheimers Dis. 2015;47:1079-84.
    PubMed     Text format    


  932. TRAVASSOS M, Santana I, Baldeiras I, Tsolaki M, et al
    Does Caffeine Consumption Modify Cerebrospinal Fluid Amyloid-beta Levels in Patients with Alzheimer's Disease?
    J Alzheimers Dis. 2015;47:1069-78.
    PubMed     Text format     Abstract available


  933. ZHAN Y, Chen K, Wu X, Zhang D, et al
    Identification of Conversion from Normal Elderly Cognition to Alzheimer's Disease using Multimodal Support Vector Machine.
    J Alzheimers Dis. 2015;47:1057-67.
    PubMed     Text format     Abstract available


  934. LIU K, Chojnacki JE, Wade EE, Saathoff JM, et al
    Bivalent Compound 17MN Exerts Neuroprotection through Interaction at Multiple Sites in a Cellular Model of Alzheimer's Disease.
    J Alzheimers Dis. 2015;47:1021-33.
    PubMed     Text format     Abstract available


  935. GLEASON CE, Fischer BL, Dowling NM, Setchell KD, et al
    Cognitive Effects of Soy Isoflavones in Patients with Alzheimer's Disease.
    J Alzheimers Dis. 2015;47:1009-19.
    PubMed     Text format     Abstract available


  936. WEILER M, Agosta F, Canu E, Copetti M, et al
    Following the Spreading of Brain Structural Changes in Alzheimer's Disease: A Longitudinal, Multimodal MRI Study.
    J Alzheimers Dis. 2015;47:995-1007.
    PubMed     Text format     Abstract available


  937. MENDEZ MF, Paholpak P, Lin A, Zhang JY, et al
    Prevalence of Traumatic Brain Injury in Early Versus Late-Onset Alzheimer's Disease.
    J Alzheimers Dis. 2015;47:985-93.
    PubMed     Text format     Abstract available


  938. QUIROZ YT, Willment KC, Castrillon G, Muniz M, et al
    Successful Scene Encoding in Presymptomatic Early-Onset Alzheimer's Disease.
    J Alzheimers Dis. 2015;47:955-64.
    PubMed     Text format     Abstract available


  939. FU Y, Zhao D, Pan B, Wang J, et al
    Proteomic Analysis of Protein Expression Throughout Disease Progression in a Mouse Model of Alzheimer's Disease.
    J Alzheimers Dis. 2015;47:915-26.
    PubMed     Text format     Abstract available


  940. LI G, Xiong K, Korff A, Pan C, et al
    Increased CSF E-Selectin in Clinical Alzheimer's Disease without Altered CSF Abeta42 and Tau.
    J Alzheimers Dis. 2015;47:883-7.
    PubMed     Text format     Abstract available


  941. CATANIA M, Di Fede G, Tonoli E, Benussi L, et al
    Mirror Image of the Amyloid-beta Species in Cerebrospinal Fluid and Cerebral Amyloid in Alzheimer's Disease.
    J Alzheimers Dis. 2015;47:877-81.
    PubMed     Text format     Abstract available


  942. ALONSO R, Pisa D, Rabano A, Rodal I, et al
    Cerebrospinal Fluid from Alzheimer's Disease Patients Contains Fungal Proteins and DNA.
    J Alzheimers Dis. 2015;47:873-6.
    PubMed     Text format     Abstract available


  943. NOVAIS F, Starkstein S
    Phenomenology of Depression in Alzheimer's Disease.
    J Alzheimers Dis. 2015;47:845-55.
    PubMed     Text format     Abstract available


  944. BANIK A, Brown RE, Bamburg J, Lahiri DK, et al
    Translation of Pre-Clinical Studies into Successful Clinical Trials for Alzheimer's Disease: What are the Roadblocks and How Can They Be Overcome?1.
    J Alzheimers Dis. 2015;47:815-43.
    PubMed     Text format     Abstract available



  945. Upcoming Meetings Related to Alzheimer's Disease.
    J Alzheimers Dis. 2015;47:787-91.
    PubMed     Text format    


  946. VALOTASSIOU V, Papatriantafyllou J, Sifakis N, Tzavara C, et al
    Clinical Evaluation of Brain Perfusion SPECT with Brodmann Areas Mapping in Early Diagnosis of Alzheimer's Disease.
    J Alzheimers Dis. 2015;47:773-85.
    PubMed     Text format     Abstract available


  947. BRADLEY-WHITMAN MA, Abner E, Lynn BC, Lovell MA, et al
    A Novel Plasma Based Biomarker of Alzheimer's Disease.
    J Alzheimers Dis. 2015;47:761-71.
    PubMed     Text format     Abstract available


  948. CHIAM JT, Lunnon K, Voyle N, Proitsi P, et al
    No Evidence to Suggest that the Use of Acetylcholinesterase Inhibitors Confounds the Results of Two Blood-Based Biomarker Studies in Alzheimer's Disease.
    J Alzheimers Dis. 2015;47:741-50.
    PubMed     Text format     Abstract available


  949. NORDBERG A, Kadir A, Andreasen N, Almkvist O, et al
    Correlations between Alzheimer's Disease Cerebrospinal Fluid Biomarkers and Cerebral Glucose Metabolism after 12 Months of Phenserine Treatment.
    J Alzheimers Dis. 2015;47:691-704.
    PubMed     Text format     Abstract available


  950. JENSEN-DAHM C, Waldemar G, Staehelin Jensen T, Malmqvist L, et al
    Autonomic Dysfunction in Patients with Mild to Moderate Alzheimer's Disease.
    J Alzheimers Dis. 2015;47:681-9.
    PubMed     Text format     Abstract available


  951. TANG X, Holland D, Dale AM, Miller MI, et al
    APOE Affects the Volume and Shape of the Amygdala and the Hippocampus in Mild Cognitive Impairment and Alzheimer's Disease: Age Matters.
    J Alzheimers Dis. 2015;47:645-60.
    PubMed     Text format     Abstract available


  952. CHO SJ, Yun SM, Lee DH, Jo C, et al
    Plasma SUMO1 Protein is Elevated in Alzheimer's Disease.
    J Alzheimers Dis. 2015;47:639-43.
    PubMed     Text format     Abstract available


  953. VIRK SA, Eslick GD
    Aluminum Levels in Brain, Serum, and Cerebrospinal Fluid are Higher in Alzheimer's Disease Cases than in Controls: A Series of Meta-Analyses.
    J Alzheimers Dis. 2015;47:629-38.
    PubMed     Text format     Abstract available


  954. NAKANO Y, Matsuzono K, Yamashita T, Ohta Y, et al
    Long-Term Efficacy of Galantamine in Alzheimer's Disease: The Okayama Galantamine Study (OGS).
    J Alzheimers Dis. 2015;47:609-17.
    PubMed     Text format     Abstract available


  955. WANG ZX, Tan L, Wang HF, Ma J, et al
    Serum Iron, Zinc, and Copper Levels in Patients with Alzheimer's Disease: A Replication Study and Meta-Analyses.
    J Alzheimers Dis. 2015;47:565-81.
    PubMed     Text format     Abstract available


  956. TIEPOLT S, Patt M, Hoffmann KT, Schroeter ML, et al
    Alzheimer's Disease FDG PET Imaging Pattern in an Amyloid-Negative Mild Cognitive Impairment Subject.
    J Alzheimers Dis. 2015;47:539-43.
    PubMed     Text format     Abstract available


  957. FLORIS G, Di Stefano F, Cherchi MV, Costa G, et al
    Multiple Spontaneous Cerebral Microbleeds and Leukoencephalopathy in PSEN1-Associated Familial Alzheimer's Disease: Mirror of Cerebral Amyloid Angiopathy?
    J Alzheimers Dis. 2015;47:535-8.
    PubMed     Text format     Abstract available


    July 2015

  958. Upcoming Meetings Related to Alzheimer's Disease.
    J Alzheimers Dis. 2015;47:531-4.
    PubMed     Text format    


  959. GIIL LM, Kristoffersen EK, Vedeler CA, Aarsland D, et al
    Autoantibodies Toward the Angiotensin 2 Type 1 Receptor: A Novel Autoantibody in Alzheimer's Disease.
    J Alzheimers Dis. 2015;47:523-9.
    PubMed     Text format     Abstract available


  960. YIN RH, Tan L, Liu Y, Wang WY, et al
    Multimodal Voxel-Based Meta-Analysis of White Matter Abnormalities in Alzheimer's Disease.
    J Alzheimers Dis. 2015;47:495-507.
    PubMed     Text format     Abstract available


  961. MATSUZONO K, Yamashita T, Ohta Y, Hishikawa N, et al
    Clinical Benefits of Memantine Treatment for Alzheimer's Disease in the Okayama Memantine Study II (OMS II).
    J Alzheimers Dis. 2015;47:487-93.
    PubMed     Text format     Abstract available


  962. LEON C, Pin S, Kreft-Jais C, Arwidson P, et al
    Perceptions of Alzheimer's Disease in the French Population: Evolutions between 2008 and 2013 and Associated Factors in 2013.
    J Alzheimers Dis. 2015;47:467-78.
    PubMed     Text format     Abstract available


  963. RANGASAMY SB, Corbett GT, Roy A, Modi KK, et al
    Intranasal Delivery of NEMO-Binding Domain Peptide Prevents Memory Loss in a Mouse Model of Alzheimer's Disease.
    J Alzheimers Dis. 2015;47:385-402.
    PubMed     Text format     Abstract available


  964. PIMENTEL LS, Allard S, Do Carmo S, Weinreb O, et al
    The Multi-Target Drug M30 Shows Pro-Cognitive and Anti-Inflammatory Effects in a Rat Model of Alzheimer's Disease.
    J Alzheimers Dis. 2015;47:373-83.
    PubMed     Text format     Abstract available


  965. HARTL D, Gu W, Mayhaus M, Pichler S, et al
    Amyloid-beta Protein Precursor Cleavage Products in Postmortem Ventricular Cerebrospinal Fluid of Alzheimer's Disease Patients.
    J Alzheimers Dis. 2015;47:365-72.
    PubMed     Text format     Abstract available


  966. STEEL AJ, Eslick GD
    Herpes Viruses Increase the Risk of Alzheimer's Disease: A Meta-Analysis.
    J Alzheimers Dis. 2015;47:351-64.
    PubMed     Text format     Abstract available


  967. ROMAN GC
    MTHFR Gene Mutations: A Potential Marker of Late-Onset Alzheimer's Disease?
    J Alzheimers Dis. 2015;47:323-7.
    PubMed     Text format     Abstract available


  968. LISTA S, O'Bryant SE, Blennow K, Dubois B, et al
    Biomarkers in Sporadic and Familial Alzheimer's Disease.
    J Alzheimers Dis. 2015;47:291-317.
    PubMed     Text format     Abstract available


  969. KINCSES ZT, Kiraly A, Vereb D, Vecsei L, et al
    Structural Magnetic Resonance Imaging Markers of Alzheimer's Disease and Its Retranslation to Rodent Models.
    J Alzheimers Dis. 2015;47:277-90.
    PubMed     Text format     Abstract available



  970. Upcoming Meetings Related to Alzheimer's Disease.
    J Alzheimers Dis. 2015;47:273-6.
    PubMed     Text format    



  971. Higher Levels of Oxidized Low Density Lipoproteins in Alzheimer's Disease Patients: Roles for Platelet Activating Factor Acetyl Hydrolase and Paraoxonase-1.
    J Alzheimers Dis. 2015;47:271.
    PubMed     Text format    


  972. VAN HARTEN AC, Mulders J, Scheltens P, van der Flier WM, et al
    Differential Expression of microRNA in Cerebrospinal Fluid as a Potential Novel Biomarker for Alzheimer's Disease.
    J Alzheimers Dis. 2015;47:243-52.
    PubMed     Text format     Abstract available


  973. EDMONDS EC, Delano-Wood L, Galasko DR, Salmon DP, et al
    Subtle Cognitive Decline and Biomarker Staging in Preclinical Alzheimer's Disease.
    J Alzheimers Dis. 2015;47:231-42.
    PubMed     Text format     Abstract available


  974. LIU-SEIFERT H, Siemers E, Price K, Han B, et al
    Cognitive Impairment Precedes and Predicts Functional Impairment in Mild Alzheimer's Disease.
    J Alzheimers Dis. 2015;47:205-14.
    PubMed     Text format     Abstract available


  975. NAKAMAGOE K, Fujimiya S, Koganezawa T, Kadono K, et al
    Vestibular Function Impairment in Alzheimer's Disease.
    J Alzheimers Dis. 2015;47:185-96.
    PubMed     Text format     Abstract available


  976. BUSSE S, Steiner J, Alter J, Dobrowolny H, et al
    Expression of HLA-DR, CD80, and CD86 in Healthy Aging and Alzheimer's Disease.
    J Alzheimers Dis. 2015;47:177-84.
    PubMed     Text format     Abstract available


  977. WANG Q, Jia J, Qin W, Wu L, et al
    A Novel AbetaPP M722K Mutation Affects Amyloid-beta Secretion and Tau Phosphorylation and May Cause Early-Onset Familial Alzheimer's Disease in Chinese Individuals.
    J Alzheimers Dis. 2015;47:157-65.
    PubMed     Text format     Abstract available


  978. WESSON ASHFORD J
    Treatment of Alzheimer's Disease: The Legacy of the Cholinergic Hypothesis, Neuroplasticity, and Future Directions.
    J Alzheimers Dis. 2015;47:149-56.
    PubMed     Text format     Abstract available


  979. WARING JF, Tang Q, Robieson WZ, King DP, et al
    APOE-varepsilon4 Carrier Status and Donepezil Response in Patients with Alzheimer's Disease.
    J Alzheimers Dis. 2015;47:137-48.
    PubMed     Text format     Abstract available


  980. JOHNSON LA, Gamboa A, Vintimilla R, Cheatwood AJ, et al
    Comorbid Depression and Diabetes as a Risk for Mild Cognitive Impairment and Alzheimer's Disease in Elderly Mexican Americans.
    J Alzheimers Dis. 2015;47:129-36.
    PubMed     Text format     Abstract available


  981. RUDNITSKAYA EA, Muraleva NA, Maksimova KY, Kiseleva E, et al
    Melatonin Attenuates Memory Impairment, Amyloid-beta Accumulation, and Neurodegeneration in a Rat Model of Sporadic Alzheimer's Disease.
    J Alzheimers Dis. 2015;47:103-16.
    PubMed     Text format     Abstract available


  982. ATWOOD CS, Bowen RL
    A Unified Hypothesis of Early- and Late-Onset Alzheimer's Disease Pathogenesis.
    J Alzheimers Dis. 2015;47:33-47.
    PubMed     Text format     Abstract available


  983. GROBLEWSKA M, Muszynski P, Wojtulewska-Supron A, Kulczynska-Przybik A, et al
    The Role of Visinin-Like Protein-1 in the Pathophysiology of Alzheimer's Disease.
    J Alzheimers Dis. 2015;47:17-32.
    PubMed     Text format     Abstract available


  984. MOOSAVI B, Mousavi B, Macreadie IG
    Yeast Model of Amyloid-beta and Tau Aggregation in Alzheimer's Disease.
    J Alzheimers Dis. 2015;47:9-16.
    PubMed     Text format     Abstract available


    June 2015

  985. Upcoming Meetings Related to Alzheimer's Disease.
    J Alzheimers Dis. 2015;46:1129-33.
    PubMed     Text format    


  986. GUSTAFSON DR, Clare Morris M, Scarmeas N, Shah RC, et al
    New Perspectives on Alzheimer's Disease and Nutrition.
    J Alzheimers Dis. 2015;46:1111-27.
    PubMed     Text format     Abstract available


  987. JONGBLOED W, van Dijk KD, Mulder SD, van de Berg WD, et al
    Clusterin Levels in Plasma Predict Cognitive Decline and Progression to Alzheimer's Disease.
    J Alzheimers Dis. 2015;46:1103-10.
    PubMed     Text format     Abstract available


  988. BURNHAM SC, Raghavan N, Wilson W, Baker D, et al
    Novel Statistically-Derived Composite Measures for Assessing the Efficacy of Disease-Modifying Therapies in Prodromal Alzheimer's Disease Trials: An AIBL Study.
    J Alzheimers Dis. 2015;46:1079-89.
    PubMed     Text format     Abstract available


  989. WANG H, Tan L, Wang HF, Liu Y, et al
    Magnetic Resonance Spectroscopy in Alzheimer's Disease: Systematic Review and Meta-Analysis.
    J Alzheimers Dis. 2015;46:1049-70.
    PubMed     Text format     Abstract available


  990. ASSELINEAU D, Benlhassan K, Arosio B, Mari D, et al
    Interleukin-10 Production in Response to Amyloid-beta Differs between Slow and Fast Decliners in Patients with Alzheimer's Disease.
    J Alzheimers Dis. 2015;46:837-42.
    PubMed     Text format     Abstract available


  991. KHAN TK, Alkon DL
    Alzheimer's Disease Cerebrospinal Fluid and Neuroimaging Biomarkers: Diagnostic Accuracy and Relationship to Drug Efficacy.
    J Alzheimers Dis. 2015;46:817-36.
    PubMed     Text format     Abstract available



  992. Upcoming Meetings Related to Alzheimer's Disease.
    J Alzheimers Dis. 2015;46:813-6.
    PubMed     Text format    


  993. TEDONE E, Arosio B, Colombo F, Ferri E, et al
    Leukocyte Telomere Length in Alzheimer's Disease Patients with a Different Rate of Progression.
    J Alzheimers Dis. 2015;46:761-9.
    PubMed     Text format     Abstract available


  994. MATSUZONO K, Yamashita T, Ohta Y, Hishikawa N, et al
    Clinical Benefits for Older Alzheimer's Disease Patients: Okayama Late Dementia Study (OLDS).
    J Alzheimers Dis. 2015;46:687-93.
    PubMed     Text format     Abstract available


  995. MOODLEY KK, Perani D, Minati L, Anthony Della Rosa P, et al
    Simultaneous PET-MRI Studies of the Concordance of Atrophy and Hypometabolism in Syndromic Variants of Alzheimer's Disease and Frontotemporal Dementia: An Extended Case Series.
    J Alzheimers Dis. 2015;46:639-53.
    PubMed     Text format     Abstract available


    May 2015

  996. Upcoming Meetings Related to Alzheimer's Disease.
    J Alzheimers Dis. 2015;46:549-52.
    PubMed     Text format    


  997. WANG C, Tan L, Wang HF, Yu WJ, et al
    Common Variants in PLD3 and Correlation to Amyloid-Related Phenotypes in Alzheimer's Disease.
    J Alzheimers Dis. 2015;46:491-5.
    PubMed     Text format     Abstract available


  998. TERNI B, Ferrer I
    Abnormal Expression and Distribution of MMP2 at Initial Stages of Alzheimer's Disease-Related Pathology.
    J Alzheimers Dis. 2015;46:461-9.
    PubMed     Text format     Abstract available



  999. Upcoming Meetings Related to Alzheimer's Disease.
    J Alzheimers Dis. 2015;46:285-7.
    PubMed     Text format    


    April 2015
  1000. WURTMAN RJ
    How Anticholinergic Drugs Might Promote Alzheimer's Disease: More Amyloid-beta and Less Phosphatidylcholine.
    J Alzheimers Dis. 2015;46:983-7.
    PubMed     Text format     Abstract available


    January 2015
  1001. PISTONO A, Jucla M, Barbeau EJ, Saint-Aubert L, et al
    Pauses During Autobiographical Discourse Reflect Episodic Memory Processes in Early Alzheimer's Disease.
    J Alzheimers Dis. 2015.
    PubMed     Text format     Abstract available


  1002. SHAKESPEARE TJ, Yong KX, Foxe D, Hodges J, et al
    Pronounced impairment of everyday skills and self-care in posterior cortical atrophy.
    J Alzheimers Dis. 2015;43:381-4.
    PubMed     Text format     Abstract available


  1003. MADERNA E, Cattaneo C, Cacciatore F, Catania M, et al
    Divergent cognitive status with the same Braak stage of neurofibrillary pathology: does the pattern of amyloid-beta deposits make the difference?
    J Alzheimers Dis. 2015;43:375-9.
    PubMed     Text format     Abstract available


  1004. TUCKER S, Moller C, Tegerstedt K, Lord A, et al
    The murine version of BAN2401 (mAb158) selectively reduces amyloid-beta protofibrils in brain and cerebrospinal fluid of tg-ArcSwe mice.
    J Alzheimers Dis. 2015;43:575-88.
    PubMed     Text format     Abstract available


  1005. SANTANGELO R, Coppi E, Ferrari L, Bernasconi MP, et al
    Cerebrospinal fluid biomarkers can play a pivotal role in the diagnostic work up of primary progressive aphasia.
    J Alzheimers Dis. 2015;43:1429-40.
    PubMed     Text format     Abstract available


  1006. HAGHIGHI M, Smith A, Morgan D, Small B, et al
    Identifying cost-effective predictive rules of amyloid-beta level by integrating neuropsychological tests and plasma-based markers.
    J Alzheimers Dis. 2015;43:1261-70.
    PubMed     Text format     Abstract available


  1007. ASO E, Sanchez-Pla A, Vegas-Lozano E, Maldonado R, et al
    Cannabis-based medicine reduces multiple pathological processes in AbetaPP/PS1 mice.
    J Alzheimers Dis. 2015;43:977-91.
    PubMed     Text format     Abstract available


  1008. GIFFORD KA, Liu D, Damon SM, Chapman WG 4th, et al
    Subjective memory complaint only relates to verbal episodic memory performance in mild cognitive impairment.
    J Alzheimers Dis. 2015;44:309-18.
    PubMed     Text format     Abstract available


  1009. KAWADA H, Blessing K, Kiyota T, Woolman T, et al
    Effects of multifunctional antioxidants on mitochondrial dysfunction and amyloid-beta metal dyshomeostasis.
    J Alzheimers Dis. 2015;44:297-307.
    PubMed     Text format     Abstract available


  1010. JOCHEMSEN HM, van der Flier WM, Ashby EL, Teunissen CE, et al
    Angiotensin-converting enzyme in cerebrospinal fluid and risk of brain atrophy.
    J Alzheimers Dis. 2015;44:153-62.
    PubMed     Text format     Abstract available


  1011. ECKERSTROM C, Olsson E, Klasson N, Berge J, et al
    Multimodal prediction of dementia with up to 10 years follow up: the Gothenburg MCI study.
    J Alzheimers Dis. 2015;44:205-14.
    PubMed     Text format     Abstract available


  1012. SIECZKOWSKI E, Milenkovic I, Venkataramani V, Giera R, et al
    I716F AbetaPP mutation associates with the deposition of oligomeric pyroglutamate amyloid-beta and alpha-synucleinopathy with Lewy bodies.
    J Alzheimers Dis. 2015;44:103-14.
    PubMed     Text format     Abstract available


  1013. ROBB E, Perez K, Hung LW, Masters CL, et al
    High order W02-reactive stable oligomers of amyloid-beta are produced in vivo and in vitro via dialysis and filtration of synthetic amyloid-beta monomer.
    J Alzheimers Dis. 2015;44:69-78.
    PubMed     Text format     Abstract available


  1014. MERRIL CR, Ghanbari HA
    Two hundred issues later: the dream comes true.
    J Alzheimers Dis. 2015;44:727-8.
    PubMed     Text format    


  1015. PERRY G
    Two hundred treasured issues!
    J Alzheimers Dis. 2015;44:725.
    PubMed     Text format    


  1016. BARRETT JP, Minogue AM, Jones RS, Ribeiro C, et al
    Bone marrow-derived macrophages from AbetaPP/PS1 mice are sensitized to the effects of inflammatory stimuli.
    J Alzheimers Dis. 2015;44:949-62.
    PubMed     Text format     Abstract available


  1017. KIM HJ, Im K, Kwon H, Lee JM, et al
    Effects of amyloid and small vessel disease on white matter network disruption.
    J Alzheimers Dis. 2015;44:963-75.
    PubMed     Text format     Abstract available


  1018. PUIG KL, Lutz BM, Urquhart SA, Rebel AA, et al
    Overexpression of mutant amyloid-beta protein precursor and presenilin 1 modulates enteric nervous system.
    J Alzheimers Dis. 2015;44:1263-78.
    PubMed     Text format     Abstract available


  1019. ORDONEZ-GUTIERREZ L, Anton M, Wandosell F
    Peripheral amyloid levels present gender differences associated with aging in AbetaPP/PS1 mice.
    J Alzheimers Dis. 2015;44:1063-8.
    PubMed     Text format     Abstract available


  1020. KOAL T, Klavins K, Seppi D, Kemmler G, et al
    Sphingomyelin SM(d18:1/18:0) is significantly enhanced in cerebrospinal fluid samples dichotomized by pathological amyloid-beta42, tau, and phospho-tau-181 levels.
    J Alzheimers Dis. 2015;44:1193-201.
    PubMed     Text format     Abstract available


  1021. LUNA-MUNOZ J, Perry G, Guevara J
    Raul Mena: 1953-2014.
    J Alzheimers Dis. 2015;45:325-7.
    PubMed     Text format    


  1022. ITO K, Fukuyama H, Senda M, Ishii K, et al
    Prediction of Outcomes in Mild Cognitive Impairment by Using 18F-FDG-PET: A Multicenter Study.
    J Alzheimers Dis. 2015;45:543-52.
    PubMed     Text format     Abstract available


  1023. MEISSNER JN, Bouter Y, Bayer TA
    Neuron Loss and Behavioral Deficits in the TBA42 Mouse Model Expressing N-Truncated Pyroglutamate Amyloid-beta3-42.
    J Alzheimers Dis. 2015;45:471-82.
    PubMed     Text format     Abstract available


  1024. STRUYFS H, Van Broeck B, Timmers M, Fransen E, et al
    Diagnostic Accuracy of Cerebrospinal Fluid Amyloid-beta Isoforms for Early and Differential Dementia Diagnosis.
    J Alzheimers Dis. 2015;45:813-22.
    PubMed     Text format     Abstract available


  1025. PENG L, Yu Y, Liu J, Li S, et al
    The chemerin receptor CMKLR1 is a functional receptor for amyloid-beta peptide.
    J Alzheimers Dis. 2015;43:227-42.
    PubMed     Text format     Abstract available


  1026. UHM KO, Kim MJ, Kawaguchi M, Akatsu H, et al
    ATBF1 is a novel amyloid-beta protein precursor (AbetaPP) binding protein that affects AbetaPP expression.
    J Alzheimers Dis. 2015;43:243-57.
    PubMed     Text format     Abstract available


  1027. LI JG, Pratico D
    High levels of homocysteine results in cerebral amyloid angiopathy in mice.
    J Alzheimers Dis. 2015;43:29-35.
    PubMed     Text format     Abstract available


  1028. GOZES I, Yeheskel A, Pasmanik-Chor M
    Activity-dependent neuroprotective protein (ADNP): a case study for highly conserved chordata-specific genes shaping the brain and mutated in cancer.
    J Alzheimers Dis. 2015;45:57-73.
    PubMed     Text format     Abstract available


  1029. SUN Y, Bresell A, Rantalainen M, Hoglund K, et al
    An Integrated Bioinformatics Approach for Identifying Genetic Markers that Predict Cerebrospinal Fluid Biomarker p-tau181/Abeta1-42 Ratio in ApoE4-Negative Mild Cognitive Impairment Patients.
    J Alzheimers Dis. 2015;45:1061-76.
    PubMed     Text format     Abstract available


  1030. NIEMANTSVERDRIET E, Feyen BF, Le Bastard N, Martin JJ, et al
    Overdiagnosing Vascular Dementia using Structural Brain Imaging for Dementia Work-Up.
    J Alzheimers Dis. 2015;45:1039-43.
    PubMed     Text format     Abstract available


    January 2014
  1031. VANGAVARAGU JR, Valasani KR, Fang D, Williams TD, et al
    Determination of small molecule ABAD inhibitors crossing blood-brain barrier and pharmacokinetics.
    J Alzheimers Dis. 2014;42:333-44.
    PubMed     Text format     Abstract available


  1032. DE BRUIJN RF, Janssen JA, Brugts MP, van Duijn CM, et al
    Insulin-like growth factor-I receptor stimulating activity is associated with dementia.
    J Alzheimers Dis. 2014;42:137-42.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Alzheimer's Disease is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: